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Abstract
Deeper understanding of the embryological origins of tissues and organs is likely to provide
insights into novel clinically relevant preventative and therapeutic strategies. To do so
effectively and at a large scale so as to have clinical significance requires an exhaustive and
meticulously accurate knowledge of normal morphological development and the underlying
molecular pathways.
A variety of lineage tracing and classical molecular biology techniques have led to key
insights but emerging technologies now offer the possibility of more fine grained and precise
measurements at the level of the single cell rather than ensembles of heterogeneous cells. In
this study the rapidly developing technology of single cell RNA sequencing was combined
with the development of state of the art computational methods to study murine gastrulation
and early organogenesis at a hitherto unprecedented granularity.
A comprehensive analysis of FLK1+ cells harvested from gastrulating murine embryos
was performed. In-silico reconstruction of pseudo-temporal and pseudo-spacial relations
were demonstrated. Using prior knowledge of known driver genes deeper substructure
was revealed in clusters that were initially defined by unsupervised algorithms, illustrating
that careful implementation of supervised approaches can outperform naïve unsupervised
methods. In this way multiple members of the leukotriene branch of the arachidonic acid
pathway were found to be enriched within a subset of the endothelial cluster that has a
molecular signature consistent with yolk sac derived definitive wave haematopoiesis. This
was subsequently validated in an in-vitro embryonic stem cell differentiation colony assay.
By developing a novel adaptation to tSNE dimensionality reduction that now allows new data
points to be mapped backed to previously calculated embeddings, the FLK1+ data set became
a reference to which cells from other experiments were mapped. The Tal1-/- knockout mutant
was characterised, reaffirming the known phenotype with complete failure of embryonic
haematopoiesis. Analysing the Tal1-/- endothelial cluster shows definitively in the in-vivo
organism no activation of an alternative cardiac fate programme as was previously postulated
from an in-vitro model system. Additionally tSNE mapped Brachyury cells into the void in
the FLK1+ dataset and identified a node like population.
Loss of spacial context remains an Achilles’ heel of single cell protocols. Generation of
the single cell suspensions leads to disruption of cellular contacts and loss of any spacial
information. A novel method is described which uses tSNE of bulk spacial data to pre-
condition a tSNE map upon which single cells can then be computationally positioned
reconstructing spacial context.
To model gene interactions and perturbations from single-cell data, a hybrid feed-forward
deep neural network was trained on branching pseudo-temporally arranged single cell qPCR
data of in-vivo wild-type murine developmental haematopoiesis. Strikingly despite the model
never having ‘seen’ a mutant, in-silico gene perturbations in the deep neural network are able
to faithfully reproduce the Tal1-/- phenotype.
In summary the use of single cell transcriptomics to probe early murine embryology com-
bined with development of new methods has uncovered a novel pathway in embryonic
haematopoietic development and allowed in-silico reconstruction of a short period of early
embryonic haematopoiesis. Critically these methods have broad application within the fields
of developmental and stem cell biology.
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Chapter 1
Introduction & Aims
1.1 Motivation and Clinical relevance
1.1.1 Congenital Anomalies
Congenital anomalies contribute substantially to the global burden of neonatal morbidity
and mortality. The World Health Organisation(WHO) estimates 276,000 neonatal deaths
per annum from congenital lesions1. Considering that many pregnancies may be non-viable
without specialist antenatal care and even where such specialist care is available parents may
elect for termination this is likely to be an underestimate having not accounted for ‘hidden
mortality’ [Brownlee et al., 2009; Harrison et al., 1978]. Though arguably the aetiology
of structural congenital anomalies for example oesophageal atresia, diaphragmatic hernia,
chest or cardiac lesions and migrational anomalies such as Hirschsprung disease may not be
wholly genetic and have environmental underpinnings, an understanding of normal biological
development is likely to provide informative insights into prevention and treatment.
Recent decades have witnessed significant improvements in neonatal mortality from con-
genital defects but in severe cases, particularly where there is inadequate tissue for surgical
reconstruction to achieve normal anatomy and physiology, morbidity is substantial [Jawaid
et al., 2012, 2013]. For example the palliative Fontan circulation in children with physio-
logically a single ventricle allows for them to survive and to some extent have a relatively
normal lifestyle but these children are chronically hypoxic and exercise tolerance and overall
survival remain limited and sub-optimal. Patients with a variety of other conditions have
similar sub-optimal outcomes including children with short bowel syndrome consequent to
1http://www.who.int/mediacentre/factsheets/fs370/en/
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vanishing gastroschisis, intestinal atresias, malrotation with midgut volvulus or total intestinal
aganglionosis. Current supportive strategies rely on mechanical devices such as ventila-
tors, extra-corporeal membrane oxygenation devices (ECMO), heamofiltration/dialysis or
parenteral alimentation to temporarily or in some cases to provide long-term support for inad-
equate organ function. These devices carry substantial risks, are often unwieldy (fig. 1.1) and
require constant monitoring and adjusting. An example in point is the comparison between
long-term dialysis and kidney transplantation. With the former patients may have to make
regular weekly/bi-weekly visits to their local dialysis centre and be on a strict fluid restriction
protocol, a transplant despite its risks and the need for life-long immunosuppression, can in
such cases be life transforming. Transplantation cannot be offered to all patients in whom it
is indicated because supply of good quality cadaveric organs particularly for paediatric use
where the organ must survive for a lifetime, is severely limited.
Fig. 1.1 Contemporary neonatal intensive supportive care. Showing a neonate with pre-operative
congenital diaphramatic hernia and pulmonary hypertension requiring ventilatory support with inspired
nitric oxide and venous-arterial ECMO for oxygenation and circulatory support. Various infusions
are running for nutrition and to modulate pressures in the systemic and pulmonary circulations to
maintain perfusion, achieve adequate oxygenation and prevent acidosis.
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1.1.2 Non-communicable diseases
Noncommunicable diseases (NCDs) are estimated to account for 38 million deaths/annum
and almost three quarters are reported to occur in middle or low income countries 2. NCDs
include diseases such as obesity, diabetes, ischaemic heart disease and cancer. These
diseases clearly have an environmental basis as reflected by the observation that higher
prevalences of these conditions in developing countries have coincided with increasing
affluence and adoption of high risk behaviours such as tobacco use, alcohol misuse, sedentary
lifestyles and unhealthy diets. But accumulating evidence suggests that the intra-uterine
environment can modulate an individual’s risks for developing such conditions, possibly
through durable epigenetic modifications [Battista et al., 2002; Dabelea et al., 2000, 2008;
Power and Jefferis, 2002; Siklenka et al., 2015; Sun et al., 2013; Yura et al., 2005; Zohdi
et al., 2014]. Furthermore evidence suggests that severely stressful events experienced by
a population, such as famine, can modify risks for complex traits in second generation
offspring, indicating that some epigenetic changes may endure, withstanding the genome
wide chromatin ‘resetting’ imposed upon germ cells and the developing ovum [Kaati et al.,
2002; Radford et al., 2014; Veenendaal et al., 2013].
1.1.3 Developmental Biology
Barring a few notable exceptions for example osteoclasts, giant multinucleated cells, histio-
cytes, germ, muscle and hepatic cells, in general cells have identical genomic (DNA) content
in the same abundance. Germ cells are unique in this context in that meiosis allows genes
to be shuffled between paternal and maternal chromosomes and results in a haploid cell.
Other cells can also shuffle specific portions of their DNA for example B-cells of the immune
system can recombine their so-called V and J regions in the case of light chains and V, D
and J regions for the heavy chains to generate antibodies. V(D)J recombinase, the enzyme
responsible for this is imprecise and can do so in several ways allowing a large repertoire of
B-cell clones to be generated. The clones are subsequently selected for to prevent self-antigen
recognition and autoimmunity, but can recognise a vast variety of invading organisms, viral
antigens displayed on infected cells, cancerous cells and abnormal cells that may have the
potential for malignant transformation.
In general, noting the occasional exception as described above and in the case of mosaicism,
cells in an individual contain identical DNA, generated from a single fertilised ovum, that by
cell divison, symmetric and assymetric establishes a multicellular organism containing in
2http://www.who.int/mediacentre/factsheets/fs355/en/
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many cases hundreds of different cell types precisely organised into functional units. The
process by which multipotent progenitor cells gradually diversify is termed differentiation
and has been described by Waddington as an abstract landscape, along which a cell travels
altering its gene expression programme until it reaches a stable point, notionally synonymous
to its terminally differentiated cell type.
A detailed and comprehensive understanding of developmental biology particularly in humans
has the potential to provide clinically significant insights in to the aetiology and pathogenesis
of not only congenital anomalies but also adult-onset diseases described in section 1.1.2. The
recommendation for folic acid supplementation in women planning a pregnancy to reduce
the risk of spina bifida stands as a paradigm for preventative strategies in birth defects.
Birth defects often co-occur as part of a syndrome or in well described sequences of associated
anomalies. For example oesophageal atresia with or without treacheo-oesophageal fistula co-
occurs with vertebral anomalies, anorectal malformations, cardiac defects, renal anomalies
and limb deformities (VACTERL) more frequently than would be statistically expected.
This is not unique in fact there are many other examples including the CHARGE sequence
(Coloboma, heart defects, anorectal malformations, intellectual disability, genito-urinary
anomalies and ear deformities), Pierre-Robin sequence, velocardial facial syndrome and
various polyploidy syndromes e.g. Down’s syndrome. Despite the cause of Down’s syndrome
(trisomy 21) being known, penetrance of the described defects is highly variable. A lack
of understanding of normal development conceals the underlying mechanisms responsible
for these associations. Some anomalies may not display an immediate clinically evident
phenotype, particularly certain cardiac, renal or spinal cord anomalies therefore screening
in selected groups is indicated as population wide screening is impractical for logistic and
economic reasons. Such screening can enable early initiation of preventative strategies. An
understanding of normal development beyond our current observational approach of described
sequences can help with defining such populations and designing screening protocols.
Accurately defined clinical phenotypes combined with massive parallel sequencing genomic
analysis can provide useful insights into critical genes and signalling pathways involved
in prenatal development, causes of birth defects and reveal potential treatment strategies.
Mosaicism appears to be an important feature in some birth defects, often with mutations
that would be lethal in the non-mosaic state. A mosaic somatic non-synonymous single
nucleotide mutation (c.548G→A, p.Arg183Gln) in GNAQ was found in 23 out of 26 patients
with Sturge-Weber [Shirley et al., 2013], mosaicism with a somatic activating mutation
(c.49G→A, p.Glu17Lys) in the oncogene AKT1 was found in 26 out of 29 patients with
Proteus syndrome [Lindhurst et al., 2011] and all 6 patients with CLOVES sequence were
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found to be mosaic for activating mutations in PIK3CA [Kurek et al., 2012]. Levels of
mosaicism varied between tissues but mutant allele frequency in affected tissues varied from
1 to 18% for GNAQ, 1 to 50% for AKT1 and 8 to 30% for PIK3CA. Lindhurst et al. [2011]
found individuals usually had the same mutant allele in all affected tissues even those from
different germ layers suggesting that the mutation occurred early in development to effect
several cell lineages. Notably these findings suggest molecular pathways that may provide
‘drugable’ therapeutic targets.
A knowledge of normal development can clearly influence clinical decision but the examples
above suggest also that the reverse is true: clinical findings can reveal potentially useful
insights into normal human development. In fact for understanding normal human devel-
opment we often have to work in reverse by describing a phenotype and finding a cause as
opposed to perturbing normal development and then observing the resultant phenotype. New
technologies such as massive parallel sequencing now offer powerful tools to work in either
direction.
Normal development in complex organisms especially mammals is extremely challenging
to understand due to the diversity of cell types, complexity and redundancies in signalling
cascades and the complicated morphogenetic movements that can lead to a cell migrating
and being subject to not only alternate paracrine morphogen gradients but also alterations in
direct cell to cell signalling. Combining this with the difficulties in real-time observation of
development in placental eutherians much work has been done on alternate model organisms
such as Drosophila melanogaster, Xenopus, Danio rerio and Caenorhabditis elegans.
1.1.4 Stem Cell Biology
The diverse cell types in complex multicellular organisms arise not from differences in
genomic material between the cell types nor do cells, in general, gradually lose genomic
information critical to normal development as they specialise through differentiation, this was
elegantly demonstrated in Xenopus laevis by Gurdon et al. [1975]. This is neither specific to
the organism nor cell type as has been confirmed in more contemporary experiments where
cloned mammals have been produced by nuclear transfer from a variety of differentiated
cells into enucleated eggs [Campbell et al., 1996; Cibelli, 2007; Hochedlinger and Jaenisch,
2002; Wakayama et al., 1998].
These observations revealed that the nuclear chromatin of terminally differentiated cells
has the plasticity to be re-organised so that it could re-run the developmental programme.
Takahashi and Yamanaka [2006] went further and showed that by over-expressing the four
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transcription factors, Oct3/4, Sox2, c-Myc and Klf4 in murine adult fibroblasts, they were able
to generate induced pluripotent cells (iPS) capable of producing teratomas in immunodeficient
mice and of contributing to all tissues of the developing mouse when injected into blastocysts.
These cells behaved like embryonic stem cells and showed that it was not necessary to hijack
the machinery and cytoplasm from an ovum to ‘reprogramme’ the nucleus of a terminally
differentiated fibroblast.
In recent years it has become clear that ‘human embryonic stem cells’ and murine embryonic
stem cells (ESCs) exist in divergent states of pluripotency [Brons et al., 2007; Nichols
and Smith, 2011]. Human ESCs appear to behave more like murine epiblast stem cells
(EpiSCs). It is difficult to expand them from a single clone and mouse EpiSCs, derived
from the post-implantation epiblast using protocols similar to those used to generate human
ESCs, do not readily contribute to chimaeras. In contrast, mouse ESCs can contribute to all
cell lineages including the germ line and are therefore defined as being in a state of naïve
pluripotency. An important feature of these naïve pluripotent cells is to contibute to tissues of
all three germ layers and to form teratomas, tumours containing disordered tissues from all
three germ layers i.e. ectoderm, endoderm and mesoderm. In fact sacrococcygeal teratomas,
tumours with varying malignant potential that can be diagnosed on antenatal sonography are
hypothesized to arise from persistent epiblast cells that failed to correctly migrate through
the primitive streak at gastrulation [Fadler and Askin, 2008; Moore et al., 2015; Solari et al.,
2011].
The discovery of iPS cells has given a significant boost to the field of regenerative medicine.
The immune system will reject any implant detected as foreign leading to not only failure
and necrosis of the implanted tissue but also in some cases a severe systemic response.
Availability of iPS cells potentially opens the possibility of generating replacement tissues
genetically identical to the host, abrogating the risk of rejection, the need for pharmaceutical
immunosuppression, the risks of live organ donation and associated ethical concerns and the
shortage of cadaveric organs as discussed earlier in section 1.1.1.
Other types of stem cells for example mesenchymal stem cells have been used in clinical
practice. Macchiarini et al. [2008] seeded a de-cellularised cadaveric trachea with epithelial
cells and mesenchymal stem cell derived chondrocytes and transplanted the trachea into
a 30 year old patient with bronchomalacia. They reported the graft remained patent, well
vascularised and completely epithelialised with normal ciliary function and mucous clearance
at 12 months [Gonfiotti et al., 2014]. Since then, there has been concern with regard to the
veracity of the claims and the lead author has been accused of scientific misconduct [Vogel,
2015].
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More significantly a 70 year Japanese woman has had an autologous iPS cell derived sheet
of retinal pigment epithelium transplanted into the eye for age-related macular degeneration
[Cyranoski, 2014]. Despite the environment within the eye enjoying immune privilege,
transplantation can activate microglia and the use of autologous cells may improve graft
survival [Xian and Huang, 2015]. Potentially more practical and useful in the near future
is the use of iPS cells to model disease and test effects both desirable and undesirable of
pharmaceuticals, in vitro.
The application of these techniques requires a good working knowledge of normal devel-
opment to produce the correct cell types, in the required proportions and with the desired
structural and spatial configuration. Pluripotent cells (iPSCs and ESCs) are maintained and
expanded under specific culture conditions to maintain the pluripotent state and prevent
differentiation, the process by which cells become increasingly fate restricted and eventually
adopt a mature stable functional state. Directing differentiation of iPS cells into mature
functional cells of the required type efficiently, without contamination from other cell types is
challenging but understanding normal development can potentially provide valuable insights.
1.2 Embryology - A brief overview
This overview of embryonic development focuses in most part on mouse embryology.
1.2.1 Pre-implantation
Fertilisation triggers a cascade of events that subject to error free progression, result in the
birth of an offspring. The successful haploid spermatazoon will have undergone capacitation
to pass through the corona radiata, acrosomal activation to penetrate the zona pellucida and
and fusion with the oocyte to eventually release its pronucleus into the ova’s cytoplasm. The
ova responds by releasing cortical lysosomal enzymes making its cell membrane impenetrable
to other sperm and altering the structure and composition of the zona pellucida to prevent
multiple sperm binding and penetration. The ovum will resume the second meitoic division
producing the second polar body and the definitive oocyte containing the female pronucleus.
There is metabolic reactivation, both pronuclei duplicate their DNA and become organised
on the spindle to undergo normal mitotic division resulting in two diploid cells with the
requisite set of chromosomes, at about 1 day post conception (E1.53).
3E1.5 is notation for embryonic day 1.5, 1.5 days since ovulation
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The two-cell zygote undergoes multiple rounds of mitosis confined within the zona pellucida,
increasing in cell number but each cell reducing in size with every cleavage. These cells
now called blastomeres, are loosely clumped until the eight-cell stage (3rd cleavage, E2.5)
when they undergo compaction by maximising their contact with neighbours and forming
tight junctions. Compaction segregates the cells into an inner group, the inner cell mass,
communicating extensively by gap junctions and an outer group. The inner cells will go
on to form the embryo proper while the outer cells generate the trophoblast, which forms
the placenta. Around E3.0, the cells divide once again to from the 16-cell morula and cells
of the trophoblast secret fluid into intercellular spaces between the inner cells. During a
process termed cavitation the fluid coalesces into a single cavity, the blastocele, marking the
the transition of the morula to a blastocyst at about E4.0. The blastocyst hatches from the
zona pellucida ready for implantation into the prepared endometrium lining the uterine cavity
(fig. 1.2). The inner cell mass becomes organised into two readily identifiable epithelial
layers, the epiblast dorsally and the hypoblast4 ventrally. Pre-implantation development of
the embryo is summarised in fig. 1.3.
Fig. 1.2 Mouse blastocyst hatching from zona pellucida [Valley et al., 2010].
1.2.2 Post-implantation
Development continues post implantation as the polar trophectoderm, the epiblast and the
primitive endoderm continue to proliferate. By E.5 a proamniotic cavity develops within the
epiblast, a similar cavity develops within the extraembryonic ectoderm and the two fuse. At
around the same time the proximal region of the extraembryonic ectoderm gives rise to the
ectoplacental cone, which rapidly divides and contributes to the placenta.
The characteristic egg cylinder with the inverted germ layers is peculiar to rodent develop-
ment. The early rodent embryo macroscopically appears to be drastically different from
equivalent stage embryonic development in humans and other model organisms but crucially
important structural relations are preserved.
4Also known as the primitive endoderm and will go on to from the yolk sac
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Fig. 1.3 Pre-implantation murine embryo. http://stemcells.nih.gov/info/scireport/pages/
appendixA.aspx
Primitive endoderm segregates into the visceral endoderm lining the ventral surface of the
epiblast and the parietal endoderm lining the opposing surface of the blastocele, leading to
the formation of Reichert’s membrane (equivalent to Heuser’s membrane in humans) between
the parietal endoderm and the trophoblast.
Despite minimal contribution to the embryo proper, the primitive endoderm and extraem-
bryonic ectoderm are instrumental in orchestrating embryo patterning e.g. anterior-posterior
(AP) axis specification in the epiblast. The distal visceral endoderm (DVE) characterised
by Lefty1+ Gata6+ cells appears in the distal pole of the egg cylinder. The DVE migrates
anteriorly and cells of the anterior visceral endoderm, distinct from cells of the DVE develop
and move anteriorly along the midline [Takaoka et al., 2011]. Both the AVE and DVE
produce Lefty1 and Cer1 to antagonise posteriorising signals mediated by Nodal, Gdf3 and
Cripto, induced in the epiblast by the convertase enzymes Furin and Pcsk6 produced in the
extraembryonic ectoderm. This inhibition from the AVE restricts the development of the
primitive streak to the posterior of the embryo, which marks the onset of the mass migration
of the epiblast in a process called gastrulation setting the blue print for further development.
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Gastrulation is a fundamental process in the post-implantation mammalian embryo that
lays out the body plan and by which the early embryo is transformed from a bilaminar to
a trilaminar structure. In the E6.5 mouse embryo, onset of gastrulation is marked by the
appearance of the primitive streak at the posterior extreme of the epiblast juxtaposed to the
embryonic-extraembryonic junction fig. 1.4. Generation of the primitive streak is induced
by Bmp4 secreted by the extraembryonic ectoderm activating Wnt3 regulatory pathways
which in turn activates expression of the canonical mesoderm marker Brachyury(T). Epiblast
cells adjacent to the nascent streak undergo epithelial to mesenchymal transition (EMT),
some migrate between the epiblast and the visceral layer of the primitive endoderm, forming
embryonic mesoderm and others intercalate displacing the primitive endoderm laterally and
forming the definitive endoderm. Not only are all three canonical germ layers generated from
the epiblast but it also contributes cells to extraembryonic mesoderm including the yolk sac
and amniotic ectoderm.
Fig. 1.4 Mid-sagittal sections through egg cylinders between E6.5 and E8.0. At E6.5 the
anterior-posterior axis of the embryo has been determined. The primitive streak appears
at the posterior extreme of the embryo at the junction with the extraembryonic ectoderm.
The visceral endoderm is shown in green lining the ectoderm, the parietal endoderm and
Reichert’s membrane are not shown. The earliest cells to ingress through the primitive streak
are extraembronic mesoderm of the yolk sac. The amniotic cavity begins to form in the
extraembryonic mesoderm forming an eccentric doughnut which finally fuses forming the
amniotic cavity. The amniotic ectoderm is not shown. At the E8.0 stage the allantois is
clearly visible at the posterior end of the embryo and blood islands can be seen in the yolk
sac.
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EMT is the process by which cells at the streak lose cohesion with their epiblast neighbours
and display a more fluid like behaviour to ingress into the potential space between the epiblast
and hypoblast. Fgf signalling plays a central role in EMT, Ciruna and Rossant [2001]
demonstrated that in Fgfr1-/- mutants epiblast cells fail to undergo EMT. At gastrulation
in the primitive streak Fgfr1 coordinates EMT and mesoderm morphogenesis through up-
regulation of Snai1 and down-regulation of E-cad a key component for maintaining cohesion
in epithelia.
As gastrulation progresses the primitive streak extends anteriorly in the midline. Embryonic
and extraembryonic mesoderm migrates around the ‘rim’ of the egg cylinder analagous
to the annular movements observed in species where the germinal layers maintain a disc
shape rather than a ‘cup’. As the extraembryonic mesodermal layer thickens greater in
the posterior a doughnut shaped ring develops with an eccentric aperture and within the
extraembryonic mesoderm the amniotic cavity develops as a ring, fig. 1.4. Eventually the
aperture located eccentrically to the anterior closes forming the amniotic cavity, lined by the
amniotic ectoderm derived from the epiblast. Concurrently the allantois develops in from
the posterior mesoderm into the amniotic cavity and will eventually communicate directly
with the trophectoderm. The blood vessels will form the umbilical vessels and the proximal
intra-embryonic part of the allantois communicates with the developing bladder. In humans
the remnant of this is clearly visible on the interior surface of the anterior abdominal wall
as the median umbilical ligament. On occasions this either does not completely regress
and postnatally a patent urachus communicates with the anterior abdominal wall or it only
partially regresses so that cystic remnants that communicate with the bladder remain and
these urachal cysts have a propensity to get infected.
The intraembryonic mesoderm becomes organised, sandwiched between the developing
ectoderm and endoderm. Centrally the axial mesoderm forms the notochord ventral to the
developing neural tube. Immediately lateral is the paraxial mesoderm, further laterally
the intermediate mesoderm and then the lateral plate mesoderm which is divided by the
intraembryonic coelom into splanchnic and somatic mesoderm.
The mesoderm will also undergo segmentation in the anterior-posterior axis, forming anteri-
orly the pharyngeal arches (from the head mesoderm) and more caudally the somites will
eventually form from the paraxial mesoderm. At E9.5 after turning, the process by which the
inverted embryo ‘flips’ inside-out, the pharyngeal arches, ventral to the developing hindbrain
and caudal to the maxillary arch and stomodeum, will be clearly evident. Each pharyngeal
arch receives contibutions from the neural crest and contains cartilaginous, neural and arterial
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components supported by a mesodermal core derived from paraxial and splanchnic lateral
plate mesoderm.
This completes the discussion for the early period of embryological development concerned
with this current project. Specifics of cardiovascular and haematopoietic ontogeny will now
be described very briefly.
1.2.3 Embryology of Cardiac Development
The developing embryo soon outgrows the ability of diffusion alone to provide adequate
oxygen and nutrient delivery. This remains highly problematic for those attempting to grow
organs for the purposes of regenerative medicine but evolution has solved this restriction
with the development of the cardiovascular and haematopoietic systems.
The heart develops from two separate mesodermal populations, the first (FHF) and second
heart fields (SHF). FHF cells, derived from the lateral splanchnic mesoderm differentiate
earlier than the SHF and predominantly populate the left ventricle. In contrast, SHF cells
though contiguous with FHF cells are more medial and in fact are a subset of the pharyngeal
mesoderm. Pharyngeal mesoderm itself is a subset of head mesoderm as described above and
undergoes gastrulation prior to trunk mesoderm. Furthermore the paraxial and lateral plate
mesoderm merge to produce the mesodermal core of the prospective pharyngeal arches. As
the heart tube loops the SHF cells contribute to the outflow tract, atria and the right ventricle.
It has been suggested that both FHF and SHF originate from a common progenitor and
Mesp1 is the earliest known marker of cardiac progenitors [Lescroart et al., 2014; Saga
et al., 1999]. The timing of lineage bifurcation is not known but Lescroart et al. [2014]
have suggested a revised model of specification for cardiac progenitors. They propose that
two temporally distinct populations of cells express Mesp1 independently and are therefore
lineage segregated prior to Mesp1 expression. Moreover utilising a formal statistical analytic
strategy combined with single cell labelling they were able to show that FHF progenitors are
unipotent and that SHF progenitors in contrast may be unipotent or bipotent, fig. 1.5.
Epiblast cells adjacent to the primitive streak lose E-cad adhesion, undergo EMT and give
rise to nascent E-cad- mesoderm which is multipotent and can differentiate to generate blood,
endothelium, smooth muscle cells and cardiomyoctes, fig. 1.6. The FHF and SHF clearly
have a common progenitor but no marker of this population has been found to date.
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Fig. 1.5 From Lescroart et al. [2014]. Summarises their revised model. Unipotent FHF
Mesp1+ cells can generate either CMs or ECs (red). SHF Mesp1+ cells in contrast can be
unipotent or bipotent (green). CM - cardiomyocyte, EPDC - epicardial derived cell, EC -
endothelial cell, SMC - Smooth muscle cell.
1.2.4 Developmental Haematology
Haematopoiesis is critical to the developing embryo and defects are lethal. The first blood
cells originate from the blood islands of the yolk sac alongside organised endothelial struc-
tures at∼ E7.5, fig. 1.4. The primitive erythrocytes produced at this stage express an alternate
β -chain of haemaglobin the βH1 with an altered oxygen binding curve compared to adult
haemaglobin, to allow for oxygen transport at lower partial pressures in the embryo. Later
the definitive yolk sac phase also produces myeloid cells and Lyve1 has been proposed as
a marker of multipotent progenitors in the yolk sac that can produce cells of the myeloid
lineage.
Production subsequently moves to the aorta-gonadal-mesonephros region (AGM) and the
haemogenic endothelium in the dorsal aorta from where definitive heamatopoietic stem cells
(HSCs) are generated and populate the foetal liver, spleen and eventually the late foetal and
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Fig. 1.6 Schematic of putative in-vivo bifurcation points in a developmental hierarchy of
nascent mesoderm to haematopoietic, endothelial, smooth muscle and cardiac cells. The
existence of an in-vivo haemangioblast as shown in this figure is controversial and the theory
that blood cells are derived from haemogenic endothelium is now gaining traction.
postnatal bone marrow, fig. 1.7 [Ciau-Uitz et al., 2014; Dzierzak and Medvinsky, 1995;
Medvinsky et al., 2011].
From E7.0 onwards in mouse all haematopoietic potential is confined to the FLK1+ and
RUNX1+ mesoderm populations [Shalaby et al., 1997]. All haematogenic cells can therefore
be separated from the remaining mesoderm using flow cytometry gating for FLK1+ and
RUNX1+.
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Fig. 1.7 The three distinct waves of haematopoeisis in mouse. YS, yolk sac; Ery, erythroid;
Myel, myeloid; EMPs, erythromyeloid progenitors; FL, foetal liver; BM, bone marrow.
Modified from Ciau-Uitz et al. [2014]
1.3 Experimental approaches in embryology
The development of the early microscope has been instrumental for scientific study in many
fields of biology, in particular experimental embryology allowing it to move beyond its
theological foundations. Charles Otis Whitman was amongst the earliest to generate a fate
map by observing early leech embryos and describing the emergence of the germ layer from
the 8-cell stage [Whitman, 1887]. Advances in imaging combined with novel methods of
disrupting developmental processes and labelling individual cells and their progeny have
led to progressively more detailed observations of normal and abnormal development in
increasingly complex organisms. Clinical observations of human congenital abnormalities
and correlation with known embryology provide additional insights into their aetiology and
pathophysiology.
1.3.1 Model organisms
Model organisms have been adopted to reveal overarching themes and concepts common to
many organisms for example gastrulation. This process by which the two primitive germ
layers generate the three definitive germ layers has garnered much research attention due to
its ubiquity albeit with some differences amongst complex multicellular organisms.
Research has often focused on species such as Danio rerio, Caenorhabditis elegans, Xenopus
laevis and Xenopus tropicalis due to their small size and the transparent nature of their
embryos allowing longitudinal time lapse imaging [Vogt, 1929]. Other organisms such as
chick and quail though not transparent in their natural form are not confined to a uterus and
simple experimental techniques can allow them to be cultured either ex-vivo and again imaged
longitudinally for significant parts of development [Dieterlen-Lievre, 1975; Le Douarin, 1969,
1973; Rawles, 1948].
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The additional advantage that embryonic cells from quail (Coturnix coturnix japonica) can
be transplanted into chick (Gallus gallus) embryos and distinguished from one another based
on their chromatin patterns and Feulgen staining was recognised and exploited by Le Douarin
[1969]. Later Le Douarin and Teillet [1973] using isotropic, isochronic transplant of quail
neural tube and neural crest into chick host experiments show that neural crest between the
1st and 7th somites prior to the 13th somite embryo stage colonise the chick gut along its total
length while cells caudal to the 28th somite, additionally provide some contribution to the
post-umbilical gastrointestinal tract. These fate mapping experiments led to key observations
on the development origins of ganglion cells which allow normal co-ordination of bowel
peristalsis and their absence is pathogonomic of Hirschsprung disease.
1.3.2 Reconstructing developmental lineage trees
Establishing lineage relationships between cells in an adult organism can uncover their
ontogenic journeys possibly revealing key molecular pathways responsible for fate decisions.
Evolutionary conservation of multicellular organism development allows insights gained from
other organisms to be cautiously applied to human embryology. Experimental techniques
include prospective and retrospective lineage tracing.
Prospective lineage tracing
Prospective methods in some cases also known as forward genetic, encompass techniques
that apply some relatively indelible mark to a single cell or a clearly defined set of cells of
interest at an early time point in an organism and then carefully examine their progeny at a
later point in development.
The earliest methods involved solely detailed direct observation with an early example
in leech [Whitman, 1887] and nearly a century later using a Nomarski microscope, the
complete description of the lineage tree of Caenorhabditis elegans by Sulston et al. [1983].
Vital dyes, stains that mark cells without killing them, can either mark the cell membrane,
cytoplasm or nucleus. Vogt [1929] an early pioneer implanted tiny agar chips of Nile Blue, a
water-soluble dye, over cells of interest and labelled different regions of the 32 cell Xenopus
blastula. Water soluble dyes though can diffuse and inadvertently mark nearby cells making
it difficult to draw conclusions about lineages. Alternatives such as carbocyanine dyes and
high molecular weight dextrans mitigate risks of diffusion but are technically more difficult
to apply, requiring injection into cells of interest. The aforementioned techniques all suffer
from the limitation that they are diluted at each cell division and can become undetectable in
highly proliferative cells.
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Transplantation of embryonic regions from pigmented strains into unpigmented strains
of chicken confirmed that, as had already been shown in amphibians, pigmented cells
were ontogenically derived from the neural crest [Rawles, 1948]. These transplantation
experiments as with quail chick experiments described previously are technically highly
demanding. Unlike lineage tracing using dyes there is no dilutional effect with transplantation
but it does require the investigator to show to a certain degree that the behaviour of the
engrafted cells is identical or at least similar to that of native cells. Cell behaviour when
transplanted may be very different from that in the steady state and what is being assayed is
cell fate potential within the transplanted tissue microenvironment rather than the fate of the
cell within an otherwise undisturbed system [Hsu, 2015].
Genetic labelling of native cells as with transplantation leaves indelible marks that are not
prone to dilution with proliferation and all progeny of a founder cell(s) will be marked.
Recombinant DNA technologies using retroviral libraries with sparse infection strategies
can incorporate a reporter gene such as β -galactosidase or green fluorescent protein along
with barcodes and allow lineage tracing. These cells are otherwise genetically identical and
though these exogenous sequences are integrated randomly and can potentially interfere
with development they are much more similar and have greater fidelity than xenotransplants.
These methods can be used in ex-vivo systems such as organotypic slice cultures or progenitor
cultures [Woodworth et al., 2017]. Combining retroviral infections with transgenic lines
expressing virus receptors only within specific cells can allow lineage tracing to be restricted
to cells of interest.
An alternative method of inserting foreign genetic material into native cells is the use of
transposons but they do not incorporate into the cells genome and again suffer from dilution
at every generation. To overcome this limitation dual plasmids can be transfected, a donor
plasmid containing the transgene of interest the researcher wishes to incorporate into the
genome and a helper plasmid containing the transposase [Wu et al., 2006]. In cells that are
transfected by both plasmids through either lipofection or electroporation, the transposase
allows the transgene flanked by terminal repeats to be stably but randomly integrated into
the genome. The transgene will then be propagated to all the cell’s progeny while the helper
plasmid with the transposase will be gradually diluted out.
Advances in genetic engineering technologies permit conditional genetic recombination in
a cell specific or tissue specific manner. Two such technologies are the Cre-loxP and the
FLP-FRT systems. Taking the Cre-loxP system as an example a mouse line expressing Cre
recombinase under the control of some cell-specific promoter may be crossed with a reporter
line that has a stop codon flanked on either side by loxP sites, followed by a reporter gene
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such as GFP knocked into a ubiquitously expressed locus such as the Rosa26. In the embryos
from the cross all cells in which the particular promoter is active will express Cre that will
excise the stop codon and the cells and their progeny will be marked by expression of the
reporter gene.
Though specific to only cells that express a particular gene there is no temporal restriction
as a gene may be expressed in the same lineage at different developmental time points. To
achieve temporal control an inducible Cre such as CreERT2 may be used that is expressed
under the control of the promoter of interest but further requires administration of Tamoxifen
(an oestrogen analogue) to allow it to translocate to the nucleus, remove the stop codon
flanked by loxP sequences and constituitively express the reporter. A further advantage is
that by administering low doses of Tamoxifen cells of interest may be labelled sparsely so
that a less than specific promoter may be used where a specific promoter line has either not
been generated or no promoter with the required specificity has been recognised.
Occasionally a cell type of interest will have the unique characteristic of two active promoters,
while each promoter alone may be non-specific. In this case a dual system either adopting
both the Cre-loxP and the FLP-FRT systems together or a split Cre may be used.
In the first instance the Flippase may be under the control of one promoter with a second
promoter driving Cre expression but with an upstream stop codon flanked by FRT . The
Cre would then remove a stop codon upstream of a reporter under control of a ubiquitously
active promoter [Hsu, 2015]. In this way both promoters must be activated in the same cell
or related cell concurrently or in sequence. A possible pitfall with this system is if a cell
activates the first promoter but not the second and one of it’s progeny then later activates the
second promoter then even with the first promoter inactivate the system will allow this cell
and all its progeny to misleadingly express the reporter gene.
In the second instance each of the two promoters will control the expression of either the
N-terminus of Cre (NH2-Cre) or the C-terminus of Cre (Cre-COOH). Each fragment is
inactive but spontaneous association of the two fragments generates the active Cre. This
spontaneous association has low efficiency and an alternative version uses an intein peptide
which enhances joining of the two fragments while is itself excised in a process that has been
termed protein splicing [Anraku et al., 2008; Casanova et al., 2003; Wang et al., 2012].
The same Cre-loxP technology can be used with either incompatible flox sites or multiple
fluorescent proteins to generate variable random recombinations. These allow cells to
randomly express some combination of fluorescent proteins. Two such technologies include
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the brainbow and confetti mice lineages and have been used to study neural and adult
gastrointestinal lineages [Livet et al., 2007; Snippert et al., 2010].
Retrospective lineage tracing
Methods taking advantage of naturally occurring somatic mutations are a relatively recent
innovation and depend on recognising the mutations that are shared between different cells
in the developed organism and then generating a relatedness tree of the cells of interest based
on maximal parsimony. There exist different genetic variants including retrotransposons,
copy number variants (CNVs), single nucleotide variants (SNVs) and microsatellite (short
tandem repeats, STRs) variants.
Retrotransposons can be grouped into two main categories long terminal repeats (LTR) and
non-LTR retrotransposons. The LTR retrotransposons are remnants of ancient retroviruses
that have incorporated into the human germline [Faulkner and Billon, 2018]. Non-LTR
retrotransposons are sub-categorised into those that can mobilise autonomously and those
that require other retrotransposons for activity. The long interspersed element 1 (LINE-1) are
the only autonomous non-LTR retrotransposons recognised in humans and are considered to
be the most active transposable elements. These have been particularly extensively studied
in the brain and it has been proposed that they are de-repressed in somatic cells and remain
active even in post-mitotic cells [Bodea et al., 2018; Faulkner and Billon, 2018].
Subchromosomal CNVs are a type of structural variant that are common in the human
genome, they have been recognised to occur in somatic tissues and a small fraction are shared
between cells indicating a common developmental ancestry and suggesting a further method
of constructing lineage trees [Cai et al., 2014; Zarrei et al., 2015]. Several mechanisms have
been postulated to give rise to CNVs and these mechanisms can be broadly classified into
homologous or non-homologous recombinations. Homologous recombination events occur
during meiosis due to mis-alignment of homologous chromosomes. Many non-homologous
mechanisms have been suggested including polymerase slippage, non-homologous or micro-
homology end-joining and break-fusion-bridge cycles.
SNVs are differences of individual bases on both strands at specific loci within the genome.
Germ line SNVs are recognised to be major sources of disease causing variants and evolu-
tionary mutations. SNVs can build up in cells during development so that a cell with an
established SNV relative to the germ line genome will pass it on to all it’s progeny providing
an almost indelible marker. Studies that have studied somatic SNVs describe differing
frequencies from 100 to 1000 SNVs per cell [Behjati et al., 2014; Hazen et al., 2016; Lodato
et al., 2015].
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Microsatellite variants are some of the most frequent somatic variants and are tandem repeats
of short nucleotide sequences. Microsatellite loci represent regions of the genome that
are highly prone to mutation in particular the number of tandem repeats. The extent of
polymorphism between individuals at these loci is high and it has been postulated that even
within a single organism somatic microsatellite variants can reconstruct its complete lineage
tree [Frumkin et al., 2005; Takezaki and Nei, 2009].
Single cells contain only 6 pg to 7 pg of genomic DNA and whole genome amplification can
allow genome wide identification of microsatellites (STRs) and CNVs [Vander Plaetsen et al.,
2017]. Alternatively, more focused analysis specifically on a set of 81 microsatellite loci in
mis-match repair deficient mice has allowed oocyte lineage to be resolved from bone marrow
and ovarian cumulus cells [Reizel et al., 2012].
Lineage tracing experiments have been classified into prospective and retrospective but
hybrid combination of these strategies exist that utilise in vivo gene editing combined with
single cell genome sequencing. The CRISPR/Cas9 system has been exploited in several
technologies including GESTALT [McKenna et al., 2016], scartrace [Junker et al., 2016] and
others [Kester and Oudenaarden, 2018].
1.4 Single cell methods
Some of the methods described previously are single cell but lack high throughput in that
they can only analyse at most a handful of genes within a confined region and these are
mostly microscopy based. In simple organisms prospective methods can be used to visualise
and document changes as they occur while in more complex organisms such as placentals
only retrospective methods may be effectively utilised.
Higher throughput methods exist but are limited by resolution and have in the past been
assays that require large numbers of cells to provide an adequate signal. These have included
microarrays and bulk mRNA capture and sequencing methods. As techniques have become
more refined assays have been developed that can use diminishing amounts of starting
material. Earlier methods include qPCR in large numbers of single cells and measuring
multiple genes but these have become quickly superseded by more advanced methods that
are high throughput in cell number and being genome wide assays precluding the need to
select genes of interest.
The idea of single cell resolved assays is highly powerful. As demonstrated in fig. 1.8
analysing cells in a bulk assay leads to an average measurement across multiple cells that is
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impossible to deconvolute. An experimental intervention may make striking alterations to
the signal from a rare cell type but this may never be discovered from a bulk assay due to the
signal being swamped by lack of effect in the majority of cells sampled. The only way to
overcome this would be to have some way of purifying the cells of interest and performing
the intervention specifically on the selected pool but such prolonged processing carries risk
of altering the cells RNA expression patterns. Single cell methods on the other hand can
allow characterisation of individual cells and post-hoc assignment of an effect to specific cell
types.
Fig. 1.8 Figure demonstrates the averaging effect of bulk sequencing as compared to single
cell methods which can resolve the expression pattern of individual cells from which bulk
data can be reconstructed. In contrast there is no practical way of inferring single cell
expression patterns from bulk data.
1.5 Aims
The development of new technologies allowing application of ‘-omics’ methods to single-
cells paves the way to understanding cell biology at much higher resolutions than previously
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possible. One application is in elucidating the journey of a progenitor cell(s) as it becomes
sequentially fate restricted until it finally reaches its destination cell type. Despite the
advances in technology it is not possible to follow this journey across multiple genes/proteins
over time in-vivo. Our technique sacrifices cells at various time points and we aim to
computationally reconstruct this journey using tools currently available.
The overarching theme of this body of work is to develop methods to reconstruct ordered
ontogenic trajectories through sequentially sampled cross-sectional data. The main focus here
being using single-cell resolved, transcriptomic data collected during early mouse embryonic
development. Where available this has been supplemented with limited, hand selected cell
surface proteomic measurements.
The aims are summarised in fig. 1.9 and are:
1. Identify cell populations
2. Trace biologically plausible trajectories
3. Identify novel molecular pathways
4. Develop models that can faithfully simulate cell progression along trajectories
This method of lineage reconstruction best fits with retrospective lineage tracing. Dependent
on the cell phenotype a subset of the exome will be sequenced but the sequence and the
genome itself has not been used for lineage reconstruction. Instead lineages are traced based
on the assumption that within a window of developmental time, cells with the most similar
transcriptional signatures are related by lineage.
Pre-existing state of the art methods will be combined with novel computational methods
and are described in the subsequent chapters. The first results chapter describes data from
single cells harvested from mouse embryos at the gastrulation phase processed using the
Smart-Seq2 protocol. The second chapter focuses on a later stage of development, early
organogenesis, uses a higher throughput microfluidics commercial system 10x Genomics®
Chromium™ to generate the dataset. Established and novel techniques are used to explore
the data and uncover novel insights. The final results chapter describes and provides the
mathematical and computational background for the novel methods that have been used in
previous chapters and also focuses more on studying models that can simulate developmental
trajectories.
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Fig. 1.9 Graphical summary of the overarching aims of this thesis
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Chapter 2
Methods
2.1 Mouse work
All procedures were performed in strict adherence to United Kingdom Home Office regula-
tions (project licence 70/8406) [Scialdone et al., 2016].
For the gastrulation project (chapter 3) dissections were chiefly performed by Dr Yosuke
Tanaka. Timed matings were set up between CD1 mice preferentially selected because they
produce large litters. Embryos were staged according to the morphological criteria of Downs
and Davies and classified broadly as early gastrulation, primitive streak, neural plate or head
fold stage [Downs and Davies, 1993].
Mice were mated at the biomedical campus mouse facility and time of conception was
assumed to be midnight on the day of plugging. Dams were sacrificed at the designated time
points E6.5 (early gastrulation), E7.0 (primitive streak), E7.5 (neural plate) and E7.75 (head
fold) and uteri harvested into ice cold PBS.
For the 10x Genomics® Chromium™ single cell experiments later stage embryos at E8.25
were harvested to span a period beyond gastrulation that incorporates early organogenesis. 2
matings (B6CBAF1/J x B6CBAF1/J) were setup but only one was productive, generating 7
E8.25 embryos. The B6CBAF1/J mice themselves are an F1 cross generated from crossing a
C57BL/6J female with a CBA/J male. Mice were all ordered and supplied by Charles River
Inc..
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Table 2.1 Genotyping primers.
ERT2 5’-GGGCTCTACTTCATCGCATTCC-3’
tF 5’-TATCCCAGTCTCTGGTCTGTGA-3’
tR 5’-TAGGACCCTACCTAGCAAAGGA-3’
2.1.1 Embryo dissections and imaging
Mice were dissected in ice cold 3 % Gibco® FBS/PBS (ThermoFisher) under a bright-field
dissecting microscope. The Brachyury-2A-nucEGFP-2A-CreERT2 embryos were imaged
under the confocal microscope by Dr Ben Steventon from Prof. Alfonso Martinez-Arias’
lab. Confocal images were captured on the LSM700 AxioObserver (Zeiss) using the Plan-
Apochromat 20x/0.8 M27 lens. z stacks were acquired every 5.6 µm. Images were viewed
using FIJI [Schindelin et al., 2012] and stacks of interest collated into a single image using
Inkscape (www.inkscape.org). Embryos that appeared abnormal or that were of the wrong
stage were discarded.
2.1.2 Genotyping
To maintain Brachyury-2A-nucEGFP-2A-CreERT2 mouse colonies ear notches were used
for genotyping. Ear notches were received in 1.5 ml Eppendorf tubes.
DNA extraction was performed using the HotSHOT method [Montero-Pau et al., 2008].
Samples were fully immersed in 50 µl of the lysis reagent and incubated at 95 ◦C for 1 h,
were allowed to cool and 50 µl of neutralising reagent was added and pipetted gently to
dissociate. The samples were centrifuged at 400G for 5 min and the supernatant transferred
to new 1.5 ml Eppendorfs. 4 µl of nuclease-free H2O was added to labelled strips of tubes.
1 µl of sample was added to each tube.
PCR was performed using 3 primers as set out in table 2.1.
The primers were ordered from Sigma-Aldrich and diluted to 100 µmol l−1 in TE (Tris EDTA)
buffer, as stock. A working batch was generated using a 1:100 dilution - 200 µl of each primer
was made. A master PCR mix was made for each sample and additionally a positive and
negative control (HoxB8 mouse cell line). Samples were transferred to a PCR thermocycler
with the following program, table 2.2.
A 1.2 % agarose gel was prepared by adding 1.2 g of agarose to 100 ml of TBE Tris−
Borate−EDTA. It was heated at full power for 2 min until fully dissolved. 5 µl of Ethidium
bromide was added to the gel and it was poured with 2 twelve well combs. After the gel set
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Table 2.2 Genotyping PCR programme.
Temp Purpose Duration Cycles
95 ◦C Denature 2 min
92 ◦C Denature 10 sec 30
58 ◦C Anneal 30 sec 30
68 ◦C Elongate 2 min 30
72 ◦C Final elongation 5 min
12 ◦C
it was transferred into the electrophoresis chamber and the left most wells were loaded with
5 µl of New England Biolab’s 2-log DNA ladder (0.1-10kB). 10 µl of sample was added in
order to each of the other wells. 100 V was applied to the gel for 45 min. The homozygous
mutant is non-viable therefore two bands at 400bp and 550bp were expected in the viable
hetrozygous mutant mice while a single 550bp fragment was expected in the wild-type mice.
2.2 Processing embryos
2.2.1 Generating single cell suspensions
To generate single cell suspensions embryos were individually placed into 250 µl of Gibco®
TrypLE™ Express (ThermoFisher®) in a 1.5 ml Eppendorf® tube. Embryos were then
incubated at 37 ◦C for 3 min to 5 min, gently pipetted to dissociate and quenched in 1000 µl
heat-inactivated serum. Cells were gently centrifuged for 5 min at 400G and washed in 3 %
FBS/PBS with supernatant carefully aspirated to avoid cell loss, three times. Cells were then
resuspended in 25 µl of FACS buffer (2 % FBS/PBS) with mouse Fc (CD16/CD32) block.
For the 10x Genomics® experiments the cells were instead resuspended in 0.04 % BSA.
2.2.2 Antibody hybridisation
For the Smart-seq2 gastrulation wild-type experiment, Tal1-/- and Brachyury-2A-nucEGFP-
2A-CreERT2 [Imuta et al., 2013] experiments cells were stained using a master mix of
antibodies and a viability stain, DAPI. For the gastrulation wild-type and Tal1-/- experi-
ments FLK1 and CD41 antibodies were hybridised to the single cell suspensions and FACS
performed by Yosuke Tanaka.
For the Brachyury-2A-nucEGFP-2A-CreERT2 experiment single cell suspensions were
stained for viability with DAPI and for 7 surface proteins as shown in table 2.3. Master mix
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(2x concentration) was made in 250 µl for the 9 embryos section 3.14.3 and fig. 3.56. Embryo
2 was sacrificed for unstained control and DAPI control. The samples were incubated with
the master mix stain at 4 ◦C for 20 min. Samples were spun and resuspended in 300 µl
FACS buffer and 1:5000 DAPI except E-CAD-biotin which was secondarily stained with
Streptavidin PCPCy5.5, 0.25 µl in 50 µl of FACS buffer for 20 min at 4 ◦C. The secondary
stain was washed and the cells suspended in 300 µl. The remaining sample was stored at 4 ◦C
while the secondary staining was performed.
Alongside the 9 samples, an unstained control and DAPI control using Embryo 2, and single
stain controls using OneComp eBeads (eBiosciences) were performed. One drop of beads
was added to sorting compatible FACS tubes with 25 µl of FACS buffer. 0.5 µl of each
antibody stain was added to the corresponding tube and incubated at 4 ◦C for 20 min. Beads
were washed and resuspended in 300 µl of FACS buffer except for the E-CAD single stain
beads.
2.2.3 Fluorescent activated cell sorting
Six 96 well plates and a test plate containing lysis buffer were prepared according to a
protocol used in the laboratory, itself adapted from Picelli et al. [2014]. The protocol was
optimised by many including Dr Nicola Wilson and Dr Fernando Calero-Nieto.
1 µl of RNase inhibitor was added to 19 µl of 0.2 % (vol/vol) Triton X-100 solution. 2.3 µl of
the mixture was aliquoted into every well of a 96 well plate. Six full plates and one test plate
with one column (8 wells) was prepared. Plates were stored at 4 ◦C.
Stained cells were sorted on the 5 laser machine (BD Influx) in single-cell mode with index
sorting by the staff at the flow sorting facility at CIMR. Cells were sorted into lysis buffer in
the six pre-prepared 96 well plates, two plates per embryo. A further 8 cells were sorted into
a ‘test plate’. The test plate was used to check optimal ERCC concentration and number of
cycles to use. After sorting plates were spun down at 700G for 1 min and stored at −80 ◦C.
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2.3 Library preparation
For the Smart-seq2 gastrulation wild-type experiment and Tal1-/- library preparation was
performed by Dr Nicola Wilson [Scialdone et al., 2016]. For the Brachyury-2A-nucEGFP-
2A-CreERT2 experiment the libraries were prepared by Sonia Nestorowa and myself with
the help of Dr Fernando Calero-Nieto.
2.3.1 Smart-seq2
Complementary DNA generation
Smart-seq2 libraries were prepared as described by Picelli et al. [2014]. Plates were removed
from −80 ◦C, allowed to thaw on ice and spun down at 700G for 1 min. Plates were kept on
ice throughout. The annealing mixture was prepared for 96 wells for sample plates or 8 wells
for the test plate. A dilution of 1:3,000,000 was selected for ERCCs based on results from
the test plate. 2 µl annealing mixture of the ERCCs, oligo-dT and dNTPs was incubated with
each single cell sample in the 96 well plate at 72 ◦C for 3 min and immediately placed on ice,
see table 2.4.
Table 2.4 Annealing mix.
1× 100 wells
ERCC 1:3×106 10 µl
Oligo-dT 100 µmoldm−3 10 µl
dNTP 10 mmoldm−3 100 µl
dH2O 80 µl
Total 200 µl
The reverse transcription mix was prepared containing Superscript II® reverse transcription
enzyme (200 U/µl), RNase inhibitor (20 U/µl), Superscript first strand buffer, dithiothreitol,
betaine, MgCl2 and transcript switching oligomer, see table 2.5. 5.7 µl of the reverse
transcription mix was added to each well and incubated at 42 ◦C for 90 min and cycled 10
times to 50 ◦C to allow secondary RNA structures to unfold as summarised in table 2.6.
cDNA was then generated by performing PCR. The PCR mix was prepared as shown in
table 2.7. 15 µl of the mix is added to each well and PCR performed, table 2.8. For the Smart-
seq2 gastrulation wild-type and Tal1-/- experiments were performed by Dr Nicola Wilson.
For the Brachyury-2A-nucEGFP-2A-CreERT2 experiment the initial test plate experiment
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Table 2.5 Smart-seq2 reverse transcription mixture.
Per well 1 × 100 wells
Superscript II RT (200 Uµl) 0.5 µl 50 µl
RNase inhibitor (20 Uµl) 0.25 µl 25 µl
5 × superscript II first strand buffer 2 µl 200 µl
100 mmoldm−3 DTT 0.5 µl 50 µl
5 moldm−3 Betaine 2 µl 200 µl
1 moldm−3 MgCl2 0.06 µl 60 µl
TSO (100 µmoldm−3) 0.1 µl 10 µl
dH2O 0.29 µl 29 µl
Total 5.7 µl 570 µl
Table 2.6 Smart-seq2 reverse transcription thermocycler programme.
cycle Temperature ◦C Time min Purpose
1 42 90 RT and template switching
10 50 2 Unfolding of RNA secondary structures
42 2 Completion of RT and template switching
1 70 15 Enzyme inactivation
- 4 Hold Safe storage
suggested the use of 21 PCR cycles was optimum for cDNA library generation and so this
was selected for the sample plates, table 2.8.
The cDNA libraries were size selected using Ampure XP® beads at a DNA:bead ratios 1:0.6.
Ampure Beads were added to each sample and the solution homogenised by pipetting and
incubated at room temperature for 8 min. The 96 well culture plates were placed on a magnet
for 5 min to allow the beads to settle, the beads with bound DNA were washed with freshly
made 80 % ethanol twice and then eluted into 23 µl elution buffer and pipetted. 20 µl of
cleaned samples were then transferred to a new sample plate. Samples of the cleaned cDNA
were quality checked on the Agilent® high-sensitivity DNA chip bioanalyser. DNA content
was quantified using the ThermoFisher Scientific® Quant-iT™ PicoGreen™ dsDNA assay
kit.
Library generation
The cDNA libraries were thawed and dilutions made so that most samples contained
0.1 ngµl−1 to 0.15 ngµl−1 of total input DNA. Sequencing libraries were generated by
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Table 2.7 PCR mix
1 well (µl) 100 wells (µl)
KAPA HiFi Hotstart ReadyMix (2x) 12.5 1250
IS PCR primer (10 µmoldm−3) 0.25 25
Nuclease-free dH2O 2.25 225
Total 15 1500
Table 2.8 PCR mix thermocycler programme
Temp ◦C Purpose Duration Cycles
98 Denature 3 min 1
98 Denature 20 sec 21
67 Anneal 15 sec
72 Extend 6 min
72 Extend 5 min 1
4 Hold - 1
tagmentation using the Illumina Nextera XT DNA kits as described by Picelli et al. [2014].
Tagmentation was performed by creating a master mix, pipetting 3.75 µl of the mix into a
new Library 96 well plate and adding 1.25 µl from the corresponding well in the sample
plate into the wells in the Library plate, table 2.9. Plates were then sealed and placed in the
thermal cycler at 55 ◦C for 10 min followed by cooling to 10 ◦C. The DNA content at this
tagmentation step was critical to ensure the tagmented DNA fragments are of the required
length.
Table 2.9 Tagmentation mix
Reagent Volume per sample µl X 96 well plate + 10 %
Tagmentaion DNA buffer 2.5 264
Amplicon Tagment Mix 1.25 132
Sample DNA 1.25
Total 5
1.25 µl NT buffer was added to the library plate so that each well now had a volume of
6.25 µl. Indices were now required to be added to the tagmented DNA fragments. 3.75 µl of
Nextera PCR Master Mix was added to each sample to give a total volume of 10 µl. Unique
index pairs were then added to each plate with 12 column indices and 8 row indices. 1.25 µl
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of each index mix was added and now the total well volume was 12.5 µl. Plates were sealed
and placed in the thermal cycler with the programme shown in table 2.10.
Table 2.10 Nextera PCR indexing programme
Temperature ◦C Time Cycles
72 3 min 1
95 30 sec 1
95 10 sec 12
55 30 sec
72 60 sec
72 5 min 1
10 hold
Since all molecules were now indexed by their cell of origin the libraries from each single 96
well plate were pooled. In this case 2 µl from each sample was pooled into a 1.5 ml Eppen-
dorf® tube for each plate. The pooled sequencing libraries were now cleaned sequentially at
three different DNA:bead ratios 1:0.8, 1:0.9 and 1:0.7 in a manner similar to that previously
described for the cDNA libraries though in this case a single clean for each pooled library was
required. The pooled cleaned libraries was assessed using the Agilent® high-sensitivity DNA
chip bioanalyser. The pooled libraries were quantified using the ThermoFisher Scientific®
Quant-iT™ PicoGreen™ dsDNA assay kit and diluted to 10 nmol to 20 nmol.
2.3.2 10x Genomics® Chromium™ Single-cell Gene Expression
The 10x Genomics® experiment libraries presented in this thesis were prepared by Dr
Fernando Calero-Nieto. Single cell suspensions from dissociated mice embryos in 0.04 %
BSA were used as input. Version 1 of the 10x Genomics® Chromium™ Single Cell 3′
Reagent Kit was used to prepare the libraries. After preparing the single cell suspensions
a cell count was performed so the desired number of cells could be loaded on the 10x
Genomics® single cell chip, table 2.11.
GEM generation and Barcoding
Gel bead in EMulsion (GEM) was generated by preparing the reverse transcription single cell
master mix table 2.12. A target output of 1200 cells was used to dilute the cell suspensions
and calculate volumes for the master mix which was made with the lowest amount of
nuclease-free H2O and additional was added to individual samples as required, table 2.11.
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Table 2.11 10x Genomics® Chromium™ single cell 3′ experiment cell suspension calcula-
tions. The column labelled additional volume provides the additional volume of nuclease-free
H2O to be added to each sample after generating the master mix with only 26.5 µl for each
sample table 2.12.
Embryo Concentration Cell suspension Nuclease-free Additional to be
cells/µl volume µl H2O µl added µl
2 235 10.9 26.5 0.0
3 710 3.6 33.8 7.3
4 365 7.0 30.4 3.9
Table 2.12 10x Genomics® Chromium™ single cell 3′ reverse transcription GEM generation
Master Mix
Reagent 1X (µl) 8.8X (µl)
Nuclease-Free H2O 26.5 233.2
RT Reagent Mix 50.0 440
RT Primer 4.0 35.2
RNase Inhibitor 1.5 13.2
Additive A 2.5 22.0
RT Enzyme 4.6 40.5
Total 89.1 784.1
89.1 µl of the master mix was added to each tube of an 8-tube strip. Additional Nuclease-free
H2O and the specified amount of cell suspension volume were added to the appropriate tubes
of the 8-tube strip, tables 2.11 and 2.13.
A 10x Genomics® Chromium™ single cell 3′ chip was placed in its holder and loaded. The
two unused lanes were loaded with surrogate fluid (50 % volume/volume glycerol/water)
with 90 µl in row 1, 40 µl in row 2 and 270 µl in row 3, table 2.13. 90 µl of the samples were
now loaded from the 8-tube strip into row 1 of the 10x Genomics® Chromium™ single
cell 3′ chip. For the sample lanes 40 µl of 10x Genomics® Chromium™ 3′ gel beads from
the kit were loaded into row 2 without introducing bubbles and 270 µl of partitioning oil
into row 3. The provided gasket was fitted and the 10x Genomics® Chromium™ single
cell 3′ chip loaded into the Chromium™ controller. The programme was run so that cells
were incorporated into gel beads and collected in the recovery wells. 105 µl of samples were
aspirated and place into an Eppendorf® twin-tec 96 well PCR plate. The plate was sealed
with a pierceable foil heat seal using a plate sealer plate block set at 185 ◦C for 6 min.
34
2.3 Library preparation
Table 2.13 10x Genomics® Chromium™ single cell 3′ sample preparation in an 8-tube strip.
Master mix Nuclease-free Sample cell suspension
Lane Embryo volume (µl) H2O (µl) volume (µl)
1 2 89.1 0 10.9
2 2 89.1 0 10.9
3 3 89.1 7.3 3.6
4 3 89.1 7.3 3.6
5 4 89.1 3.9 7.0
6 4 89.1 3.9 7.0
7 Surrogate fluid
8 Surrogate fluid
Reverse transcription was now performed with the cells trapped in the GEMs with unique 10x
Genomics® barcodes. Reverse transcription was performed in the Bio-Rad C1000 Touch™
with the programme set out in table 2.14, lid temperature set at 55 ◦C and reaction volume
set at 25 µl.
Table 2.14 10x Genomics® Chromium™ single cell 3′ GEM-RT
Temp ◦C Time Cycles
55 2 h 1
85 5 min 1
4 Hold
Post GEM-RT cleanup & cDNA Amplification
After the GEM-RT step the mRNA moieities from cells had been captured on the barcoded
primers and the first strand cDNA of the full length mRNA generated capped with a TSO on
the 3′ end. Since the individual molecules from each cell had been barcoded the emulsion
was safely broken. The samples were transferred from the Eppendorf® twin-tec 96 well PCR
plate to an 8-tube strip. The emulsion was separated by adding 125 µl of Recovery agent.
The recovered mixture was now biphasic containing distinct layers, the clear aqueous phase
and the pink recovery agent/partioning fluid. 125 µl pink layer was aspirated and discarded.
A clean-up step using Silane DynaBeads ensued. The DynaBeads Cleanup Mix was prepared,
table 2.15. 200 µl of the DynaBeads Cleanup Mix was added to each sample. The sample
and mix were pipetted and incubated at room temperature for 10 min. After the first 5 min
the mixture was re-pipetted.
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Table 2.15 DynaBeads Cleanup Mix
Reagent 1X (µl) 8.8X (µl)
Buffer for sample cleanup 1 182 1602
DynaBeads MyOne Silane 14 123
Additive A 4 35
Total 200 1760
Elution solution I was prepared as shown in table 2.16. After the 10 min incubation the 8
tube strip was placed in the 10x Genomics® Magnetic Separator in the high position until the
solution was clear. The supernatant was carefully aspirated and discarded. 300 µl of freshly
prepared 80 % ethanol was added to the pellet while still on the magnet and allowed to stand
for 30 sec. This was carefully removed without disturbing the pellet and a further 200 µl of
80 % ethanol was added to the pellet and allowed to stand for 30 sec before being removed.
The strip was centrifuged briefly and placed again in the 10x Genomics® Magnetic Separator
this time in the low position. Any remaining ethanol was discarded and the samples allowed
to dry for 2 min. The tube was removed from the magnet and 50.5 µl of Elution solution I
added and mixed thoroughly by pipetting 15 times and then incubated at room temperature
or 1 min. The solution was once again placed in the 10x Genomics® Magnetic Separator in
the high position until the solution was clear. 50 µl of supernatant was aspirated from each
sample and transferred to a new 8-tube strip.
Table 2.16 Elution Solution I
Reagent 1 reaction (µl) 10 reactions (µl)
Buffer EB 98 980
10 % Tween20 1 10
Additive A 1 10
Total 100 1000
In the next step excess primers and TSO were removed using Beckman Coulter SPRIselect
magnetic beads. Elution solution II was prepared as shown in table 2.17. The SPRIselect
reagent was vortexed until full resuspended, 30 µl was added to each of the 6 samples in
the 8 tube strip and mixed by pipetting 15 times. The mixtures were incubated at room
temperature for 5 min. The strip was placed in the 10x Genomics® Magnetic Separator in
the high position until the solution was clear and the supernatant aspirated and discarded.
125 µl of freshly prepared 80 % ethanol was added to each of the sample pellets, allowed
to stand for 30 sec and then discarded. This ethanol was was repeated once. After the final
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ethanol wash the tube was briefly centrifuged, placed in the magnet in the high position and
any remaining ethanol was discarded. The sample/bead pellets were allowed to dry for 1 min,
then the 8-tube strip was removed from the magnet and 35.5 µl of Elution solution II added.
The solution was mixed by pipetting 15 times and incubated at room temperature for 2 min.
The strip was replaced on to the 10x Genomics® Magnetic Separator in the low position and
35 µl of supernatant transferred to a new 8-tube strip.
Table 2.17 Elution Solution II
Reagent 1 reaction (µl) 10 reactions (µl)
Buffer EB 99 990
Additive A 1 10
Total 100 1000
The cDNA reaction mix was now prepared, table 2.18. 65 µl of the cDNA amplification
reaction mix was added to each tube containing 35 µl of sample. Tubes were then capped
and loaded into the Bio-Rad C1000 Touch™ thermocycler, with the lid temperature set at
105 ◦C and reaction volume set at 100 µl. The PCR programme is given in table 2.19.
Table 2.18 10x Genomics® Chromium™ cDNA amplification reaction mix.
Reagent 1X (µl) 8.8X (µl)
Nuclease-free H2O 8 70
Amplification Master Mix 50 440
cDNA Additive 5 44
cDNA Primer Mix 2 18
Total 65 572
Table 2.19 10x Genomics® Chromium™ single cell 3′ cDNA amplification reaction pro-
gramme.
Temperature (◦C) Time Cycles
98 3 min 1
98 15 sec 14
67 20 sec
72 1 min
72 1 min 1
4 Hold
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A further clean-up step with SPRIselect leads followed. SPRIselect reagent was vortexed
until fully resuspended and 60 µl added to each sample and mixed thoroughly by pipetting
15 times. The mixture was incubated at room temperature for 5 min and then placed in the
10x Genomics® Magnetic Separator in the high position until until the solution was clear.
The supernatant was carefully aspirated and discarded. The sample/beads were washed with
freshly prepared 80 % ethanol twice by adding 200 µl of ethanol, allowing to stand for 30 sec
and discarding at each wash. The tube was then briefly centrifuged, replaced on the magnet
in the low position and any remaining ethanol discarded. The pellet was allowed to air dry
for 2 min, the tube was removed from the magnet and the beads resuspended in 55.5 µl of EB
buffer (Qiagen®). The solution was thoroughly mixed by pipetting 15 times and incubated at
room temperature for 2 min. The strip was placed in the 10x Genomics® Magnetic Separator
in the high position and 55 µl of supernatant transferred to a new strip. 1 µl of each sample
was diluted 1:2 in nuclease-free H2O and run on the Agilent® high sensitivity DNA-chip
bioanalyser.
Library construction
51 µl of each sample were sheared using the Covaris® S220 focused ultrasonicator™ to
achieve a target peak size of 200bp for a standard DNA sample. Post shearing samples were
centrifuged briefly and 50 µl transferred to a new 8-tube strip.
Post shearing a double ended size selection step using SPRIselect beads followed. SPRIselect
reagent was vortexed until fully resuspended. 30 µl of SPRIselect beads was added to
each 50 µl sample and thoroughly mixed by pipetting 15 times. The strip was incubated at
room temperature for 5 min. The 8-tube strip was placed in the 10x Genomics® Magnetic
Separator in the high position until the solution was clear. 75 µl of the supernatant was then
transferred to a new 8-tube strip and the SPRIselect beads discarded. An additional 10 µl of
SPRIselect beads were then added to the 75 µl sample and SPRIselect reagent mix. This was
incubated at room temperature for 5 min and the 8-tube strip placed in the 10x Genomics®
Magnetic Separator in the high position until the solution was clear. The supernatant was
very carefully removed and discarded without disturbing the beads. A total of two washes
were then performed with 125 µl of 80 % ethanol allowing the solution to stand for 30 sec
before discarding. After the second wash the 8-tube strip was briefly centrifuged, replaced
on the magnet in the low position and any remaining ethanol removed. The 8-tube strip was
then removed from the magnet and resuspended in 50.5 µl of EB buffer thoroughly mixing
by pipetting 15 times. The samples were incubated at room temperature for 2 min placed on
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the 10x Genomics® Magnetic Separator until clear and 50 µl of the sample transferred to
new 8-tube strip.
The end repair and A-tailing mix was prepared as shown in table 2.20. 10 µl of the end repair
and A-tailing mix was added to each 50 µl sample and mixed thoroughly by pipetting 15
times. The samples are then placed in the Bio-Rad C1000 Touch™ thermocycler, with the
lid temperature set at 85 ◦C, reaction volume set to 60 µl and the programme given in table
table 2.21.
Table 2.20 End repair and A-tailing mix preparation.
Reagent 1X (µl) 8.8X (µl)
End Repair and A-tailing Buffer 7 62
End Repair and A-tailing Enzyme 3 26
Total 10 88
Table 2.21 End repair and A-tailing thermocycler programme.
Temperature (◦C) Time Cycle
20 30 min 1
65 30 min 1
4 Hold
Adaptors were now ligated by preparing the Adaptor ligation mix as shown in table 2.22.
50 µl of the adaptor ligation mix was added to 60 µl samples after end repair and A-tailing.
The solution was mixed thoroughly by pipetting 15 times and incubated in the Bio-Rad
C1000 Touch™ thermocycler with lid temperature 30 ◦C and reaction volume 110 µl for
15 min at 20 ◦C.
Table 2.22 Adaptor ligation mix.
Reagent 1X (µl) 8.8X (µl)
Nuclease-free H2O 7.5 66
Ligation buffer 30 264
DNA ligase 10 88
R1 Adaptor Mix 2.5 22
Total 50 440
Post adaptor ligation cleanup was performed twice. For the first cleanup 88 µl of SPRIselect
beads were added, mixed thoroughly by pipetting 15 times and incubated at room temperature
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for 5 min. The 8-tube strip was then place in the 10x Genomics® Magnetic Separator in the
high position until the solution was clear. The supernatant was discarded followed by two
30 sec, 200 µl 80 % ethanol washes allowing. The samples were briefly centrifuged, replaced
in the 10x Genomics® Magnetic Separator, any excess ethanol discarded and allowed to
dry for 2 min. The beads were removed from the magnet and resuspended in 30.5 µl EB
buffer, thoroughly mixed by pipetting 15 times and incubated at room temperature for 2 min.
The 8-tube strip was replaced in the 10x Genomics® Magnetic Separator until the solution
was clear and the 30 µl supernatant transferred to a new 8-tube strip. The cleanup step was
repeated with 50 µl of SPRIselect beads with 125 µl ethanol washes and again resuspending
in 30.5 µl of EB buffer and transferring 30 µl to a new 8-tube strip.
Sample indices were selected from the supplied kit and were now ligated by preparing the
sample index PCR mix, table 2.23. 60 µl of the sample index PCR mix and 10 µl of an
individual single cell 3′ sample index was added to each of the 6, 30 µl samples and mixed
thoroughly by pipetting 15 times. The sample indices were used sequentially and recorded to
allow later de-multiplexing. The samples were then placed in the Bio-Rad C1000 Touch™
thermocycler with lid temperature 105 ◦C and reaction volume 100 µl with the programme
shown in table 2.24.
Table 2.23 10x Genomics® sample index PCR mix.
Reagent 1X (µl) 8.8X (µl)
Nuclease-free H2O 8 70
Amplification master mix 50 440
SI-PCR Primer 2 18
Total 60 528
Table 2.24 10x Genomics® Chromium™ sample index PCR thermocycler protocol.
Temperature (◦C) Time (sec) Cycles
98 45 1
98 20 10
60 30
72 20
72 60 1
4 Hold
A further two SPRIselect bead cleanup steps were performed after the sample index PCR
stage. The SPRIselect beads were vortexed until fully resuspended. The cleaning steps were
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as previously described but 100 µl of beads was added to the 100 µl of sample and washed
twice with 200 µl of ethanol. Finally the sample was eluted off the beads in 50.5 µl of EB
buffer and 50 µl was transferred to a new 8-tube strip. In the second wash 50 µl of SPRIselect
beads was added and two washes with 125 µl 80 % ethanol were performed. After the final
wash the sample was resuspended in 35.5 µl and 35 µl was transferred to a new 8-tube strip.
1 µl of each of the final sample libraries was diluted 1:10 and assessed using the Agilent®
high sensitivity DNA-chip bioanalyser. The individual sample libraries were quantified using
the ThermoFisher Scientific® Quant-iT™ PicoGreen™ dsDNA assay kit. Since an estimate
of cell counts had been made, DNA content per cell could be quantified and the libraries
were pooled with relative volumes selected by aiming to achieve equal DNA content per cell
in the pooled libraries.
2.4 Sequencing
2.4.1 Smart-seq2 experiments
The sequencing libraries for the wild-type experiments and Tal1-/- experiments were sub-
mitted by Dr Nicola Wilson. They were all sequenced on the Illumina® HiSeq2500 in
high-throughput mode. The Brachyury-2A-nucEGFP-2A-CreERT2 libraries were submit-
ted to the CRUK sequencing facility. For all Smart-seq2 prepared libraries 96 cells from
each plate were sequenced individually in a separate lane of a Illumina® high-throughput
sequencing flowcell.
2.4.2 10x Genomics® Chromium™ single cell experiments
The sample indices allowed the 10x Genomics® Chromium™ libraries to be pooled prior to
submitting for sequencing and they were pooled aiming to achieve equivalent DNA content
per cell. The libraries were submitted by Dr Fernando Calero-Nieto and sequenced on the
Illumina® HiSeq2500 in high-throughput mode across 16 lanes on 2 flowcells. The libraries
were sequenced with an additional two unrelated samples.
2.5 Pre-processing
The sequence data was processed and barcoded reads de-multiplexed by the CRUK sequenc-
ing facility resulting in 1 fastq file per cell. The fastq files were assessed using FastQC
(version 0.11.3) available from https://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
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2.5.1 Alignment and QC
The Smart-seq2 data was aligned using GSNAP with default parameters (version 2017-11-
15 available at http://research-pub.gene.com/gmap/src/gmap-gsnap-2017-11-15.tar.gz) to
Ensembl’s mouse genome build release 88 (http://mar2017.archive.ensembl.org/index.html).
Gene level read counts were produced by providing the aligned sam files output by GSNAP to
HTseq (version 0.8.0). QC was performed using the bglab package (version 2.0.6, available
at https://github.com/wjawaid/bglab). For wild-type mice the thresholds used were greater
than 200,000, greater than 20 % of reads mapping to endogenous genes and less than 20 %
of mapped reads arising from mitochondrial genes.
For the 10x Genomics® Chromium™ single cell 3′ experiment the pooled libraries required
multiple layers of de-mulitplexing were required. The sequencing facility de-multiplexed
the samples from the sample indices with each sample index having four potential sequence
pairs. CellRanger (version 2.1.1) a computational tool provided by 10x Genomics® was then
used to perform first pass quality control, cell-level de-multiplexing and alignment for which
it uses STAR aligner. It then generated gene-level count data for each cell. Ensembl’s mouse
genome build release 88 was used to generate a bespoke reference genome for Cell Ranger.
Counts from the same embryos were aggregated together using Cell Ranger.
2.5.2 Normalisation and feature selection
Smart-seq2 data was normalised using bglab (version 2.0.6) which provides a wrapper that
accesses the normalisation algorithm implemented by scran (version 1.2.2) using default
values. Feature selection was performed within the bglab package using the algorithm
described by Brennecke et al. [2013] but without using ERCC spike-ins with the model only
fitted on genes with mean counts greater than 10 rather than the quantile threshold originally
described and an FDR of 0.1.
Scanpy (version 1.2.2) was used for the initial exploration and normalisation in the 10x
Genomics® Chromium™ single cell 3′ experiment. Cells with greater than 5 % of reads
mapping to mitochondrial genes and cells with more than 6000 expressed genes were
excluded from further analysis. Unexpressed genomic features were excluded from further
analysis. Feature selection was performed by fitting a linear model to the log transformed
mean, coefficient of variance relationship and all 7585 genes above the fitted line were
included for downstream analysis.
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2.6 Data exploration
2.6.1 Clustering
For the Smart-seq2 wild-type data clustering was performed by Dr Antonio Scialdone using
the dynamic tree cut algorithm [Langfelder et al., 2008]. Parameter selection was performed
by bootstrapping 100 samples and selecting the most robust parameters.
The Louvain method for community detection was used for clustering the 10x Genomics®
Chromium™ single cell 3′ dataset [Blondel et al., 2008]. A graph was first generated from
the counts data using the roots package (https://www.github.com/wjawaid/roots), additionally
it provided a convenient wrapper to igraph for performing Louvain clustering.
2.6.2 Visualisations
Throughout the thesis the figures were almost exclusively produced in R using either the
bglab (version 2.0.6) or roots (version 1.0.4) packages.
Heatmaps were produced in bglab with hierarchical clustering, dissimilarity calculated using
Spearman rank correaltion, Ward’s link agglomerative clustering and a fast leaf re-ordering
algorithm [Bar-Joseph et al., 2001; Murtagh and Legendre, 2014].
PCA and PCA loading plots were produced in the bglab package. Areas of interest were
interactively selected in plots generated in R using the gatepoints package (version 0.1.3,
available from CRAN at https://cran.r-project.org/package=gatepoints or https://www.github.
com/wjawaid/gatepoints). To present multiple PCA dimensions pairs plots were generated
from R’s base graphics package.
2-dimensional tSNE dimensionality reduction plots were produced by calculating a distance
matrix based on the Spearman Rank correlation using the bglab package which itself relied on
the modified Rtsne package (version 0.13) originally written by Jesse Krijthe (https://github.
com/jkrijthe/Rtsne) and available through CRAN (https://cran.r-project.org/package=Rtsne).
The modified version is available at https://www.github.com/wjawaid/Rtsne.
Diffusion maps were generated in roots. All dimensionality plots with gene expression
were produced in bglab. Other scatter plots, boxplots, density plots were produced in base
R. gatepoints was used to select points and mark regions of interest on plots. Cell cycle
assignment was performed using the cyclone function within scran.
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2.6.3 Pseudotime inference
Pseudotime inference was performed in two complementary ways. Diffusion pseudotime
was calculated as described by Haghverdi et al. [2016] using the roots implementation.
Additionally a principal curve was fitted to the data and the distance along the curve from the
start to the projection of the cell of interest taken as the pseudotime [Hastie and Stuetzle, 1989].
Principal curves were calculated using the package princurve version 1.1-12 available from
CRAN at https://cran.r-project.org/src/contrib/Archive/princurve/princurve_1.1-12.tar.gz.
Smoothed gene expression profiles along inferred trajectories with 95 % confidence intervals
were calculated using Gaussian process regression as implemented in the package gpr version
1.1 available at https://www.github.com/wjawaid/gpr.
2.7 ESC to blood differentiation assay
The ESC haematopoietic culture assays to assess the in-vitro effects of the leukotriene LTC4
were performed by Dr Vasilis Ladopoulos. The methods described here are from Ibarra-Soria
et al. [2018] and were written by Dr Vasilis Ladopoulos.
HM-1 murine ESCs (kindly provided by D. Melton) were grown in Knock-Out DMEM
(Gibco) supplemented with 15 % serum batch tested for maintenance of pluripotency (Hy-
clone), 1000 U/ml leukaemia inhibitory factor (LIF) (Millipore), 2 mmoldm−3 L-glutamine
/ 100 U/ml penicillin / 100 µgml−1 streptomycin (Gibco), 0.1 mmoldm3 β -mercaptoethanol
(Gibco) at 37 ◦C, 5 % CO2, on gelatinized plates (Falcon, Corning) at a plating density of
≈ 2×104 cells/cm2. Cells were split every 2–3 days as necessary. ESCs were validated by
their ability to differentiate into derivatives of the three germ layers and tested negative for
mycoplasma contamination.
ESCs were harvested and plated on gelatinized dishes at a density of 4×104 cells/cm2 in
standard ESC growth medium (described above). The cells were dissociated and plated on
gelatinized dishes at a density of 4×104 cells/cm2 24 h later. The cells were then dissociated
again 24 h later and washed once with PBS to remove all remaining ESC medium and LIF.
The cells were resuspended in Iscove’s modified Dulbecco’s medium (IMDM)-based in vitro
differentiation (IVD) medium containing 15 % serum batch tested for embryoid body differ-
entiation (Gibco), 10 % protein-free hybridoma medium II (Gibco), 2 µmoldm−3 l-glutamine
/ 100 U/ml penicillin / 100 µgml−1 streptomycin, 0.15 µmoldm−3 monothioglycerol (MTG),
180 µgml−1 human transferrin (Roche) and 50 µgml−1 l-ascorbic acid (Sigma) at a density of
1×104 cells/ml. The cells were plated in Costar low-adherence 6-well plates (Corning) and
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incubated for 4 days at 37 ◦C, 5 % CO2 to form embryoid bodies. Zileuton (Sigma), LTC4
(Abcam) or carrier were added on day 3 at the indicated concentrations. The embryoid body
suspension was harvested on day 4, transferred to appropriate tubes and the embryoid bodies
were left to settle by gravity for 10 min. The medium was discarded, the embryoid bodies
were washed with PBS and left to settle again by gravity. PBS was removed, and the em-
bryoid bodies were completely dissociated by addition of 1 ml TrypLE and gentle pipetting.
TrypLE was inactivated by adding 10 ml IMDM containing 20 % embryoid body serum. The
cells were counted, centrifuged at 300g for 5 min at room temperature and resuspended in
IVD medium. 4×104 cells were transferred in 4 ml of MethoCult GF M3434 (STEMCELL
Technologies) supplemented with 100 U/ml penicillin / 100 µgml−1 streptomycin (Gibco).
1 ml aliquots were plated in triplicate in 35 ml low-adherence dishes (Corning). Colonies
were counted on day 14, and differences in colony numbers were tested with a two- tailed
Student’s t-test.
To ensure that treatment with Zileuton or LTC4 does not affect the proliferation of the mouse
ESCs, 1×106 cells were harvested by centrifugation after dissociation of embryoid bodies
on day 4 and washed in PBS. The cell pellet was resuspended in residual volume and fixed
by dropwise addition of ice cold 70 % methanol. The cells were incubated at 4 ◦C for 1 h
and then washed twice with PBS. The cells were resuspended in 300 µl propidium iodide-
staining buffer (200 µgml−1 RNaseA, 20 µgml−1 propidium iodide, 0.1 %Triton X-100 in
PBS) and stained at room temperature for 1 h. The cells were analysed on a BD Fortessa.
Post-acquisition analysis was performed with the FlowLogic suite.
To ensure that treatment with Zileuton or LTC4 does not affect the viability of the mouse
ESCs, 1×106 cells were harvested by centrifugation after dissociation of embryoid bodies
on day 4 and washed in PBS. The cells were resuspended in 100 µl Annexin binding buffer
(10 mmoldm−3 HEPES, 150 mmoldm−3 NaCl, 5 mmoldm−3 KCl, 1 mmoldm−3 MgCl2,
1.8 mmoldm−3 CaCl2) containing 5 µl Annexin V APC (BD Biosciences; Cat. no. 550474;
Lot. 16808) and 1 µgml−1 4,6-diamidino-2-phenylindole (DAPI). The cells were diluted
up to 400 µl with Annexin binding buffer and analysed on a BD Fortessa cytometer. Post-
acquisition analysis was performed with the FlowLogic suite.
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Chapter 3
Single-cell transcriptomic analysis of
murine gastrulation
3.1 Background
Substantial progress has been made in understanding the molecular processes that govern
embryological development since the landmark chick quail chimera experiments that utilised
differences in appearance of the Feulgen stained interphase nuclei [Dieterlen-Lievre, 1975;
Le Douarin, 1973; Le Douarin and Teillet, 1973]. At the macroscopic level the well orches-
trated and highly stereotyped unidirectional process begins with a single-cell, the fertilised
ovum that by cell division, symmetric and asymmetric, progressing through gastrulation
forms the well recognised germ layers. The trilaminar disc establishes a multicellular or-
ganism containing in many cases hundreds of different cell types precisely organised into
functional units.
Understanding the mechanisms underlying this progression in mammals remains challenging.
Advances in molecular biology have built on the early avian chimera-based fate mapping
experiments. In particular temporal, spatial and cell-type specific genetic manipulations that
for example with the use of a reporter enzyme or fluorescent label allow lineage tracing
of early cell types selectively marked by their expression of a particular gene at a chosen
time [Livet et al., 2007; Utomo et al., 1999]. Transgenic mice can then be used to activate a
permanent genetic change in a specific cell type at a specified developmental stage and all its
progeny. This change may be the expression of a readily measurable marker e.g. a fluorescent
protein or a reporter enzyme [Livet et al., 2007; Utomo et al., 1999]. But they rely on apriori
identifying a specific and early genetic marker, possibly in cell subpopulations identified as
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label retaining in pulse-chase type experiments [Barker et al., 2007]. Additionally leaky and
non-specific expression can make interpretation and reproducibility difficult.
Furthermore many of the downstream measurements of gene expression of cell subpop-
ulations are averages over several hundreds of cells. Multiple and sequential time series
experiments can elucidate gross trends but transient and rare cell subpopulations may be
difficult or impossible to identify with such methods, particularly if the individual cells
making independent fate decisions are out of developmental phase and each cell enters and
leaves the transient state of interest asynchronously [Magwene et al., 2003]. In contrast,
single-cell data can potentially quantify intercellular heterogeneity within populations and
may allow for finer temporal resolution.
Reconstruction of a developmental chronology from single cell data during the critical gas-
trulation phase, which lays the foundation of future organogenesis, combined with gene
expression data provides a means to infer gene expression changes along developmental
trajectories. Mining this rich source of data for master regulators that direct differentiation
will reveal critical molecular pathways and the temporal order at which these master regu-
lators are required to form normal tissues. This deeper understanding will permit a more
systematic and practical approach to designing protocols for the in vitro differentiation of
naive pluripotent iPS or ES cells into mature tissues of interest.
The mesoderm provides a framework and support, structural and nutritional for the epithelial
layers and critically has been implicated in directing epithelial growth and differentiation,
yet is poorly understood and studied [Rankin et al., 2015]. Early multipotent mesodermal
progenitors can form cardiac myocytes, pericytes, smooth muscle cells, endothelium and
haematopoietic precursors, see fig. 1.4. Uncovering normal differentiation trajectories can
provide not only a basis from which to design robust protocols for differentiating naïve cells
to desired target cell types for use in generating disease models and cell-based regenerative
therapies but also insights into normal embryological development.
In the early post-implantation murine embryo the epiblast undergoes a substantial trans-
formation characterised by stereotyped morphogenetic movements. The primitive streak
appears posteriorly at the epiblast-extraembryonic ectoderm border and extends anteriorly to
the distal vertex of the cup, the prospective location of the future node. The process begins
at approximately E6.5 and is essentially complete by E8. Prior to the onset of gastrulation
the ventral dorsal axis is at least conceptually identified by the dorsal epiblast and ventral
endoderm. The appearance of the primitive streak, though possibly secondary, defines the
anterior-posterior axis thereby fixing the left right axis at a global level even if molecular
differences are not yet discernible.
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A key challenge in the development of multicellular organisms is the limit of diffusive
capacity, when nutrient delivery and waste removal can be maintained no longer, as numbers
of cells and the size of the organism increases. In preparation for surpassing this critical
threshold, many organisms have evolved circulatory systems consisting of pumps, vessels
and a nutrient and waste exchange fluid. The earliest cells to lose adhesion from the epiblast
by undergoing epithelial to mesenchyme transition (EMT) are thus directed towards cardiac,
endothelial and blood fates. These cells, barring cardiac, generated at the posterior primitive
streak migrate proximally into extraembryonic tissues forming blood islands, where the first
wave of blood is generated.
The rapid but continuous changes occurring throughout this period offer an opportunity
to use single-cell transcriptomic profiling to interrogate some of the molecular processes
governing this ‘metamorphosis’. To achieve this in a cost-effective manner fluorescent
labelled antibodies and flow activated cell sorting can prove useful to sort cells prior to
mRNA extraction, cDNA construction and preparation of sequencing libraries from specific
populations at post-E6.5 embryonic stages. Two cell surface markers (FLK1, CD41) were
used to sort the required cell populations prior to mRNA extraction and library preparation.
A brief overview and introduction to each molecular marker is given below.
Fetal Liver Kinase (Flk1) also known as the kinase insert domain receptor (KDR) or vascular
endothelial growth factor receptor 2 (VEGFR-2) is a cell surface receptor transcribed from
the KDR locus. Shalaby et al. [1997] showed that Flk1-/- mice are non-viable failing
to develop mature epithelium and haematopoiesis. Additionally Flk1-/- embryonic stem
cells are able to contribute to neither endothelium nor embryonic or definitive waves of
haematopoiesis in chimera experiments suggesting a cell autonomous role in these lineages
[Shalaby et al., 1997]. FLK1 provides a useful cell surface marker to enrich for progenitors
of several mesodermal derived tissues in this experiment, particularly for early embryonic
haematopoietic precursors, see fig. 1.4 [Evseenko et al., 2010; Kabrun et al., 1997; Kattman
et al., 2006; Nishikawa et al., 1998; Yang et al., 2008].
Cluster differentiation 41 (CD41) another cell surface marker, transcribed from the Integrin
alpha-IIb (Itga2b) locus is present on blood cells but is expressed particularly highly on
platelets [Dumon et al., 2012; Ferkowicz et al., 2003]. In platelets, Itga2b forms a heterodimer
with Itgb3 to form the cell surface glycoprotein IIb/IIIa receptor which binds fibrinogen
playing a central role in platelet aggregation, adhesion and thrombus formation [Xiang et al.,
2016]. In development, CD41 antigen is expressed not only by greater than 80% of embryoid
body derived haemogenic precursors but also most yolk sac and AGM haematopoietic progen-
itors [Mitjavila-Garcia et al., 2002]. CD41 expression in yolk sac primitive haematopoiesis
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makes it a useful target to enrich for mesoderm derived cells destined toward a blood fate
that may have formerly down-regulated FLK1 [Ferkowicz et al., 2003; McGrath et al., 2015].
Therefore combining FLK1 and CD41 markers at appropriate embryological stages allows
capture of a more complete developmental trajectory.
Early development of the FLK1+ mesodermal sub-compartment has been previously studied
by the Gottgens group. Single cell qPCR gene expression for 48 selected genes in nearly
4000 FLK1+ mouse embryo derived cells has been measured using the Fluidigm® Biomark™
HD system [Moignard et al., 2015]. Dimensionality reduction techniques have been used to
infer developmental trajectories and a boolean gene regulatory network has been synthesised
from the state space graph. The data and analysis show the expected trajectories (endothelial
vs. haematogenic) but given that genes were selected apriori this is unsurprising. A more
general transcriptome wide analysis will therefore be more revealing.
This chapter describes a transcriptome-wide survey of single cells spanning gastrulation
focusing particularly on the heamatopoietic mesoderm using the surface markers FLK1+ and
CD41+. To try and capture early gastrulation an unbiased sample of single cells from the
E6.5 stage mouse embryo was processed in a similar fashion.
3.2 Cell sampling and library preparation
Single cell unbiased whole transcriptome RNAseq analysis was performed in mouse embryos
at 4 timepoints spanning gastrulation: E6.5; E7.0; E7.5 and E7.75. In total 33 mouse embryos
were processed supplying 1205 cells that passed quality control. 501 cells from seven E6.5
whole embryos were harvested by generating a single cell suspension from the distal end of
the egg cylinder. Single cell suspensions generated from larger older embryos acquired at
E7.0 (138 cells, 3 embryos), E7.5 (259 cells, 12 embryos) and E7.75 (307 cells, 11 embryos)
were FACS sorted for FLK1 or CD41.
Embryos were dissected under magnification in ice-cold 2% FBS/PBS. The yolk-sac was
preserved during dissection and the embryos tranferred into TrypLE™ and incubated at 37 ◦C
for 5 to 10 minutes until the embryos were visually determined to be sufficiently dissociated.
Larger embryos were dissected into smaller fragments to aid dissociation and avoid excessive
periods in TrypLE™.
Single cell suspensions generated from E6.0 embryos were cell sorted using a viability stain
only (DAPI). All three E7.0 embryos , four E7.5 and three E7.75 embryos were sorted for
Flk1+ and no index data was collected. Eight E7.5 embryos and eight E7.75 embryos were
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Fig. 3.1 Mid-sagittal sections through embryos at sampling stages E6.5-E7.75 similar to
fig. 1.4. From left to right schematics of mouse embryos from early streak (E6.5); mid-streak
(E7.0); neural plate (E7.5) and head fold (E7.75) stages are shown. In colour are shown the
expected anatomical locations within the developing embryo of the cells sampled from the
defined sorting strategies. Numbers of cells collected after quality control are shown below
the images.
sorted on CD41 expression with collection of FLK1 index data, figs. 3.1 to 3.3. The embryo
dissections and FACS was performed by Dr Yosuke Tanaka and Victoria Moignard compiled
the FACS panels, fig. 3.3, for Scialdone et al. [2016]. This sorting strategy subset the cells that
were sampled from the embryo into nascent mesoderm FLK1+/CD41-, progenitor populations
FLK1+/CD41+ and committed cells FLK1-/CD41+. Presumed anatomical locations from
which the cells with different markers were sampled at each stage are outlined in fig. 3.1.
In total fifteen 96-well plates were processed and sent for sequencing, corresponding to a
maximum number of 1440 cells but four wells were reported as empty from FACS. The few
number of empty wells reflects the protocol used at the time, which involved refilling wells
marked as empty by the cell sorter. Later we found that one of the four wells marked as
empty in fact produced reads and passed all quality control to be identified as a normal cell.
This highlighted the risk of potentially introducing two cells into a well with a strategy of
refilling and the protocol was accordingly modified by abstaining from refilling to prevent
such doublets in future experiments.
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Flk1+
CD41−
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CD41+
Flk1−
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NA 55 78
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Fig. 3.2 Top: Simplified haematopoietic differentiation from FLK1+ CD41- nascent meso-
derm cells to double FLK1+ CD41+ primed and single positive committed FLK1- CD41+
erythroid cells. Middle: Density plot of expected relative numbers of the different population
of cells at the sampled time points. Bottom: Number of cells sorted with each strategy at
each sampling stage. Flk1 sorting was performed without collecting any index data (First
row). All other cells were sorted for CD41high and FLK1 index data was collected. (Second
and Third rows)
The cells were sorted into freshly made lysis buffer containing RNAase inhibitor and then
stored at −80 ◦C. Dr Ian MacCauley and Dr Nicola Wilson generated single-cell libraries
using the Smart-Seq2 protocol as described by Picelli et al. [2014].
After lysis, pre-prepared ERCC-92 external polyadenylated RNA spike-ins were added prior
to capturing native and spike-in polyadenylated mRNA molecules by oligo-dT primers with
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Fig. 3.3 a, FLK1+ cells were sorted from three E7.0; four E7.5 and three E7.75 stage
embryos. No further index data was collected for them and they are shown plotted against
SSC. S, Streak; NP; Neural Plate; HF; Head fold. b, Gating of CD41+/FLK1+ (Green) or
CD41+/FLK1- (Red) cells by embryo. The FACS plots presented here were produced by
Victoria Moignard from sorting data collected by Yosuke Tanaka, as part of Scialdone et al.
[2016].
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Table 3.1 Primer sequences used in the Smart-Seq2 protocol. Note the identical segments
in the oligo-dT primer and TSO allowing for a single ISPCR primer to be used in the PCR
reaction. V, Adenosine, Cytidine or Guanosine; N, any nucleotide; TSO Template switching
oligomer; rG riboguanosine; +G, modified guanosine to produce a LNA [Picelli et al., 2014].
Note that the Oligo-DT primer and the TSO have the ISPCR at the 5′end.
Name Sequence
Oligo-dT30VN 5′-AAGCAGTGGTATCAACGCAGAGTACT30VN- 3′
TSO 5′-AAGCAGTGGTATCAACGCAGAGTACATrGrG+G-3′
ISPCR oligo 5′-AAGCAGTGGTATCAACGCAGAGT-3′
a universal anchor sequence, table 3.1. Superscript™ II a synthetic form of the Moloney
murine leukaemia virus reverse transcriptase was used for first strand synthesis adding 2
to 5 additional non-templated cytosine residues to the 3′ end of the new strand, the 5′ end
of the template fig. 3.4. A template switching oligomer (TSO) with two riboguanosines
and a modified guanosine with a locking nucleic acid (LNA) at the 3′ end, hybridises to the
additional cytosine residues allowing the Superscript™ II to switch templates and synthesise
a sequence complementary to the TSO, fig. 3.4 [Matz et al., 1999]. The stability of the
RT enzyme allows essentially full-length product to be generated for transcripts up to 12.3
kilobases in length [Kotewicz et al., 1988]. The use of identical 5′ and 3′ regions allows for a
single primer PCR reaction, table 3.1 and fig. 3.4.
Number of cycles of cDNA amplification PCR reaction are based on previous experiments
particularly if a test plate was collected at the same time as the sample. Ideally the cells in
the test plate would be identical to the sample plate. The purpose of the test plate being to
ensure that cells were correctly placed in wells during sorting, to provide an indication of the
number of cycles required to get sufficient product from the PCR reaction and to confirm the
batch of reagents was good.
Solid phase reversible immobilisation (SPRI) magnetic bead size selection was performed
after cDNA generation to remove excess primers, primer dimers and TSO concatemers.
Libraries were now generated by tagmentation adding Tn5 transposome to an appropriate
dilution of cDNA. It was critical to ensure the sample was not over concentrated so that
libraries with insert lengths of the desired length were generated for optimal clustering on
the sequencing flowcell.
The Tn5 transposome is engineered to randomly fragment and insert the predetermined Read
1 or Read 2 oligonucleotides in a single step, see table 3.2 and fig. 3.4. After Read 1 and
Read 2 adaptors have been annealed, unique combinations of indexed P5 and P7 primers are
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3.2 Cell sampling and library preparation
Fig. 3.4 Overview of Smart-seq2 protocol. Image from Picelli et al. [2014].
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Table 3.2 Nextera® XT DNA sample preparation kit primers. i5 & i7 indicate the positions
of the 8 base pair index tags. The underlined regions highlight the matching regions that the
P5 or P7 primer will anneal to on the complementary strand, see fig. 3.4.
Name Sequence
Read 1 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3′
Read 2 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3′
P5 PCR primer 5′-AATGATACGGCGACCACCGAGATCTACAC[i5] TCGTCGGCAGCGTC-3′
P7 PCR primer 5′-CAAGCAGAAGACGGCATACGAGAT[i7] GTCTCGTGGGCTCGG-3′
added to each of the 96 wells for the enrichment PCR step producing dual-indexed libraries
with Illumina sequencing adaptors, table 3.2 and fig. 3.4. There are 8 different indexed P5
(S502-S508,S517) adaptors and 12 different indexed P7 adaptors (N701-N712) thus yielding
96 unique dual-indices.
A further SPRI magnetic bead cleanup step yielded the final libraries that were quantified,
diluted and pooled to achieve the target concentration of DNA required by the sequenc-
ing facility. This dilution step is critical for optimal sequencing by preventing under or
overclustering on the sequencing flowcell as will be discussed in section 3.3.
3.3 Sequencing and Alignment
Sequencing was submitted by Dr Nicola Wilson to be performed by the sequencing service
offered at the Cambridge Institute - Cancer Research UK. The 15 samples of 96 well plates
were sequenced on the Illumina® HiSeq 2500 in high throughput mode with one sample per
lane.
The libraries which were generated to incorporate the sequencing adaptor as described in
section 3.2 were denatured and loaded on to separate lanes of the flowcells where the adaptor
hybridised to a complementary surface bound sequence, see top panel of fig. 3.5. The bound
molecules then underwent solid state bridge amplification to form clonal clusters of up to a
thousand molecules, centre and bottom panels of fig. 3.5.
Loading libraries of the correct concentration was critical as having highly concentrated
libraries loaded onto the flow cells would have resulted in a high density of clonal clusters
making it difficult or impossible for the downstream image analysis software to differentiate
between two different seeding molecules. In contrast, too low concentration libraries would
have resulted in reduced efficiency and higher costs.
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Fig. 3.5 Illumina® sequencing platform. Upper: Compatible libraries are loaded
onto the flowcell and hybridise to a lawn of complementary sequences. Mid-
dle and bottom: Repeated cycles of bridge amplification generate large clonal
clusters - neighbourhoods of identical DNA sequences. Figures modified from
https://www.illumina.com/Documents/products/Illumina_Sequencing_Introduction.pdf and
https://www.cegat.de/en/services/next-generation-sequencing/ (accessed 15 October 2017).
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(a) (b)
Fig. 3.6 a: At each cycle one of the four reversible fluorescent labelled terminator
bound dNTPs are added by a DNA polymerase, images are taken, reagents washed
off, fluorescent label and terminator cleaved and a new cycle initiated. This is done
in parallel for all clusters making the process very high throughput. Figure from
https://www.illumina.com/Documents/products/Illumina_Sequencing_Introduction.pdf. b:
Fake colour composite image generated from individual channels. From http://www.dkfz.de/
de/presse/pressemitteilungen/2012/ images/120227_rippe_mertens_abbildung_pm.jpg (ac-
cessed 15 October 2017.)
The Illumina platform chemistry performs sequencing by synthesis (SBS) using four re-
versible fluorescent labelled terminator bound dNTPs. At each cycle a DNA polymerase
catalyses single nucleotide addition to the DNA template in parallel and fluorescent images
are taken for each of the colour channels corresponding to the fluorescent label for each base,
fig. 3.6. By doing this in parallel for millions of molecules per lane, very high-throughput is
achieved. The reagents are washed off, the fluorescent label and terminator are cleaved and
removed and the cycle repeated until the required length of read is generated.
Initially the P7 bound fragments are cleaved leaving only the P5 bound bridge amplified
molecules. The primers for i5 index, read1 and i7 index are added and sequencing by
synthesis performed in turn. For paired end reads a further phase of bridge amplification is
performed and on this occasion the P5 bound molecules are cleaved leaving the P7 bound
molecules, now the read2 primer is added and the second read sequenced.
The sequencers perform image analysis and base calling producing raw bcl files. These are
then demultiplexed using the library barcodes into individual fastq files, one per cell. The
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fastq files contain the sequence data in a text based format that can be viewed directly or
passed to a sequence aligner along with a genome reference. Each read in a fastq file has 4
lines, the first is a header, the second contains the actual raw read, the third a separating ‘+’
and the final line contains the Phred quality score, box 3.1 and table 3.3 [Cock et al., 2010].
Box 3.1: Example read extracted from fastq file
@K00252:103:HHH7TBBXX:3:2228:6644:48772 1:N:0:TAGGCATG+CTAAGCCT
CCCCATGTACTCTGCGTTGATACCACTGCTTCCATGTACTCTGCGTTGAT
+
AAAAFJJJJJJJJJJJJJJJJJJJJJJJJFJJJJJJJJJJJJJJJJJJJJ
Table 3.3 Breakdown of first line of fastq quartet, from box 3.1
Text Meaning
@ Starts header line for each new read
K00252 Unique instrument name
103 Run ID
HHH7TBBXX Flowcell ID
3 Flowcell lane
2228 Tile number within the flowcell
6644:48772 x & y coordinates of the cluster within the tile
1 For paired end reads, 1 or 2
N Y if the read is filtered, N otherwise
0 0 when none of the control bits are set, some even number otherwise
TAGGCATG+CTAAGCCT Indices from the demultiplexing - In this case dual indexed
The Phred quality score Q, assigns confidence to each reported base and is calculated as
Q =−10log10 P
, where P is related to the base-calling error probability. The sequencer calculates the
probabilities P based on internal Illumina® algorithms. The characters in the fourth line of
the fastq represent an encoding whereby Phred quality scores from 0 to 93 are represented by
ASCII characters 33 to 126, see Cock et al. [2010] for further details.
Reads were aligned by Dr Antonio Scialdone on the EBI cluster for the related paper,
Scialdone et al. [2016]. For the purposes of the work presented here I have redone the
sequence alignment using gsnap [Wu and Nacu, 2010; Wu and Watanabe, 2005] from the
raw demultiplexed fastq files generated by the sequencing service. The reads were aligned to
a bespoke genome which included the mouse genome build and the ERCC spike-ins. The
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aligned bam files generated were then passed to HTSeq to produce gene-level transcript
counts for each cell [Anders et al., 2015].
Subsequent analyses were predominantly performed in the R language and environment
for statistical computing [R Core Team, 2017]. For reproducibility all functions have
been extensively documented and packaged into bglab which is freely available online at
https://www.github.com/wjawaid/bglab.
3.4 Quality Control
1440 libraries were generated from the fifteen 96-well plates. Some of the wells may have
no cell, a damaged cell or a highly quiescent cell resulting in poor libraries. Down stream
analyses of data such as normalisation and selection of highly variable genes can be unduly
affected by these poor quality libraries which effectively are treated as cells at this stage. To
prevent this, poor quality cells are removed based on empirical cut-off values. To remain
consistent, where possible these cutoff values should be maintained across all experiments.
Though highly quiescent cells can make normalisation and other downstream analyses
challenging it may be necessary to reappraise their removal as they could have great biological
significance. An example is long lived multipotent stem cells of mature adult systems
maintaining homeostasis in a steady state.
Of the possible 1440 cells 1205 passed QC criterion, remarkably this included a cell cor-
responding to a well that was marked as empty during FACS. This highlights the risk of
inadvertently making libraries from cell doublets, when employing a strategy of refilling
wells reported by the sorter to be empty.
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Box 3.2: Quality Control
Three QC criteria were used for each cell (library):
• > 200,000 mapped reads.
This appears to be a reasonable cut-off to remove libraries that may be generated
from wells containing either damaged or fragmented cells.
• > 20% of mapped reads map to either nuclear or mitochondrial genes.
The remaining reads would either be unmapped or map to ERCCs. Most un-
mapped reads are often TSO concatemers or primer dimers.
• < 20% of mapped reads map to mitochondrial genes.
Damaged cells are found to have higher mitochondrial mapping genes.
For each of the 96 well plates (output from one lane of the sequencer) multiple plots were
generated during QC, an example is given in fig. 3.7. In all the subplots each point represents
a cell and the abscissa represents the total number of reads from the library generated from
that cell. This includes all mapped and un-mapped genes and also those mapping to ERCC
spike-ins. In the example shown in fig. 3.7 only 2 cells failed due predominantly to a low
number of mapped reads; the red dashed lines show the thresholds as declared in box 3.2.
These two samples likely represent severely damaged cells, cell fragments or small highly
quiescent cells providing low input RNA for the assay, so that primer dimers and TSO
concatemers are preferentially generated during cycles of PCR.
Table 3.4 Descriptions of QC parameters plotted in fig. 3.7
Feature Description
Total reads All reads mapped and unmapped
Mapped reads Reads mapped to native mRNA or spike-ins
Nuclear reads Reads mapped to nuclear annotated genes
Genes Proportion of reads mapped to native mRNA relative to total
No feature reads Reads not mapping to an annotated genomic region
Ambiguous reads Reads that map to a single locus but overlap two annotated regions
Low quality reads Reads with poor low quality
Unaligned reads Reads not mapping to anything in the reference genome including spike-ins
Alignment not unique Reads mapping to multiple locations
High coverage reads Number of genes with reads greater than 10 reads per million for that cell
Mitochondrial reads Mapping to mitochondrial reads
ERCC Reads mapping to spike-ins
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Fig. 3.7 Several plots of parameters used to assess quality, further details in table 3.4. Each
point represents a cells and the red dashed line represents QC thresholds, box 3.2.
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3.5 Normalisation
The libraries generated are only pooled at the final steps and libraries from different 96 well
plates are processed completely separately. Technical variability in single cell RNA can be
high due to the low amount of starting RNA and variations in capture efficiency. Furthermore
capture of longer mRNA transcripts is known to be higher than for short transcripts one
reason being there is a greater probability of two Tn5 transposomes attacking a long transcript
and randomly annealing a P5 on one end and P7 on the other. This makes comparison of
abundancies between genes uninformative.
An important part of downstream analysis is comparing transcript counts between cells but
this can only be achieved if the libraries have been adequately normalised. Some methods
adopted from bulk RNAseq include FPKM, TPM, TPKM and the DESeq size factor [Conesa
et al., 2016; Love et al., 2014; Risso et al., 2014]. Newer methods have become available
since, specifically targeting single cell analyses such as scran, SCDE and more advanced
but computationally intensive algorithms such as SCnorm [Bacher et al., 2017; Kharchenko
et al., 2014; Lun et al., 2016a].
In Scialdone et al. [2016], DESeq size factor normalisation was used and works well for
Smart-Seq2 protocol single cell RNAseq generation where the dropout effect is not as
conspicuous as for other protocols. For the purposes of this analysis scran an adaptation
of the DESeq size factor algorithm that incorporates pooling in an attempt to overcome
the effect of dropout was used. In the case of this dataset there is little difference between
normalisation by DESeq size factor or scran.
Given an array of counts x for m genes G and for n cells C of dimensions m×n the geometric
mean gm is calculated for every g ∈ G as
gmg =
(
n
∏
c=1
xcg
) 1
n
, for c ∈C.
Then the size factor f is calculated for every cell as
fc = ∑
j∈G∗
xcj
gm j
, for G∗ ⊂ G, ∀ j ∈ G∗ : gm j ̸= 0.
The size factor therefore is only calculated using genes that are expressed in every single
cell, any gene that has dropped out in even one cell will be excluded from the calculation.
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Where dropouts are common this becomes problematic so Lun et al. [2016a] have modified
the DESeq size factor calculation method by repeated systematic pooling of similar cells
based on their cosine distance and solving the resulting linear system of equations. These
normalisation methods do not account for gene length nor is there any sort of gene wise
normalisation, so counts between genes cannot be reliably compared. Furthermore the
methods used or discussed here do not use spike-ins for normalisation, such methods may
provide superior results [Bacher et al., 2017; Ding et al., 2016].
3.6 Feature selection
Data generated from single cell RNAseq is large and high-dimensional. The gene counts
matrix is rather sparse and as such suffers from the curse of dimensionality. Despite the
large numbers of cells, the feature space sampled diminishes to insignificance, in comparison
to the vast volume of space spanned by the high number of annotated genomic features.
This becomes highly problematic when calculating distances [Adachi, 2017]. Many of the
genomic features may not carry any usable information and therefore simply add noise to
calculations. To somewhat mitigate against this we planned to use a feature selection method
that estimates technical noise from spike-ins and only selects genomic features that vary
beyond the estimated technical variance [Brennecke et al., 2013].
Spike-ins were added to the samples for technical noise estimation but an underlying as-
sumption is that equal amounts of ERCC spike-ins are titrated into each sample [Brennecke
et al., 2013]. To assess this assumption, the ERCC to mapped read ratios were plotted for
all cells by sequencing flowcell lane equivalent to each 96 well plate, fig. 3.8. From fig. 3.8
it is clearly evident that there is significant variation in the amount of ERCC spike-in for
each 96 well plate and this assumption does not hold. Spike-ins were therefore not used to
infer technical noise but a mean CV-squared1 relationship was inferred on the data itself
[Brennecke et al., 2013]. 1937 genes out of 41,388 annotated genomic features were found
to vary beyond the technical limit of detection in the 1205 cells sampled, fig. 3.9 and were
carried forward for further analysis. Though this was a stringent choice, it was only for
purposes of dimensionality reduction and identifying clusters. This set of genes or other sets
similarly calculated may be referred to as highly variable genes in the remainder of the text.
1coefficient of variance squared = σ
2
µ2
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Fig. 3.9 Mean normalised count against CV2 for each gene. Red coloured dots represent
genes that vary beyond the expected technical detection limit of the experiment (10% FDR),
grey coloured dots are not. Red dashed line shows threshold and data points to the right of
the vertical black dotted line were used for parameter fitting.
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3.7 Identification of cell populations
3.7.1 Hierarchical clustering
Identification of cell types within the sampled population requires some form of clustering
or grouping of similar cells together separate from others. Hierarchical clustering involves
building a clustered tree or dendrogram of cells so that those most similar are closest together
nested within larger groups. Hierarchical clustering can be performed either ‘bottom-up’
also known as ‘agglomerative’, merging the most similar cells (clusters) together iteratively
or ‘top-down’ also called ‘divisive’, separating a single group into two subgroups, again
repeated iteratively. Clustering algorithms require some notion of similarity (or dissimilarity)
between cells and most employ an agglomerative approach, box 3.3.
Box 3.3: Agglomerative hierarchical clustering
1. Each cell is assigned to its own cluster
2. The closest clusters (cells in the first step) are merged into a single cluster, so
there is now one less cluster
3. New similarities (or dissimilarities) are calculated for the newly merged cluster.
4. The steps are repeated until all cells are in one cluster.
Various methods of recalculating dissimilarities from consolidated clusters in step 3 above,
have been described including single linkage, complete linkage, group averaging, weighted
averaging, centroid/median or Ward’s method. Single linkage calculates the new similarity
as that between the closest cells (points in high dimensional space) in the clusters having
the disadvantage that it can lead to clusters being merged prematurely. In contrast, complete
linkage calculates the new dissimilarity as that between the furthest points in the clusters,
now causing delayed merger of clusters. Adachi [2017] has presented a single parameterised
equation that encompasses the calculation of all these linkage methods:
d
(
Ci∪C j,Ck
)
= α1d (Ci,Ck)+α2d
(
C j,Ck
)
+βd
(
Ci,C j
)
+ γ
∣∣d (Ci,Ck)−d (C j,Ck)∣∣ ,
where Ci and C j are the clusters that form the new merged cluster Ci∪C j, Ck is either a cell
or a previously merged cluster, with a function d(a,b) that calculates dissimilarity between a
and b. α1, α2, β and γ are parameters as set out in table 3.5.
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Table 3.5 Parameters set out in linkage equation from Adachi [2017]. ni,n j,nk are numbers
of items in each cluster.
method α1 α2 β γ
single 12
1
2 0 −12
complete 12
1
2 0
1
2
group average nini+n j
n j
ni+n j
0 0
weighted average 12
1
2 0 0
centroid nini+n j
n j
ni+n j
−nin j
(ni+n j)
2 0
median 12
1
2 0 −14
Ward ni+nkni+n j+nk
n j+nk
ni+n j+nk
−nk
ni+n j+nk
0
Though hierarchical clustering generates a dendrogram of relatedness it does not generate
discrete clusters per se; to achieve this the dendrogram must be suitably ‘cut’. Hierarchical
clustering using group average linkage and a dynamic tree cut [Langfelder et al., 2008] were
performed by Dr Antonio Scialdone and robust parameters were selected by testing on 100
bootstrapped samples [Scialdone et al., 2016]. The heatmap in fig. 3.10 shows the clusters
with a handful of genes that are most highly uniquely differentially expressed.
Figure 3.10 shows the clusters and some selected genes but it is useful and re-assuring to
take an overall view (all highly variably expressed genes) and directly assess the clustering
dendrogram. This can be seen by repeating the clustering on a dissimilarity matrix calculated
on the Spearman rank correlation using R’s hclust function with Ward’s linkage agglomerative
clustering method [Murtagh and Legendre, 2014] combined with a fast leaf re-ordering
algorithm [Bar-Joseph et al., 2001]. Adding an indicator of the clusters inferred from the
dynamic tree cut algorithm shows consistency with the dendrogram calculated this way,
fig. 3.11. It is re-assuring that this alternate strategy reproduces similar clusters and only
cluster 5 is not so clearly defined but diffusely interposed between clusters 4 and 7.
3.7.2 Assigning identities to clusters
Cluster assignment was a complex task and was performed chiefly by Yosuke Tanaka and
myself [Scialdone et al., 2016]. This was performed by identifying differentially expressed
genes using a variety of methods including DESeq2 and by visualising the distribution of
gene expression on the dimensionality reduction tSNE plot, see section 3.7.4. Putative cell
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Fig. 3.10 Heatmap with clusters identified by a dynamic tree cut performed by AS on all
1205 cells and 1937 highly variable genes. Bootstrapping was used to select parameters.
Upper horizontal bar defines cluster as found by dynamic tree cut and lower horizontal bar
depicts the stage of the embryo from which the cell was harvested. Image was produced by
Vicki Moignard.
cluster
Fig. 3.11 Hierarchical clustering of all 1205 cells using all 1937 highly variable genes shows
consistency with the dynamic tree cut. The horizontal bar corresponds to clusters in fig. 3.10
types were assigned and refined through comparison with available in-situ hybridisation and
immunofluorescence experiments. The similarity between cell types also provided clues to
the biological identity of the cells. A web interface was developed and is provided online so
that gene expression of user selected genes can be viewed on a dimensionality reduction plot
http://gastrulation.stemcells.cam.ac.uk.
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Cluster
Number
Cluster
colour
Main
stage
Assigned ID Key genes & references
1 Magenta E6.5 Visceral endoderm
Amn,
Cubn [Du et al., 2010]
2 Pink E6.5
Extra-embryonic
endoderm
Essrb [Mitsunaga et al., 2004],
Elf5 [Donnison et al., 2005]
3 Turquoise E6.5
Epiblast and
primitive streak
Nanog [Morkel et al., 2003],
Sox2 [Wood and Episkopou, 1999]
4 Blue PS/NP
Mesodermal
progenitors
Mesp1 [Saga et al., 1999],
Mixl [Pearce and Evans, 1999],
Wnt3 [Du et al., 2010]
5 Orange NP
Posterior
mesdoerm
6 Red HF
Endothelium
(Yolk sac)
Sox18 [Pennisi et al., 2000],
Pecam1 [Baldwin et al., 1994],
Lyve1 [Gordon et al., 2008; Padrón-
Barthe et al., 2014]
7 Yellow NP Blood progenitors
Tal1 [Kallianpur et al., 1994; Robb
et al., 1995],
Runx1 [North et al., 1999; Tanaka
et al., 2012, 2014]
8 Brown HF
Primitive erythroid
cells
Hbb-bh1 [Palis et al., 1995],
Klf5 [Drissen et al., 2005; South-
wood et al., 1996],
Gata1 [Silver and Palis, 1997]
9 Black HF Allantois
Pitx1 [Lanctôt et al., 1997],
Tbx4 [Naiche et al., 2011],
Col1a1 [Tamplin et al., 2008]
10 Green HF
Pharyngeal
mesoderm
Tbx1 [Lania et al., 2015],
Prdm1 [Vincent et al., 2014]
Table 3.6 Collation of evidence for assigning cell types to data-driven cluster identification.
Table and references reproduced from that collated by Victoria Moignard.
This assignment of cell type was critical for attributing biological meaning to the single cell
data and combined with dimensionality reduction hinted at tentative relationships between
cell populations.
The approach taken here is manually intensive and highly supervised but if this turns out to
be an accurate ‘curation’ of cell states it will be possible to assign cells/samples sequenced
in future to clusters using an automated bioinformatic approach.
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Cell cycle is a fundamental biological process but we do not expect our clusters at this
embryological stage to be solely driven by this process. The clustering of cells does not
appear to be grossly cell cycle driven, fig. 3.12. There are some notable differences but the
small numbers of cells in some clusters preclude any definitive differences about variations
in cell cycle between different populations to be ascertained. Given that the algorithm used
was developed on ESCs it was felt that this algorithm was not sufficiently robust to pursue
this avenue of enquiry.
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Fig. 3.12 Proportions of each annotated cell population assigned to different stages of the
cell cycles. Numbers in bar give the actual number of cells. Cell cycle assigned by using the
‘cyclone’ function in the R package ‘scran’.
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3.7.3 PCA
A useful and commonly deployed method of assessing the overall structure of the data is
principal component analysis (PCA). Essentially the scaled and centered gene count data set
is considered to span a high-dimensional space. Eigenvectors and eigenvalues are calculated
on the covariance matrix to find a linear transformation of the data that maximises variance
in the basis vectors. Dimensionality reduction to an n-dimensional representation is achieved
by retaining eigenvectors corresponding to the largest n eigenvalues. Eigenvectors are unit
vectors and the eigenvalues give an indication of the proportion of variability explained by
the corresponding eigenvector.
The 2-dimensional PCA representations of the first 5 eigenvectors of the dataset are displayed
in fig. 3.13 with cells coloured according to the previously defined clusters. The different
components pick out disparate cell types. PC1 does not appear to pick out any biologically
meaningful aspect of the data nor is there any trend relating to either: the embryo, the stage of
the embryos, forward scatter, side scatter, DAPI intensity or FLK1/CD41 fluorescence. Some
lanes of the flow cell appear to have a trend towards more negative values for PC1, fig. 3.14,
giving a clue that this may be related to some technical artefact during library preparation. To
investigate further PC1 was correlated against the number of mapped reads (ρ = 0.862, p <
2.2×10−16) and ratio of unaligned to total reads (ρ =−0.606, p < 2.2×10−16), fig. 3.15.
The relationships are non-linear but monotonic therefore strength of the association was
tested using Spearman’s rank correlation. Both the number of mapped reads and the ratio
of unaligned to total reads act as proxies for the amount of input RNA; so PC1 appears to
correlate most strongly with either the amount of RNA in the cell or at least the efficiency
of the initial reverse transcriptase step of library production. This is additionally supported
by the variation in ERCC:mapped ratio displayed in fig. 3.8. Where input RNA is low,
mapped reads as a proportion of total reads are much lower than would be expected and most
unaligned reads are generated from either TSO concatemers or PCR primers.
PC2 segregates the epiblast cluster in particular, PC4 the endothelium, PC5 picks out both
the extraembryonic endoderm and extraembryonic ectoderm clusters and PC3 distinguishes
the remaining clusters with the blood cluster having low values in PC3 while the nascent
mesoderm having high values. The consistent separation of clusters on PCA as defined
by hierarchical clustering and dynamic tree cut provides additional re-assurance for the
robustness of the analysis.
An advantage of PCA is that it is a linear transformation with weights attributed to each
feature in this case genes for each component. These weights provide a means of visualising
the genes driving the separation in the corresponding principal component in way of loading
72
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Fig. 3.13 Pairs plot of the first 5 principal components of 1205 cells using 1937 highly
variable genes.
plots. Cells allocated to the putative E6.5 epiblast cluster have lower PC2 coordinates than
others, fig. 3.13. In fig. 3.16 the plot on the right focuses on the region highlighted in the
plot on the left. This indicates that the genes driving PC2 include Cdh1 (E-cad), Otx2,
Tdgf1 (Cripto), Pou5f1 (Oct4), Trh, Fgf5 and Dnmt3b amongst others. E-cad is not only
expressed in the epiblast but has been shown to play a critical role in the epiblast maintaining
pluripotency and preventing the epiblast from deliquescing into a mesenchymal state [Burdsal
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Single-cell transcriptomic analysis of murine gastrulation
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Fig. 3.14 Box plot of PC1 coordinates by lane of sequencing flow cell.
et al., 1993; Götz et al., 2000; Ohtsuka et al., 2012; Sumi et al., 2013]. Otx2 and Cripto
are expressed in the early epiblast and have a role in translating the proximal-distal axis
to an anterior-posterior axis [Boyl et al., 2001; Ding et al., 1998; Fiorenzano et al., 2016;
Kimura et al., 2001]. Oct4 a marker of pluripotency is highly expressed in the E6.5 epiblast
later becoming restricted to primordial germ cells (PGCs) [Song et al., 2016]. Thyrotropin
releasing hormone Trh, known most widely for its activity on the hypothalmic pituitary
thyroid axis is dynamically expressed through development and is expressed in the E6.5
epiblast [McKnight et al., 2007]. Fgf5 is a known marker of the post-implantation epiblast
and a marker of epiblast stem cells [Khoa et al., 2016]. DNA methyltransferase 3B Dnmt3b
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3.7 Identification of cell populations
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
ll
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l l
ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l l
l
l
l
l
l
l
ll ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
ll l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l
l l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
−60 −40 −20 0 20 40
2e
+0
5
5e
+0
5
1e
+0
6
2e
+0
6
5e
+0
6
PC1
N
uc
le
ar
 re
ad
s
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
ll
l l
l
l
l
l
ll
l
l
l
l
l l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
ll l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
ll
l l
l
l
l
l
l
l l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l ll
l l
l
ll
l
l
l
l
l
l
l
ll
l
ll
l
l
l
l
ll
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l l
l
l
ll
l
l
l
l
l
l
l
l l
llll l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l l
l
ll
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l ll lll
l
l l l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l l
l
ll
l
l
l l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
ll
ll
ll
ll
ll
ll
l
l
l
l
ll
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
ll
l
ll
ll
ll
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
ll
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l l
l
l
l l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l l
ll
l
l
l
l
l
l
l
l l
l
l
l
ll l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l l
l
l
l
l
ll
ll
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
ll
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
ll
ll
l
ll
l l
l
l
l
ll
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
−60 −40 −20 0 20 40
0.
3
0.
4
0.
5
0.
6
0.
7
PC1
Un
al
ig
ne
d:
To
ta
l
Fig. 3.15 Relationship between the first principal component coordinate of each cell with the
number of mapped nuclear reads (left) or the ratio of unmapped to total reads (right). The
nuclear mapped reads are plotted on a log scale.
encodes a key regulatory protein involved in denovo methylation of cytosine residues in DNA
chiefly at CpG islands thereby modulating gene expression and mutations have been causally
associated with human disease [Xie et al., 2006]. The post implantation embryo undergoes a
wave of demethylation re-establishing a developmentally primed methylation pattern from
the hypomethylated blastocyst state [Monk et al., 1987; Smith et al., 2017]. Expression of
Dnmt3b correlates with increasing methylation patterns in the E6.5 epiblast [Auclair et al.,
2014]. The preceding synopsis gives a brief introduction to how cell types were annotated by
gradually collating supporting evidence from the literature and visualising gene expression
in clusters primarily using tSNE dimensionality reduction section 3.7.4.
Looking at genes driving PC2 in the positive direction it is clear that haematopoietic genes
play a major role with expression of Tal1, Fli1, Lmo2 amongst many others. Another key
set of genes that have not previously been implicated in developmental haematopoiesis
but play key roles in T-cells include Nfatc1, Skap1, Cd59a. Their role in developmental
haematopoiesis though beyond the scope of the current work, warrants further attention
particularly due to their recognised role in inter-cellular signalling.
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Fig. 3.16 PCA loadings plot for PC2 and PC3. Left panel shows all highly variable genes.
The dotted box indicates the zoomed in plot that is shown in the right panel. (Cldn6 and
Cdh1 are overlapping at (-0.09,-0.03))
Fig. 3.17 Evidence collated from published literature showing the E6.5 epiblast localisation
of gene/protein expression for genes identified by the PCA loadings plot fig. 3.16. All
images are of E6.5 mouse embryos. RNA in-situ hybridisation images for Oct4, Trh, Cripto;
immunohistochemistry for OTX2, E-CAD and immunofluoresence for DNMT3B and FGF5
[Auclair et al., 2014; Boyl et al., 2001; Burdsal et al., 1993; Ding et al., 1998; Fiorenzano
et al., 2016; Götz et al., 2000; Khoa et al., 2016; Kimura et al., 2001; McKnight et al., 2007;
Ohtsuka et al., 2012; Song et al., 2016; Sumi et al., 2013; Xie et al., 2006].
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3.7 Identification of cell populations
3.7.4 tSNE
PCA is a linear transformation and reveals some structure to the data fig. 3.13 but it cannot
capture a non-linear manifold in the high dimensional space to which the data may be
constrained. The non-linear mapping technique t-distributed stochastic neighbourhood
embedding tSNE, reduces a high-dimensional dataset to a given number of lower dimensions
maintaining as far as possible the same distance relations between samples in this case cells.
Mathematical details of how this is performed will be discussed in section 5.3. In this case
the data is reduced to a 2-dimensional representation, figs. 3.18a and 3.18b.
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Fig. 3.18 tSNE dimensionality reduction of all cells and highly variable genes. Coloured by
the stage of the embryo (a) or by previously defined clusters (b).
Data driven clusters identified from hierarchical clustering with dynamic tree cut are con-
sistently co-localised in the tSNE even more so than with PCA, other than the posterior
mesodermal cluster (orange). This is split in two between the nascent mesoderm in blue and
the blood progenitors in yellow.
Not only do they separate well but their spatial arrangement imply biologically meaningful
relationships. At the sampled point in development blood and endothelium are predominantly
located in the yolk sac. The allantois is developing from the posterior of the embryo and will
later also contribute to heamatopoiesis and through vasculogenesis and angiogenesis develop
the prospective umbilical vessels. Additionally the blood progenitor (yellow) and blood
(brown) clusters are closely related suggestive of developmental progression, section 3.10.
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Single-cell transcriptomic analysis of murine gastrulation
Though unsupervised dimensionality reduction techniques provide a powerful tool for visual-
ising the data and allude to biologically meaningful relationships, prior biological knowledge
is required to assert for example spatial or temporal relations. These observations advocate
taking a more nuanced and cautious approach when assigning biological meaning to the
data. Despite this and although cluster identity was described earlier in the text in table 3.6,
tSNE dimensionality reduction was indispensable for ascribing identity to clusters. It was
extensively used to plot gene expression gradients to quickly visually determine the regions
of tSNE with high expression and so identifying associated clusters as seen in fig. 3.19.
Plotting gene expression on tSNE permitted rapid comparison with published RNA in-situs,
immunohistochemistry or immunofluorescence allowed gradual aggregation of supportive
evidence.
Figure 3.19 summarises key marker genes, their localisation and more importantly their co-
localisation on tSNE aiding cluster cluster assignment. Several known markers of expected
tissues can be used to identify their location on the tSNE. Marker genes can be assessed
individually or using different colour channels in combination.
Markers of extraembryonic endoderm include Afp and Ttr both being specific within the cell
populations assayed in this current experiment. Amn is not specific but in combination with
the others extraembryonic endoderm is clearly defined on the tSNE and though there appears
to be a single point, several cells are condensed into the same point due to their relative
similarity. The extraembryonic ectoderm cluster is similarly condensed onto what appears to
be a single point on the tSNE. Known markers Essrb, Elf5 and Cdx2 are co-expressed only
within this region as can be clearly seen on the combined three colour images. Such images
are frequently used in immunofluorescence to appreciate co-expression of proteins in single
cells and are readily interpretable.
The endothelial, pharyngeal mesoderm and allantoic clusters can be identified in a similar
fashion. The utility of co-expression, with marker expression represented by the three primary
colours, can be appreciated for these clusters where none of the markers individually are
highly-specific but in combination are expressed more intensely in their expected regions.
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3.7 Identification of cell populations
Fig. 3.19 Gene expression patterns in clusters for individual genes and combinations using
the 3 primary colours in imuunofluorescence-like tSNE maps. Schematics on left show
anatomically expected locations.
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Single-cell transcriptomic analysis of murine gastrulation
3.8 E6.5 cluster is polarised
Gastrulation as discussed earlier is a critical component of embryonic development and at
the very least it distributes cells to the appropriate region of the embryo but may also play a
role in specification. Brachyury is a key player in gastrulation, highly expressed within the
primitive streak at the streak stage. Figure 3.20 from Rivera-Pérez and Magnuson [2005]
shows expression of Brachyury circumferentially in the extra-embryonic ectoderm juxtaposed
to the epiblast and highly asymmetrically in the epiblast with the posterior epiblast having
high expression. Plotting its expression on tSNE shows that the E6.5 cluster is polarised
with the tapered end populated by the transforming cells undergoing ingression through the
primitive streak, fig. 3.21a. To focus in on this data highly variable genes fig. 3.21b and tSNE
embedding were recalculated on this restricted E6.5 epiblast population, fig. 3.21c.
Fig. 3.20 From Rivera-Pérez and
Magnuson [2005] shows expression
of Brachyury circumferentially in the
extra-embryonic ectoderm and poste-
riorly in the epiblast of an E6.5 em-
bryo
Having transcriptome wide gene expression at single-cell resolution it is possible to search for
other genes showing similar or opposing patterns of expression to Brachyury, by performing
a correlation analysis, fig. 3.22. This revealed genes known to be associated with gastrulation
Evx1 [Bell et al., 2016], Fgf8 [Tam and Behringer, 1997], Frzb , Wnt3 [Kemp et al., 2005;
Lickert et al., 2005; Rivera-Pérez and Magnuson, 2005] and Mixl1 but we also identify novel
markers e.g. 5730457N03Rik (known to be an antisense non-coding RNA to Evx1) and
Cxx1c. GO gene set enrichment analysis of the top 100 highly Brachyury correlated genes
using EnrichR (https://www.github.com/wjawaid/enrichR an R interface to a comprehensive
gene set enrichment web server [Kuleshov et al., 2016]) showed significant enrichment of
genes related to gastrulation (p = 1.3×10−3), angiogenesis (p = 5.7×10−3) and mesoderm
formation (p = 1.3×10−3) after adjustment for multiple testing. Single cell RNAseq therefore
can provide a powerful technique to identify novel genes related to a particular biological
process. Further analysis may allow for generation of testable hypotheses regarding the
involvement of these novel genes in gastrulation.
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Fig. 3.21 Capturing the transcriptome-wide gene expression programme of mouse gastrula-
tion. (a) Superimposes gene expression level of Brachyury (T) onto the tSNE representation
of the dataset. (b) Highly variable genes are recalculated on the subset of E6.5 cells only. (c)
tSNE recalculated on the E6.5 population with T expression.
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3.9 Spacial axis dichotomy - ‘Pseudospace’
3.9 Spacial axis dichotomy - ‘Pseudospace’
Careful examination of the tSNE representation of the data and exploration of gene expression
superimposed upon it, suggest cluster 4 representing nascent mesoderm may be divided in
two. Superimposed partially transparent cell representation as shown in the left subplot of
fig. 3.23 suggests that the nascent mesoderm has two centres of densities. Similarly the right
subplot of fig. 3.23 displaying contours of cell density superimposed on the tSNE, is highly
suggestive of two separate zones within the nascent mesodermal cluster.
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Fig. 3.23 Nascent mesoderm is composed of two zones. Left: A figure identical to fig. 3.18b
with the same colour scheme but the cells are partially transparent allowing for some appre-
ciation of cell density. This suggests two centres of densities or possibility of two separate
zones within the nascent mesoderm cluster. Right: Similar two left with a contour plot of
cell densities again highly suggestive of two separate populations.
Plotting expression of key marker genes suggests that the these zones represent spatial regions
within the embryonic mesoderm. More specifically a proximal zone expressing Tbx2, Tbx3,
Efna1 and Bmp4 [Du et al., 2010; McBride and Ruiz, 1998; Singh et al., 2005; Weidgang
et al., 2013]. On whole mount in-situs these are expressed in the proximal region and mostly
posterior but circumferentially extended around the cup into rostral mesodermal areas, see
lower row of panels on fig. 3.25. To visualise these expression patterns tSNE gene expression
plots focused on the nascent mesoderm cluster, fig. 3.24.
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Fig. 3.24 Expression of selected transcripts on a cropped tSNE (fig. 3.23) differentially
expressed between putative proximal, upper two rows of panels in blue and distal zones,
lower three panels in green of the nascent mesoderm on tSNE.
84
3.9 Spacial axis dichotomy - ‘Pseudospace’
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Single-cell transcriptomic analysis of murine gastrulation
Transcripts expressed more in the distal cup include epithelial to mesenchymal transition
related genes, Snai1, Mesp1, Mesp2, Twist1, Lefty1, Lefty2, Foxc1, Foxc2, Wnt related genes
Wnt3, Wnt5a, Frzb, Fzd7, Pou5f1, Map-kinase related genes Mapk4, Spry4, Notch signalling
genes Dll1, Dll3 and Tbx6 [Du et al., 2010; Lickert et al., 2005; Minowada et al., 1999]. In
contrast to proximal zone transcripts that are expressed circumferentially in whole mount
in-situ images, these are mostly restricted to the posterior half of the distal cup, see lower
three rows of fig. 3.24 and the upper panels of fig. 3.25.
Cells making up both the anterior and posterior zones are almost exclusively from streak and
neural plate stages of embryonic development (fig. 3.18a). Whole mount in-situ images have
thus been selected at the appropriate developmental stage to support the proposal that the two
zones represent spacially distinct but possibly overlapping regions of mesoderm, fig. 3.25.
Additionally when interpreting in-situs one must remain congnizant that only FLK1 positive
cells were sorted and analysed during these stages.
The Hox genes with evolutionary conserved homeodomains are colinearly ordered on chro-
mosomal clusters and play key roles in morphogenesis. Hox gene temporal and spatial
expression during embryogenesis mirrors their genomic order on the chromosome in an
anterior to posterior axis and a 3′ to 5′ arrangement. Hox clusters in Drosophila and their
4 counterpart orthologous clusters in mouse are summarised in fig. 3.26. Hox genes may
provide additional supporting evidence to the proximal and distal zone segregation within
the nascent mesoderm.
To further evaluate the putative anterior posterior axis in the dataset, gene expression of the
HoxA and HoxB cluster genes was plotted on the cropped tSNE, figs. 3.27 and 3.28. There is
a clear predilection of the more cephalad expressed genes in fig. 3.26 to be expressed in the
anterior region in comparison to the later more caudal genes. This is consistent between both
HoxA and HoxB genes.
The Hox gene expression pattern in the more caudally and later expressed genes does not
exactly match that which would be expected from fig. 3.26 partly because the cells captured
in the dataset are restricted both temporally and by their surface marker identity so that only
FLK1 or CD41 expressing cells have been assayed. Despite this caveat a spacial segregation
can be appreciated on the tSNE representation of the data.
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3.9 Spacial axis dichotomy - ‘Pseudospace’
Fig. 3.26 Hox gene patterns are evolutionarily conserved across species and or-
dered 3′ to 5′. Compare these expected Hox gene expression patterns with gene
expression in the putative anterior and posterior regions in the single-cell dataset
figs. 3.27 and 3.28. Image from http://www.ehu.eus/ehusfera/genetica/2012/12/16/
un-modelo-matematico-aplicado-a-los-genes-hox-explica-la-formacion-de-los-dedos/ ac-
cessed January 2018.
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Single-cell transcriptomic analysis of murine gastrulation
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3.10 Charting a developmental journey - ‘Pseudotime’
Assignment of clusters 7 and 8 to blood progenitor and erythroid suggests a developmental
relationship. Computationally ‘isolating’ these cells, recalculating highly variable genes
allows for the cells to be ordered to provide a temporal ordering.
A tool that has been adopted for this purpose of temporal ordering in single-cell data is
diffusion maps, where-by a Gaussian kernel is applied allowing for calculation of a first-order
Markovian transition matrix with jump probabilities of transitioning from one cell to another
in a random-walk. The spectral decomposition of this matrix then provides a means of
calculating the diffusion distance. Due to spectral decay of ordered eigenvalues, the first few
eigenvectors (excluding the first trivial solution) are sufficient to provide a good estimate
of diffusion distance - thus forming the basis of diffusion map dimensionality reduction
[Angerer et al., 2016; Coifman et al., 2005; Haghverdi et al., 2015; Nadler et al., 2006].
3.10.1 Diffusion Maps
Given an array of normalised expression values X ∈ Rm×n of m genes G and n cells C,
for Euclidean distance the isotropic positive semi-definite Gaussian kernel L ∈ Rn×n is
calculated:
Li, j =
√
2σiσ j
σ2i +σ2j
exp
− ∥xi−x j∥
2
2(σ2i +σ2j ) , for i ̸= j, where xi,x j ∈ Rm are column vectors of X
In the case above a distance function d is defined:
d(x,y) = ∥x− y∥ , x,y ∈ Rm
For cell i an ordered set of distances to all other cell, from closest to furthest can be constructed
Bi ∈ Rn. σi can then be calculates as [Haghverdi et al., 2016]:
σi =
√
Biknn+1
2
where knn ∈ Z is the k-th nearest neighbour. In this case the knn+1 cell is chosen as the
closest will be the cell itself.
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A feature of Diffusion map is the ability to tune the influence of data point density and this
can be parameterised with α:
L(α)i, j =
Li, j
(∑k∈C Li,k∑k∈C Lk, j)α
In the remainder of the analysis we have set α = 1 so approximating the Laplace-Beltrami
operator. The density corrected kernel can be re-written:
L′ = D−1LD−1
Where D ∈ Rn×n is a diagonal matrix wth entries Di,i = ∑ j Li, j. Finally the matrix must be
row normalised to form the transition matrix of a Markov chain, M.
M = B−1D−1LD−1
Where B ∈ Rn×n is a diagonal matrix with entries Bi,i = ∑ j L′i, j ̸= 0. The matrix M allows
one to imagine a random walk with probability of jumping from cell i to cell j given
by p(c j, t + 1|ci, t) = Mi, j. Jump probabilities at t steps is given by raising the transition
matrix to the appropriate power Mti, j. The computational complexity of such naïve matrix
multiplication can be prohibitive, O
(
n3
)
. The spectral decomposition or Jordan canonical
form can provide a useful means of calculating probabilities at higher values of t. The
singular value decomposition can allow such calculations:
Mti, j =∑
l
λ tl φl(xi)ψl(x j)
Where λl is the l-th ordered eigenvalues, φl (xi) the i-th component of the l-th left eigenvector
and ψl
(
x j
)
the j-th component of the l-th right eignevector.
The spectral decomposition of M, specifically the right eigenvectors now form the diffusion
map but though the graph Laplacian L is positive semi-definite and will have positive real-
valued eigenvalues and real valued eigenvectors, it is not clearly so for B−1D−1LD−1:
B−1D−1LD−1Ψ=ΨΛ, Ψ,Λ ∈ Cn×n
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Where Ψ ∈Cn×n is a matrix of ordered right eigenvectors and Λ ∈Cn×n is a diagonal matrix
of correspondingly ordered eigenvalues. But since B ∈ Rn×n is diagonal with all non-zero
diagonal entries a numerically stable solution can be found and shown to be real valued by
solving the related symmetric system:
(
B−
1
2 D−1LD−1B−
1
2
)
Ψ′ =Ψ′Λ′, Ψ′,Λ′ ∈ Rn×n
Where Ψ′ ∈Rn×n is a matrix with columns composed of ordered eigenvectors and Λ′ ∈Rn×n
is a diagonal matrix of ordered eigenvalues. Now multiplying both sides by B−
1
2 gives:
(
B−1D−1LD−1
)(
B−
1
2Ψ′
)
=
(
B−
1
2Ψ′
)
Λ′
A numerically stable and accelerated algorithm can now be implemented to calculate eigen-
vectors of the related symmetric system and Ψ calculated by simply applying the diagonal
matrix B−
1
2 :
Ψ= B−
1
2Ψ′ and Λ= Λ′
Furthermore since B ∈ Rn×n with only diagonal entries and Ψ′ ∈ Rn×n we can now also say
Ψ,Λ ∈ Rn×n making them more easily interpretable. This method combined with either the
Arnoldi or Lanczos algorithms [Arnoldi, 1951; Lanczos, 1950] provides a computationally
efficient way of calculating the diffusion map dimensionality reduction and is implemented
in the roots package available on CRAN and Github at https://github.com/wjawaid/roots.
3.10.2 Ontogenic reconstruction of embryonic blood development
The blood progenitor and blood clusters were selected on the tSNE, highly variable genes
calculated and diffusion map dimensionality reduction performed. The first three diffusion
map components are plotted in a pairs plot in fig. 3.29.
Diffusion component (DC) 1 segregates blood progenitors from more differentiated blood
cells in a manner consistent with a pseudo-temporal developmental process. In contrast
DC2 and DC3 do not appear to resolve any meaningful biological process. Additionally
DC2 appears to be strongly correlated with library size as compared to DC1 and DC3, see
table 3.7. Given this DC1 and DC3 were selected for future visualisation within this dataset.
DC2 though does provide some evidence that certain cells may be outliers and so may need
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Fig. 3.29 Diffusion map dimensionality reduction. A pair splot showing the first 3 diffusion
map components. Similar cells are closer in diffusion distance and are placeed closer on the
diffusion map so that related cells are adjacent. Yellow - Blood progenitors, Brown - Blood
see fig. 3.18b. The geometric relationship is reminiscent of an ontogenic progression from
blood progenitor towards blood as would be expected from the cell type assignment. This
is further supported by plotting the stage of the embryo from which the cell was harvested
fig. 3.30a showing a progression from blood progenitors to blood.
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Table 3.7 Correlation of diffusion components with library size shows strong correlation
between DC2 and library size, so DC3 was favoured over DC2 for visualisation.
DC1 DC2 DC3
Pearson Correlation -0.0625 0.2098 0.0148
p-value 0.3052 0.0005 0.8084
to be removed from downstream analysis. Plotting embryonic stage of the embryo from
which the cell was harvested provides support to the temporal ontogenic progression from
left to right on the diffusion map fig. 3.30a.
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Fig. 3.30 Diffusion components (DC1 and DC3). In (a) each cell is coloured by the stage of
the embryo from which it was harvested. In (b) cells are coloured by the assigned cluster see
fig. 3.29. The path is a principal curve [Hastie and Stuetzle, 1989]and the arrow indicates the
expected direction of developmental progression.
DC1 may in this context be used as a surrogate for ontogenic progression, alternatively a
principal curve [Hastie and Stuetzle, 1989] fitted and the cell projection along this used
as developmental progression (fig. 3.30b) but Haghverdi et al. [2016] have proposed a
formal method to calculate pseudotime based on the calculations used in diffusion maps but
without necessitating any dimensionality reduction. This utilises the Markovian matrix and
its spectral decomposition to evaluate the time evolution of a starting probability distribution
f (t) ∈ Rn:
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f (t) = Mt f (0)
Haghverdi et al. [2016] have argued that it is not important whether the asymmetric matrix,
M = B−1D−1LD−1 or the symmetric matrix S = D−1LD−1 are used, since diffusion maps
reveal the underlying geometry of the manifold rather than directions on the manifold. Now
the eigen decomposition of S can be used for calculating St :
Sti,k =
n
∑
l=1
λ tl ψl(xi)ψl(xk), S ∈ Rn×n
Where ψ ∈ Rn and λ ∈ Rn now represent the ordered eigenvectors and eigenvalues of
S, respectively. Now rather than using a particular t and to account for asynchrony of
differentiating cells, Haghverdi et al. [2016] suggest taking the infinite sum of the time
evolution:
∞
∑
t=1
f (t) =
∞
∑
t=1
St f (0)
Using the eigenvector decomposition this becomes:
∞
∑
t=1
Sti,k =
∞
∑
t=1
n
∑
l=1
λ tl ψl(xi)ψl(xk)
Re-arranging summations:
∞
∑
t=1
Sti,k =
n
∑
l=1
∞
∑
t=1
λ tl ψl(xi)ψl(xk)
This geometric sum will converge as long as all eigenvalues λl < 1. The first eigenvalue
representing the stationary distribution with λ1 = 1 and ψ1 ∈ Rn with all entries of value 1√n .
The stationary distribution only contains information of the cell sampling density and not
about the temporal evolution [Haghverdi et al., 2016]. This can therefore be removed and we
now call this new matrix T with entries T (i,k):
T (i,k) =
n
∑
l=2
∞
∑
t=1
λ tl ψl(xi)ψl(xk)
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and so as t → ∞ the geometric sum equates to:
T (i,k) =
n
∑
l=2
λl
1−λlψl(xi)ψl(xk)
Haghverdi et al. [2016] now consider T (i, .), the i-th row of matrix T to be the feature
representation for cell xi. They then define the diffusion pseudotime distance measure
dpt(i, j) as:
dpt2(i, j) = ∥T (i, .)−T ( j, .)∥2
=
n
∑
k=1
(T (i,k)−T ( j,k))2
=
n
∑
k=1
(
n
∑
l=2
ψl(xk)
(
λl
1−λl
)(
ψl(xi)−ψl(x j)
))2
and since the eigenvectors are chosen to form an orthonormal basis:
dpt2(i, j) =
n
∑
l=2
(
λl
1−λl
)2 (
ψl(xi)−ψl(x j)
)2
This now provides a method for calculating diffusion pseudotime and ordering cells in an
ontogenic pseudotime. It is also evident that diffusion pseudotime is a weighted Euclidean
distance in diffusion map space; each eigenvector distance weighted by a function of the
corresponding eigenvalue.
The eigenvalues and so the weights decay quickly suggesting that a good approximation can
be achieved by limiting the number of eigenvectors used in diffusion pseudotime calculation
so as to reduce computational resource usage, fig. 3.31a. This method is implemented in the
R package roots available on CRAN and Github, https://github.com/wjawaid/roots.
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Applying this to the subset of cells forming the embryonic blood and progenitor populations
reveals a developmental progression consistent with the diffusion map representation and
the principal curve, figs. 3.30b and 3.31. Additionally it becomes even more apparent that
some of the cells may be outliers and should be excluded when generating gene dynamics,
fig. 3.32.
Diffusion pseudotime [Haghverdi et al., 2016] and the projection on to the principal curve
[Hastie and Stuetzle, 1989] fitted to the diffusion map are consistent in their time ordering
showing strong correlation pearson’s correlation ρ = 0.968 and p = 5.7×10−146) fig. 3.33.
Subsequent analyses have been limited to using diffusion pseudotime.
3.10.3 Inferring gene dynamics during primitive-wave haematopoiesis
Armed with transcriptome-wide single cell gene expression along this developmental trajec-
tory it is possible to define the dynamics of gene expression as progenitor cells differentiate
into committed erythroid cells. Faithful reconstruction of these gene expression dynamics
may provide a means to infer gene interactions and therefore provide insights into the gene
regulatory networks that govern differentiation within this subset of cells.
Gene expression profiles though are affected by noise from experimental measurement
fidelity limits, which in single cell data includes drop-out. ‘Drop-out’ refers to the failure to
capture an mRNA molecule from a cell despite moieties being present due to the random
nature of the capture technique, fig. 3.4.
A supervised learning approach can be used to fit a model to the noisy data providing two
main advantages:
1. Smooth out the noise in the data
2. Make predictions at unmeasured time points
A variety of methods exist including generalised linear regression where model complexity
e.g. order of polynomial may be selected; the model fitted followed by subsequent model
selection. Selecting models may be difficult with simple models not fitting data well and
more complex models overfitting the training data. For the purposes of fitting gene expression
dynamics we adopted an alternative approach of giving a prior probability to every possible
function but higher probabilities assigned to functions considered to be more likely, for
example smoother functions. Rasmussen and Williams [2005] describe how this can be done
using a generalisation of the Gaussian probability distribution - the Gaussian process. This
defines a fully stochastic model of gene expression so that the expectation (mean) and the
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Fig. 3.32 Outlier cells were excluded based on DC2 (above). The corresponding cells are
marked on the DC1/DC3 plot as black squares (below).
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Fig. 3.33 Diffusion pseudotime and principal curve pseudotime are highly correlated ρ =
0.968, p = 5.7× 10−146. This high correlation provides empirical support that diffusion
pseudotime appears to be resolving a temporal progression mapped out by the principal curve
on the diffusion map, see fig. 3.29.
variance may be calculated at any pseudotime, additionally a marginal likelihood can be
calculated to allow formal model comparison.
Gaussian processes can be fully specified by a mean function m(x) and a covariance function
k(x,x′) in this case for a gene expression profile function f (x), from Rasmussen and Williams
[2005]:
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m(x) = E[ f (x)],
k(x,x′) = E[( f (x)−m(x))( f (x′)−m(x′))]
The covariance function that will be used here is the parameterised squared exponential:
k(x,x′) = σ2f exp
(
− 1
2l2
∣∣x− x′∣∣2)+σ2n δxx′
where the length-scale l, the signal variance σ2f and the noise variance σ
2
n assuming inde-
pendent noise are hyperparameters [Rasmussen and Williams, 2005]. δxx′ is the Kronecker
delta:
δxx′ =
1, if x = x′,0, if x ̸= x′.
Assuming that we have observations (x,y) where x ∈ Rn in the current application is a
vector of pseudotime of n cells and y ∈ Rn is the value of expression of any particular
gene corresponding to the pseudotime x. Now we wish to make predictions (x∗, f∗) of the
generating process under the multivariate normal distribution prior for the joint distribution
[
y
f∗
]
∼ N
([
µ x
µ x∗
]
,
[
K(x,x)+σ2n I K(x,x∗)
K(x∗,x) K(x∗,x∗)
])
where the function K is a vectorised function, such that A = K(p,q), p ∈ Rm and q ∈ Rr
returns A ∈ Rm×r with Ai, j = k(pi,q j). I ∈ Rn×n is the identity matrix. µ x = m(x) and
µ x∗ = m(x∗) and both µ x = 0 = µ x∗ where 0 ∈ Rn is the zero vector. Given such a joint
distribution the marginal distribution of f∗ is simply given by
f∗ ∼ N
(
µ x∗,K(x∗,x∗)
)
and the conditional distribution of f∗ given y is
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f∗|x,y,x∗ ∼ N
(
f¯∗,cov(f∗)
)
, where
f¯∗ = µ x+K(x∗,x)
[
K(x,x)+σ2n I
]−1
(y−µ x), and
cov(f∗) = K(x∗,x∗)−K(x∗,x)
[
K(x,x)+σ2n I
]−1
K(x,x∗)
Inversion of the symmetric positive semi-definite covariance matrix
[
K(x,x)+σ2n I
]
may be
computationally challenging and is addressed by using the Cholesky decomposition, where
L is a lower triangular matrix
[
K(x,x)+σ2n I
]
= LLT
Gaussian process regression using a naïve uninformative prior mean function m(x) = 0 and
the squared exponential function with σ f = 1, l = 0.2,σn = 1 hyperparameters, was applied
to gene expression profiles along diffusion pseudotime to fit smoothed curves. This was
implemented in the R package gpr that can be downloaded at https://github.com/wjawaid/gpr.
This completely naïve uninformative prior led to a poor fit at the edges of the dynamic process
due to the sparsity of the data. Choosing a better prior should circumvent this problem. There
are several choices but a simplistic method is that given we are modelling gene g with mean
expressions x¯gp in the progenitor blood population and x¯
g
b in the more differentiated blood
population on the pseudotime interval [0,T ], we assume a linear mean prior:
m(t) =
x¯gb− x¯gp
T
t+ x¯gp
Expression profiles of a few key haematopoietic genes are shown in fig. 3.34. This demon-
strates some of the expected dynamics with Hbb-bh1 steadily increasing and Kdr (encoding
the protein FLK1) steadily decreasing. The variance around the mean in Gaussian process
regression shown in the shaded grey region depends on the sampling density around that
pseudotime and on the amount of variance within the dataset itself.
Gene dynamics across the transcriptome along this differentiation process can now be com-
pared by correlating the smoothed expression profiles along the pseudotime and clustering
into the main gene dynamic profiles. Furthermore since noise is explicitly modelled the
variance for the mean of each gene along pseudotime can be compared to evaluate genes
that have similar noise patterns. This noise pattern comparison would be more useful in a
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Fig. 3.34 Gene expression patterns showing Tal1 a gene that is activated even at the earliest
time, Gfi1b that becomes activated early then plateaus, Hbb-bh1 that continues to increase
and Kdr which starts with high expression and is no longer expressed toward the end of
pseudotime. The red line represents the mean and the shaded region either side marks the
limit of the 95% confidence interval. Each point represents a cell and marks the actual data
i.e. the log10 transformed normalised counts.
bifurcating process as a noisy system may resolve with expression profiles of cells converging
around two different expression levels.
Gaussian process regression was performed on the 9286 genes annotated by ENSEMBL as
protein-coding, expressed in at least 30% of cells within the heamogenic progenitor and
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embryonic blood clusters. These gene expression profiles typically form a time-series and
as such methods designed for analysing time-series based on dynamic time warping (dtw)
[Sakoe and Chiba, 1971, 1978] were used to characterise dissimilarity, to perform clustering
and to extract per cluster prototypic gene expression profiles. Before progressing genes were
further filtered to keep only those genes that have sufficient variation, so that only genes
with posterior fitted means having a standard deviation across the whole dynamic process of
greater than 0.2 were clustered. This yielded 1546 gene profiles that were analysed using the
dtwclust package in R using fuzzy clustering (https://cran.r-project.org/package=dtwclust),
see methods for further details. Six distinct clusters were identified and a prototypic gene
profile from each cluster is displayed in fig. 3.35. Table 3.8 shows some genes that are most
strongly linked with each of the fuzzy clusters.
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Fig. 3.35 Gene profiles of a prototypic gene from each of the fuzzy clusters. Some of the
genes assigned to these clusters are shown in table 3.8
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Table 3.8 Genes dynamic profiles clustered using dynamic time warping distances and
fuzzy clustering. Genes cluster assignments for some key genes are shown. See fig. 3.35 for
expected dynamics from each cluster.
Cluster Genes
1 Smad4, Cmtm7, Fn1, Bcorl1, Rab31, Nek6, Fign, Golim4, Sepn1, Sertad1,
Klhl2, Trim44, Gpr108, Sptbn1, Emilin1, Arhgef2, Rhbdd2, Vgll4, Tmbim1,
Myo5a, Appl2, Zyx, Plcl2, Arfgef1, Cx3cl1, Dyrk2, Bend4, Amot, Fbxo18,
Fam21, Pex6, Hspg2, Clic6, Sh2b3, Nfxl1, Hhex, Cmtm3, Pde4a, Wwc2,
Map4k4, Hapln1, Sall2, Brd1, Smurf2, Igf2, Depdc1b, Smpd2, Elmo2,
Thap3, Stx6
2 Pced1b, Fam84b, Tsku, Lef1, Tmem98, Phlda2, Gnai1, Dscr3, Sh3rf1,
Prickle1, Phf6, Csrp2, Tmod2, D17H6S53E, Map3k1, Gpc3, Rnf103,
Rgs19, Zfp260, Ap1s2, Tbx3, Wwtr1, Ptprk, Plekha1, Plk2, Klf5, Dusp16,
Rbp1, Nid2, Ank2, Saysd1, Basp1, Frmd6, Dst, Dcbld2, Adam23, Krt8,
Zscan21, Ehd2, Grrp1, Serpinb6a, Tinf2, Ptpn13, Nr4a1, Galnt11, Map1b,
Pcsk7, Rasl11b, Slc30a4
3 Chchd10, Grina, Pradc1, Sept4, Slc38a5, Epb4.2, Tuba4a, Sord, Kcnn4,
Smox, Fads3, Smim1, Cpne7, Rgs10, Xk, Psmb10, Ube2l6, Uros, Agfg2,
Cpeb4, Hpdl, Ppox, Gstm1, Gabra4, Nmrk1, Car2, Syngr1, Slc25a37,
Gm6665, Tmod1, Akap7, Blvrb, Angptl4, Slc14a1, Cercam, Hbb-bh1,
Ndufaf7, Dhrs11, Hebp1, Mt1, Slc16a10, Daam1, Alas2, Trim10, Rab3il1,
Ell2, Hba-x, Mtg1, Spef1
4 Rbms1, Cep55, Dag1, Cnn3, Vcl, Ptpn9, Zfp521, Gng12, Gng2, H2afy2,
Kif2c, Pcgf5, Rbm4b, Mpnd, Fnbp1l, Zfp36l1, Efcab14, Mapk3, Smtn,
Kifc1, Wtip, Shc1, Fli1, Rbpms, Ndfip1, Elavl2, Ckap4, Sptlc2, Kif1b,
Dock1, Pvrl2, Tmem185b, Podxl, Nde1, Zfp652, Kif13a, Bcl2l1, Rras2,
Limd2, Fkbp7, Serpinh1, Dock11, Cfl2, Rasal2, Cenpf , Sox11, Itpkb,
Rpp25, Kdr
Continued on next page
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Table 3.8 – continued from previous page
Cluster Genes
5 Ddx26b, Prkca, Bid, Mpp2, Gucy1a3, Slc25a12, Cep70, Atmin, Pfkm,
Bsn, Ehd3, Micall2, Gamt, Lgals9, Epor, Itga2b, Ajap1, Ppargc1b, Spns2,
Gja6, Nfe2, St3gal5, Was, Cited4, Gne, Mfsd2b, E2f8, Taok3, Tspan32,
Ccnb1ip1, Rps2, Gfi1b, Hk1, Gsta4, Treml2, Homer2, Gata1, Matn1,
Mbnl1, Fam110c, Cacna2d2, Hivep1, Sla2, Hes6, Ano2, Abcg1, Fam58b,
Syk, Igsf3, Mxi1
6 Rnf125, Tie1, Plxnc1, Capn2, Afap1l1, Col18a1, Egr1, Oaf , Itga6,
Lrp11, Src, Bcl11b, Ier5, Ptrf , Bcr, Dpysl3, Sdc3, Ogfod1, Dusp2,
Unc45a, Dpy19l1, Slc18a2, Plec, Fam160b2, Sipa1, Ascl2, Pear1, Timp3,
AI467606, Fam193b, Zswim6, Actr5, Slc9a3r2, Gna12, Atad2b, Ikzf2,
Nrros, Kit, Mgat4b, Bcl9l, Tnfaip8, Tgm2, Pigl, Gpr97, Cmtm4, Inf2,
Rcor2, Pank1, Ctla2a, Hist3h2ba
Clusters 1, 2 and 4 include genes that are predicted to decrease during the course of blood,
fig. 3.35. Cluster 2 decreases during the earliest periods of the time-course while cluster 4
is decreasing from the beginning but has expression falls more rapidly during the second
half of the time-course. Cluster 1 appears to stay constant over the first-half and then shows
falling expression in the second-half of the pseudotime. Genes contributing to these clusters
include Kdr, Fli1, Sox11, Klf5, Tbx3, Igf2 and Hhex amongst others.
Clusters 3 and 5 are composed of genes that show an activating expression profile over the
inferred pseudotime with cluster 5 showing early plateauing compared to cluster 3 fig. 3.35.
These clusters include genes such as Hbb-bh1, Hba-x, Blvrb, Angptl4, Cercam, Itga2b, Nfe2,
Cited4, Gfi1b and Gata1.
Cluster 6 interestingly shows dynamics of activation with subsequent deactivation during
this inferred haemogenic development. It includes genes such as Tie1, Bcr, Bcl11b, Dusp2,
Ikzf2, Kit and Ctla2a.
These lists contain genes known to be involved in embryonic blood development and their
known dynamics support the pseudotime ordering but also genes previously not associated
with embryonic haemogenesis are identified and they may provide promising avenues for
further study revealing hitherto unrecognised targetable pathways.
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3.11 Coarse temporal data corroborates findings
A useful feature of this experiment is the collection of metadata, this can provide supporting
evidence and inform certain choices we make, for example the starting point of a pseudotime.
The stage of the embryo is one of the features that was included in the metadata, it gives
coarse temporal information and can provide useful insights into the underlying biology.
Taking the whole data set but excluding E6.5 the tSNE was recalculated, fig. 3.36. The reason
for excluding E6.5 cells is that there is a substantial developmental gap between this time
point and the next so that intermediate cells are likely to have been missed by our sampling
strategy as is evidenced by the separation of the E6.5 epiblast cluster from the remainder of
the timepoints which show reasonable mixing on the original tSNE fig. 3.18
To evaluate how cell populations evolve over developmental time, cells were plotted in
separate panels by stage of embryo from which the cell was harvested, fig. 3.37. Care must
be taken when interpreting plots split by embryo stage because of the pitfalls of not taking
account of the different sorting strategies deployed so it is useful to keep fig. 3.2 in mind, as
it provides an overview of the experimental protocol and therefore the cell population that
was sampled. The number of FLK1+ sorted cells were about the same at all stages but no
CD41+ were sorted at the primitive streak stage.
At the primitive stage there appear to be three groups, two not so discrete within the nascent
mesoderm cluster (see fig. 3.36a) and one in the blood progenitor population that goes on to
expand substantially in the neural plate and head fold time points bifurcating to form blood
and possibly endothelium, lower arrow in fig. 3.37. This supports initiating a pseudotime
trajectory from the blood progenitor population rather than the posterior subset of the nascent
mesoderm or even the epiblast.
Moving on to the neural plate stage there appears to be significant proliferation of the group
in the blood progenitor population but this may arise from enriching CD41+ by the sort
strategy rather than an underlying biological effect. Another observation is that the anterior
compartment of the nascent mesoderm has been depleted of cells as compared to the PS
stage while the cell density in the posterior compartment has increased.
By the head fold stage the region populated by nascent mesoderm is depleted and the FLK1+
cells are now endothelial or pharyngeal mesoderm. The pharyngeal mesoderm in particular
is replete of cells, the origin of this cluster of cells though is unclear from this data set. It is
also interesting that the density of cells in the blood progenitor and the subset of the posterior
107
Single-cell transcriptomic analysis of murine gastrulation
mesoderm cluster nearest to it appear subtly less populated while this is not apparent in
region near the posterior mesoderm cluster interspersed with the nascent mesoderm.
Another population that is almost exclusive to the head fold stage is the allantois and it is
adjacent but non-overlapping with the posterior compartment of the nascent mesoderm and
appears to be derived from the posterior and nascent mesodermal cells. Additionally the
erythroid cluster particularly towards the apex has increased cell density at the HF stage as
compared with the NP stage, possibly indicating the emergence of terminally differentiated
embryonic blood.
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Fig. 3.36 tSNE performed after removing the E6.5 cells and recalculating highly variable
genes. (a) Coloured by stage of embryo from which cell was harvested. (b) Coloured by
sorting strategy. The CD41+ sorted cells were indexed for FLK1. (c) Coloured by cluster
assignment.
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Fig. 3.36 tSNE after removing E6.5 cells (contd.)
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Fig. 3.37 Coarse temporal separation of cells. Separated by stage of embryo from which the
cell was harvested, primitive streak (PS, purple), neural plate (NP, green) and head fold (HF,
red) stage.
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3.12 Finding substructure within clusters
Data driven cluster identification has robustly defined cell subpopulations but it is clear
from the dendrogram in fig. 3.11 that there may be biologically meaningful substructure
within these ‘macroclusters’. Polarisation of the epiblast and the anterior/posterior axis of
the nascent mesoderm clusters demonstrate this point (see sections 3.8 and 3.9 for further
details).
Further delineation of the clusters is possible by utilising even relatively limited prior
knowledge of biological processes and developmental biology. This is exemplified within
this dataset by studying the pharyngeal mesoderm and endothelial clusters more closely as
described below.
3.12.1 Structure within the pharyngeal mesoderm
The second heart field (SHF) is known to arise from the pharyngeal mesoderm and express
the molecular marker Nkx2.5 early in development [Zhang et al., 2014]. The pharyngeal
mesoderm cluster contains both Nkx2.5+ and Nkx2.5- cells on the tSNE, fig. 3.38. The Nkx2-5
expressing cells of the pharyngeal mesoderm likely constitute the second heart field.
To identify genes related to early cardiac specification, cells were empirically split by Nkx2.5
expression into two groups using a normalised log transformed gene count threshold of 0.5.
Differential gene expression identified 14 genes (Mann Whitney U-test with multiple testing
correction, 5% FDR), fig. 3.39. Several of these genes, Mef2c [Vincentz Joshua W. et al.,
2008], Gata5 [Bonachea et al., 2014; Hempel et al., 2017], Cfc1 [Goldmuntz et al., 2002],
Isl1 [Colombo et al., 2018; Peng et al., 2013; Zhuang et al., 2013], Hand2 [Laurent et al.,
2017], Gata4 [Neshati et al., 2018; Yu et al., 2018]and Tcf21 [Yang et al., 2017] are known
to be involved in cardiac development. In fact Isl1 is considered to be a marker of the second
heart field.
CRYPTIC (encoded by Cfc1), is a protein known to be associated with heterotaxia, particu-
larly conotruncal cardiac malformations and isomerism, is expressed at the head fold stage
in FLK1 positive cells with high Nkx2.5 expression [Goldmuntz et al., 2002]. Notably we
have also identified Lrrn4, a gene that is highly correlated with CRYPTIC within the pharyn-
geal mesoderm cluster as a novel gene that may be involved in early cardiac development,
exemplifying how this rich dataset can be used generate new hypotheses.
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Fig. 3.38 Figure showing Nkx2-5 expression within a subset of pharyngeal mesoderm cells
likely corresponding to the second heart field. (a) shows region of tSNE plot on which
expression of Nkx2-5 is displayed in (b).
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Fig. 3.39 Heatmap displaying log10 normalised counts within the pharyngeal mesoderm
cluster cells in columns and genes found to be differentially expressed between Nkx2.5+
(Black in horizontal bar) and Nkx2.5- cells (Grey in horizontal bar) in rows. Rows are
clustered, there is no clustering on the columns. Row side colours: Dark green - Up-regulated
in Nkx2.5+; Light green - Down-regulated in Nkx2.5-.
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3.12.2 Discovery and validation of a novel pathway
Taking the same approach as described for the pharyngeal mesoderm, a sub-cluster was iden-
tified within the endothelial cluster corresponding to a putative erythroid myeloid progenitor
(EMP) subset. The EMP population was identified using prior knowledge of genes related to
induction of the EMP programme in haemogenic endothelium, namely Gfi1b, Itga2b (CD41)
and Itgb3 (CD61). Analysis was limited to the endothelial cell population, the suggested
source of EMPs.
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Anxa6
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Itga2b
Scarf1
Tie1
Ctla2a
Ctla2b
Hbb−bh1
Hba−x
Nfe2
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Eltd1
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Cited4
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Color Key
Fig. 3.40 Clustering of endothelial cluster using genes that are highly correlated with Gfi1b,
Itga2b and/or Igtb3.
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Spearman’s rank correlation was used to identify genes highly correlated with Gfi1b, Itga2b,
Itgb3. Multiple testing correction was applied by weighting genes as described by Ignatiadis
et al. [2016] and p < 1×104 for the adjusted p-values was considered significant, yielding
28 highly correlated genes. Hierarchical clustering resulted in 2 major gene clusters and 4
cell sub-types, fig. 3.40. The cyan colour in the bar over the heatmap in fig. 3.40 indicates
the cluster of cells that appears to have a gene expression signature consistent with an EMP
progenitor. Gene ontology enrichment focusing on biological processes, for the 28 highly
correlated genes strongly suggest a role for the leukotriene/lipoxin branch of the arachidonic
acid pathway in yolk sac definitive-wave haematopoiesis, see table 3.9. Nearly all of the top
10 hits are related to the arachidonic acid pathway specifically to the genes Alox5, Alox5ap
and Ltc4s.
Table 3.9 GO Biological process enrichment analysis using enrichR. Hits are ordered by
adjusted p-value and top 10 are shown with p-values. Enrichment analysis performed using
enrichR available from CRAN (https://cran.r-project.org/package=enrichR) or GitHub (https:
//github.com/wjawaid/enrichR). Database interrogated is GO_Biological_Process_2017.
GO Biological process term adjusted p-values
(×10−3)
lipoxin biosynthetic process (GO:2001301) 3.8
leukotriene catabolic process (GO:0036100) 3.8
lipoxin metabolic process (GO:2001300) 3.8
lipoxin B4 metabolic process (GO:2001304) 3.8
lipoxin A4 metabolic process (GO:2001302) 3.8
green leaf volatile biosynthetic process (GO:0010597) 3.8
leukotriene D4 biosynthetic process (GO:1901750) 6.2
regulation of cell migration (GO:0030334) 6.2
leukotriene D4 metabolic process (GO:1901748) 6.2
leukotriene metabolic process (GO:0006691) 6.2
This leukotriene branch of the arachidonic acid pathway has not previously been implicated
in embryonic haemogenesis while there is evidence of other arachidonic acid metabolic
branches being involved in zebrafish embryonic haematopoiesis: prostaglandin E2 and
Epoxyeicosatrienoic acids have been shown to play critical roles [Li et al., 2015; North et al.,
2007].
We then took advantage of our recently published chromatin immuno-precipitation sequenc-
ing (ChIP-Seq) reference experiment looking at several key heamatopoiesis related transcrip-
tion factors in a mouse embryonic stem cell (ESC) differentiation model of haematopoiesis
[Goode et al., 2016]. The data can easily be accessed through CODEX (http://codex.stemcells.
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cam.ac.uk/). First we looked for binding of key transcription factors TAL1/SCL, PU.1, FLI1,
LMO2, GFI1 and GFI1B around gene loci of Alox5, Alox5ap and Ltc4s.
There were several consistent peaks found at the Ltc4s locus in haematopoietic progenitors,
haemangioblasts and haemogenic endothelium. Alox5 and Alox5ap loci also show consistent
convincing binding peaks (not shown, can be looked up at http://codex.stemcells.cam.ac.uk/).
This provides supportive evidence that Ltc4s, a key enzyme in the leukotriene pathway, is a
direct target of several heamatopoietic transcription factors.
Next we interrogated DNAase I hypersensitivity data from Goode et al. [2016]. This showed
that the genomic region at the peak located ≈ 2kb from the TSS for Ltc4s is open in both
haemogenic endothelium and haematopoietic progenitors but not in ontogenically earlier
mesodermal progenitors or haemangioblasts nor in the more mature macrophages fig. 3.42.
Arachidonic acid is a poly-unsaturated fatty acid and an integral part of the phospholipid
bilayer forming the cell membrane. Arachidonic acid is metabolised through several pathways
forming active substances including prostaglandins, eicosanoids and leukotrienes all of which
have been implicated in both physiological and pathological inflammatory responses.
Alox5, Alox5ap and Ltc4s form a complex on the outer nuclear envelope and generate
leukotrienes in particular leukotriene C4 (LTC4). The pathway is summarised in fig. 3.43,
produced by Dr Vasilis Ladopoulos. Arachidionic acid itself is generated by the action of
phospholipases on phospholipids from the cell membrane phospholipid bilayer.
To further study the role of the leukotriene pathway in HE and EMP ontogeny, we used a
frequently used in-vitro embryonic stem cell (ESC) differentiation assay [Coulombel, 2004;
Pereira et al., 2007]. This assay is designed to assess the number of seeded cells that can go
on to form haematopoietic colonies. Further it can be used to assess the type of colonies
generated. Rather than liquid culture where cells are mobile in this semi-solid medium cells
are plated at low density and then the number of colonies counted prior to them merging with
cells from neighbouring colonies.
These experiments were all performed by Dr Vasilis Ladopoulos. Mouse ESCs maintained
in serum/LIF were differentiated into embryoid bodies (EBs) and exposed to either Zileuton,
a pharmacological Alox5 inhibitor approved clinically for use in patients with asthma or to
LTC4 , fig. 3.44. At Day 4, EBs were dissociated and the compounds washed out. Cells
were counted and plated at equivalent numbers in methylcellulose to perform the short-term
colony forming cell (CFC) assay [Coulombel, 2004; Pereira et al., 2007]. Total colonies were
enumerated at day 14, colony morphology itself was not assessed.
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Fig. 3.41
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Fig. 3.41 (contd.) Tracks of Chip-Seq data (from UCSC genome browser using CODEX
http://codex.stemcells.cam.ac.uk/) for transcription factors Lmo2, Spi1, Runx1, Gfi1, Tal1/Scl
and Fli1 and their genomic binding in haematopoietic progenitors (Figure previous page) and
haemangioblasts and haemogenic endothelium (Above). A consistent peak in all populations
for several transcription factors is found ≈ 2kb upstream of the transcription start site (TSS)
of Ltc4s. The peak is located within a evolutionary conserved region of the genome (see
conservation tracks bottom of figure previous page).
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Fig. 3.42 DNAase I hypersensitivity tracks in embryonic stem cells (ESC), mesodermal cells
(MES), haemangioblasts (HB), haemogenic endothelium (HE), haemogenic progenitors (HP)
and macrophages (MAC). Confirming that the genomic locus previous noted for binding
of haematopoietic transcription factors in fig. 3.41 has an open chromatin conformation in
HE and HPs but not in ESCs, MES or MACs. The tracks at the bottom show evolutionary
conserved sites as in fig. 3.41.
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Fig. 3.43 Schematic diagram summarising the role of ALOX5, ALOX5AP and LTC4S in
the leukotriene pathway - They form a complex on the outer nuclear envelope that converts
arachidonic acid to LTA4 and subsequently to LTC4. LTC4 can then be transported out of the
cell and converted to downstream leukotrienes like LTD4 by gamma-glutamyltransferases
(GGT1 and GGT5). Zileuton is a synthetic drug that inhibits ALOX5. Arachidonic acid itself
is produced by the action of phospholipases. Figure produced by Dr Vasilis Ladopoulos and
for the paper Scialdone et al. [2016].
Day 0
LIF withdrawal
Day 3
add compounds
Day 14
count colonies
mESC
EB
differentiation
to embryoid
body
Day 4
wash out compounds
dissociate EBs and
plate for colony assay
Fig. 3.44 Overview of experimental protocol generating erythroid bodies (EBs) from murine
embryonic stem cells (mESCs) and subsequent colony assays after adding either Zileuton or
LTC4 at Day 3. Cells are cultured and colonies counted before reaching confluence at Day
14. LIF, Leukaemia Inhibitory Factor.
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Zileuton, LTC4 or carrier were added during EB generation on day 3. Zileuton was added
at 10 µM, 50 µM and 100 µM and LTC4 at 50 nM, 100 nM and 300 nM. All experiments were
performed in triplicate.
Zileuton at 10 µM and LTC4 at 50 nM had no effect on colony counts, fig. 3.45. Zileuton at
higher concentration significantly inhibited colony formation in a dose-dependent manner
while addition of LTC4 significantly stimulated colony numbers again in a dose-responsive
fashion, fig. 3.45.
This provides strong supportive evidence from an in vitro assay that the leukotriene branch
of the arachidonic acid pathway alters the number of haematopoietic progenitors present in
EBs at Day 4.
Taken together with finding of activation of the leukotriene pathway (fig. 3.40 and table 3.9)
in vivo suggests that this branch of the arachidonic acid pathway plays a key role in the
yolk-sac embryonic erythroid myeloid progenitor haematopoiesis.
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Fig. 3.45 Bar plot showing the fold change in the number of colonies relative to carrier
control when embryoid bodies were treated with the indicated concentrations of Zileuton or
LTC4 for 24 hours. Error bars represent the mean plus standard deviation of n = 3 biological
replicates. Significant changes compared to controls were tested with a one-tail Student’s
t-test (p = 0.004 for Zileuton (50 µM); 0.002 for Zileuton (100 µM); 0.027 for LTC4 (100 nM);
0.007 for LTC4 (300 nM)). Figure produced by Dr Vasilis Ladopoulos.
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3.13 Single-cell resolved characterisation of a mutant
The T-cell acute lymphocytic leukaemia protein 1 encoded by Tal1 also known as stem
cell leukaemia (Scl) is a basic helix-loop-helix transcription factor that is essential for
haematopoiesis and as shown previously is expressed throughout the time-course from the
blood progenitor to blood clutsers, fig. 3.34.
Shivdasani et al. [1995] generated a Tal1 knock-out mouse line and mated heterozygous
Tal1+/- mice, finding no reduction in the number of homozygote knock-out Tal1-/- embryos
at E8.5 but by E10 all surviving embryos were either homozygous wild-type Tal1+/+ or
heterozygotes Tal1+/-, there were no surviving Tal1-/- embryos. They also found that by E9.5
Tal1-/- embryos were smaller, with profound pallor, had a dilated pericardial sac and that their
yolk sacs and placentas were bloodless. Despite this other major developmental milestones
were achieved normally, including chorio-allantoic fusion, rotation of the embryo, closure
of the caudal neural pore and initiation of cardiac contractions. Other mesodermal tissues
including somites, blood vessels and myocardium were present and foetal loss was attributed
to the severe anaemia resulting from an early block of embryonic erythropoiesis.
Porcher et al. [1996] used haematopoietic in-vitro differentiation assays and chimeric mice
to overcome the universal embryonic lethality of the homozygous Tal1-/-. They demonstrate
an absolute requirement for Tal1 in the generation of all haematopoietic lineages. Lancrin
et al. [2009] demonstrate that Tal1 is indispensable for the establishment of haemogenic
endothelium. Tal1 has also been used in combination with other transcription factors to
re-programme fibroblasts to generate haemogenic progenitors through a haemogenic endothe-
lium intermediate [Batta et al., 2014].
Given the early and central role of Tal1 in early embryonic and definitive haematopoiesis
we sought to study the in vivo differences in gene expression between wild type (WT) and
Tal1-/- mice in the FLK1+ sorted population during during gastrulation.
The Tal1lacZ/+ knock-in mouse was used, fig. 3.46 [Elefanty et al., 1998]. Since the back-
ground of these mice, generated from the ES cell line W9.5, an embryonic cell line derived
from the 129/S mouse strain [Stevens, 1970; Szabo and Mann, 1994], was different from
the CD1 mouse line used in the previous experiments it was deemed prudent to additionally
sample some wild-type embryos on this background.
Dr Yosuke Tanaka and I performed the embryo dissections and generated the single cell
suspension. During dissection some extra-embryonic tissue was set aside for genotyping
to identify the homozygous embryos to be used for further study. The generated single
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Fig. 3.46 The Tal1 (also known as Scl) LacZ knock-in mutant generation strategy (from
Elefanty et al. [1998]). The SCL-lacZ targeting vector is shown above the Tal1 genomic
locus with regions of expected homologous recombination shown by crosses. Exons IV and
V are completely replaced and exons III and VI are partially replaced knocking out Tal1
transcription at the locus.
cell suspensions were single cell sorted into lysis buffer plates using FACS for FLK1 with
indexing for CD41, fig. 3.47. This confirmed that the Tal1-/- embryos were almost completely
devoid of CD41+ cells.
The sorted cells were stored at −80 ◦C awaiting genotype characterisation of each embryo.
Genotyping was performed by Victoria Moignard and images of the genotyping gels are
shown in fig. 3.48.
Selecting 8 homozygous embryos, marked by the red asterisks in fig. 3.48, the appropriate
plates were thawed and sequencing libraries prepared by Victoria Moignard as previously
described in section 3.3. There were 3 embryos at neural plate stage, 3 at head fold stage
and 2 at the four somite stage (E8.25) table 3.10. The prepared libraries were submitted for
sequencing and processed through the previously described pipeline of QC, normalisation
and feature selection as described in sections 3.4 to 3.6. 482 cells passed QC and were used
for downstream analysis. An example of QC performed on one of the 96-well plates from
this dataset is shown in fig. 3.49 a comparison can be made with fig. 3.7. The ERCC to total
mapped genes is significantly higher and this is suggestive of either less input mRNA or a
higher amount of ERCC spike-in, the latter being more likely.
Additionally though both Tal1+/+ and Tal1-/- samples were processed in parallel, exactly the
same equipment could not be used simultaneously. This meant that the different genotypes
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Fig. 3.47 Sample of flow cytometry of WT and Tal1-/- embryos at head fold (HF) stage and
at the four somite stage (E8.25). This shows a severe depletion of cells in the CD41+ gate in
Tal1-/- embryos compared with the Tal1+/+ embryos as would be expected from the known
haematopoietic defect in Tal1-null mutants. Image produced from flow cytometry data by
Victoria Moignard.
Fig. 3.48 PCR genotyping gels from Tal1LacZ/+ crosses. Lower band is the wild-type allele
and upper band is the mutant allele carrying a neomycin knock in fig. 3.46. Presence of both
bands indicates heterozygosity. Embryos from which sequencing data were obtained are
indicated with a red star. The embryo numbers match those available in the metadata from
Scialdone et al. [2016]. Genotyping and image produced by Victoria Moignard.
124
3.13 Single-cell resolved characterisation of a mutant
4179 , failed = 29
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Fig. 3.49 QC plots generated for plate 4179 containing FLK1 sorted cells from a wild type
Tal1+/+ embryo. Comparison should be made to fig. 3.7 from the reference experiment and to
cells sorted from a null mutant Tal1-/- fig. 3.50. The ratio of ERCC to total mapped genes is
considerably higher in this sample as compared to the previous experiment suggesting higher
input amounts of ERCC spike-ins.
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4178 , failed = 53
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Fig. 3.50 QC plots generated for plate 4178 containing FLK1 sorted cells from a null mutant
Tal1-/-. Comparison should be made to fig. 3.49. The total number of counts appear to be
much higher in some cells than others giving the impression of 2 clusters. The cause of for
this is discussed in the text and summarised in fig. 3.51.
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Table 3.10 Summary of Tal-/- and Tal1+/+ experiment. Embryonic stage, embryo number
matching with fig. 3.48, Genotype with Null corresponding to Tal1-/- and WT with Tal1+/+,
Lane showing the sequencing flow cell lane matching with fig. 3.51 and Cell number the
number of cells that passed QC. NP - Neural plate stage, HF - Head fold stage and 4SP - 4
somite pairs stage.
embryoStage embryo Genotype Lane Cell number
post initial QC
Cell number
post final QC
NP 9 Null 4175 44 26
NP 17 WT 4179 67 57
NP 18 WT 4180 73 66
HF 10 Null 4176 56 36
HF 14 Null 4178 43 24
HF 11 WT 4177 62 60
4SP 7 Null 4174 57 35
4SP 3 WT 4173 80 73
were often processed simultaneously but consistently in different blocks of our thermocycler.
Assessing the total number of reads mapped to nuclear genes and how the cells were arranged
on the 96-well plates it becomes apparent that cells on the outskirts of the plate in the Tal1-/-
experiments generated fewer reads compared to those located more centrally fig. 3.51. This
is not so for the Tal1+/+ plates. The most likely cause for this is drying of the peripherally
located samples on each plate due to the thermocycler lid not fitting tightly. Each 96-well
plate was sequenced in a separate lane of the sequencer and the total DNA concentration
loaded on to each lane of the sequencing flow cell was titrated to that recommended by
Illumina, this led to oversampling of the cells more centrally placed on the 96 well plate
during sorting for the Tal1-/- plates.
A key concern with the over-sampled cells is duplicate reads. This is where the same mRNA
molecule is counted twice. Post-tagmentation duplicates can be readily recognised in genes
with low to moderate counts since reads are unlikely to start at exactly the same location
due to the random nature of the tagmentation reaction, see fig. 3.4 for experiment protocol
summary. Pre-tagmentation duplicates though cannot be easily recognised. Several of the
outlier cells had greater than 80% duplicate read rate, all cells meeting this criteria were
therefore excluded as a final step in the QC, table 3.10.
A popular method for visualising high-dimensional data that additionally allows projection
on to a previously calculated representation is PCA. Performing PCA de-novo on the whole
dataset after normalising together and re-calculating highly variable genes, highlights a
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Fig. 3.51 Heatmap of mapped reads on the 96 well plates with null mutants Tal1-/- on the left
column and Tal1+/+ samples on the right. All samples of the same genotype were processed
in the same block of the thermocycler but Tal1-/- plates were all processed on a different
block from the Tal1+/+ plates. In the Tal1-/- plates there is a clear preponderance for reads
to be amassed by centrally located wells on the plate. In contrast reads are more evenly
distributed across the plate in Tal1+/+ plates.
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significant number of outliers cells in the lower right fig. 3.52a. There is an additional set
of outliers in the upper right that have not been specifically highlighted. In the lower right
set there are 74 cells and 72 are in plates sorted from Tal1-/- mice. In fact they correspond
very tightly with the highly sequenced cells shown in fig. 3.51. This suggests that the
normalisation and feature selection methods alone in this case are not able to deal with
experimental batch effects to recover signals of biological interest.
Focusing on the former de-novo PCA and not recognising that the outliers represent a batch
effect, it may appear that these outlier cells represent an aberrant cell type produced in-
vivo from the failure of normal haematopoiesis due to lack of the master regulator Tal1.
Differential gene expression though shows that nearly all genes are more highly expressed in
this outlier set and it becomes apparent this has arisen due to the increased sequencing depth
of some cells due to their position on the plate as discussed earlier.
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(b)
Fig. 3.52 (a) PCA calculated de-novo after normalising the combined experiments together
and re-calculating highly variable genes. Polygon in the lower right outlines the cells from
the Tal1 experiment that appear to be outliers. Each point is a cell and is coloured using
the legend colours above note slightly different colour schema from fig. 3.13. (b) The new
Tal1 dataset is projected onto the previously calculated PCA fitting neatly onto the previous
populations and giving some indication of the cell types present.
An alternative to performing de-novo PCA is to use the same gene set as calculated previ-
ously for the reference dataset (see section 3.6) but sticking with the new normalised log-
transformed counts and projecting onto the PCA calculated on the reference dataset, fig. 3.13.
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The cells from the new experiment now map neatly onto the old populations of cells fig. 3.52b.
A caveat to keep in mind with such analysis is that a new cell state can possibly be missed if
it cannot be identified with the previously selected feature set.
A random forest algorithm was trained on the reference dataset to predict cell type by Dr
Antonio Scialdone as described in Scialdone et al. [2016]. The random forest algorithm
was then used to assign cluster identity to the newly assayed 482 cells from the Tal1 dataset.
Alternative cluster assignment using nearest medioids gave a very similar result indicating
the robustness of the data. Cluster assignment reveals a clear lack of the haematopoietic
progenitor and blood population in cells from Tal1-/- embryos, table 3.11. Enumeration of
the remaining populations except the extra-embryonic ectoderm shows similar numbers in
Tal1+/+ and Tal1-/- embryos.
Table 3.11 Random forest assigned clusters to Tal1 dataset.
Genotype
Assigned cluster Tal1-/- Tal1+/+
Blood 0 26
Blood progenitors 0 46
Endothelial 51 68
Allantois 12 16
Nascent mesoderm 27 47
Posterior mesoderm 15 16
Pharyngeal mesoderm 12 20
Extra-embryonic ectoderm 1 8
Epiblast 3 9
Projection on to the previously calculated PCA compared to de-novo PCA calculation
indicates the benefit of using a previous data-set to understand a newly collected dataset.
But the visualisation method used previously to explore the data was mainly tSNE, which
provided better spacial segregation of the previously assigned clusters. Unfortunately no
‘projection’ method existed for tSNE when calculated in this manner. For our paper Scialdone
et al. [2016] we recalculated the complete tSNE de novo and used colour to identify the new
locations of the previously defined clusters.
Developing a new method it is now possible to position or ‘project’ new points on a previously
calculated tSNE. The method is described later in Chapter 5. Harnessing this approach and
calculating positions for the new cells we can appreciate the new Tal1 data set on the
previously calculated tSNE fig. 3.53. Figure 3.53a shows the Tal1 data with the reference
data set faded in the background but coloured by cluster. Figure 3.53b shows the same data
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3.13 Single-cell resolved characterisation of a mutant
set but now the reference data set is greyed out and the Tal1 data set coloured by the newly
assigned clusters calculated according to the random forest algorithm implemented by Dr
Antonio Scialdone [Scialdone et al., 2016]. The projected data confirms the absence of blood
progenitor and blood populations from the Tal1-/- mice consistent with previous publications
and the lack of CD41 cells on index sorting fig. 3.47. Additionally the random forest assigned
cluster identities appear to conform well to their spatial localisation on the tSNE fig. 3.53b.
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Fig. 3.53 (a) Tal1+/+ light grey filled circles and Tal1-/- dark filled circles cells are projected
on the previously calculated tSNE from the reference experiment fig. 3.36. The points
representing the cells from the reference experiment are faded into the background to
allow better visualisation of the Tal1 experimental data. (b) Cells generated from the Tal1
experiment coloured according to their assigned cluster as designated by the random forest
algorithm calculated by Dr Antonio Scialdone [Scialdone et al., 2016]. This shows good
correspondence between the random forest algorithm and the ‘projected’ tSNE. It also allows
a more accurate cluster assignment by allowing selection of only those cells that are consistent
on the tSNE for example in the case of the endothelial, only those red points that are within
the dashed area in (b) are confirmed as endothelial.
To establish a more accurate and confident cluster assignment for the endothelial population
the cells mapped to endothelium by the random forest algorithm was filtered to only include
those that were consistent with the tSNE fig. 3.53b. Gene expression between Tal1+/+ and
Tal1-/- cells within this filtered set were compared to assess the affect of the Tal1 deletion in
this population that is critical for definitive haematopoiesis. The filtering resulted in 43 Tal1-/-
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cells and 53 tal1+/+ cells. These were compared using the DESeq algorithm revealing 205
genes that were significantly downregulated in the Tal1-/- compared to the Tal1+/+ endothelial
cell population. This included several known key regulators of early blood development
including Itga2b [Dumon et al., 2012], Lyl1 [Capron et al., 2006], Fli1 [Zhao et al., 2018],
Ets2 [Stankiewicz and Crispino, 2009], Sox7 [Lilly et al., 2017], Gata2 [Kaimakis et al.,
2016] and Hoxb5 [Chen et al., 2016] consistent with the known function of Tal1 in specifying
a heamatopoietic fate in embryonic endothelial progenitor cells. Hoxb5 notably has recently
emerged as a powerful marker of definitive blood stem cells [Chen et al., 2016].
Strikingly in contrast to recent findings of cardiac fate specification after in vitro culture of
yolk sac endothelial progenitors from Tal1-/- embryos [Org et al., 2015] we find no identifiable
activation of any cardiac related pathways when looking at the differentially expressed genes.
This led us to propose an alternate mechanism for fate specification in the early mesoderm
whereby rather than acting as bipotential switch between haematopoietic and cardiac fates as
suggested in Org et al. [2015], Tal1 is a master regulator of blood development as evidenced
by its absolute requirement for in-vivo embryonic haematopoiesis but the loss of Tal1 is not
sufficient by itself to switch cells towards an alternative cardiac fate [Scialdone et al., 2016].
3.14 Brachyury plugs the hiatus
BRACHYURY encoded by the T gene is the founder member of the T-box family of DNA
binding transcription factors [Herrmann et al., 1990]. Heterozygous T+/- mice have a short
kinked tail while homozygous T -/- mice are non-viable and die shortly after gastrulation
around day 10 of gestation [Dobrovolskaïa-Zavadskaïa, N, 1927].
Studies in mutant embryos demonstrate that BRACHYURY plays a critical role in gastru-
lation and defects are described in several mesoderm tissues including extra-embryonic
mesoderm where crucially there is failure of development of the allantois and subsequent
chorioallantoic fusion [Gluecksohn-Schoenheimer, 1944]. Furthermore intra-embryonic
mesodermal defects include an apparently absent notochord with abnormal somites and
neural tube [Beddington et al., 1992].
Quantification of mesoderm:ectoderm ratios and chimeric experiments suggest that morpho-
genetic cell movements are abnormal supported by the observations of accumulation of T -/-
in the caudal region of the embryo and higher levels of chimerism in the ectoderm than the
mesoderm [Beddington et al., 1992; Yanagisawa et al., 1981].
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In humans mutations of the T-box family of genes have been associated with congenital
diseases such as DiGeorge and Holt-Oram syndromes, characterised by defects in the
mesodermally-derived cardiac tissues [Bruneau et al., 2001; Ryan and Chin, 2003].
In this chapter thus far, we have described utilising FK1+ to sort mesoderm specified cells
with the advantage that it is expressed on the cell surface and FACS validated antibodies
were readily available in the lab, so that this population of cells could be selected and
sorted, for subsequent single-cell analysis. A more widely expressed protein within the
mesodermal population is BRACHYURY but this is a transcription factor and so cannot be
readily detected using standard FACS protocols. But given the large sampling gap between
the epiblast population, a random sample of cells at E6.5, and the nascent mesodermal
population collected by sorting on FLK1 and the high expression of T in both regions around
the gap (see figs. 3.18 and 3.21a) we speculated that sorting Brachyury+ cells would help
identify the missing population of cells bridging the gap and possibly provide insights into
mechanism of early fate diversification.
3.14.1 Genetic Brachyury reporter
Taking advantage of a previously generated Brachyury knock-in reporter line that was
available locally at the Gurdon Institute we set out to capture a wider range of mesodermal
cells. The line described by Imuta et al. [2013] is summarised in fig. 3.54. This knocks in the
Brachyury-2A-nucEGFP-2A-CreERT2 construct into the Brachyury locus in a TT2 ES cell
line, which themselves are derived from a F1 embryo crossed between a C57BL/6 female
and a CBA male [Yagi et al., 1993].
The construct was designed to express Brachyury from the knocked-in sequence but some
heterozygous mice had variable degrees of tail defects including curled, short or no tail
while the homozygous was non-viable [Imuta et al., 2013]. The Brachyury-2A-nucEGFP-
2A-CreERT2 sequence includes the self cleaving 2A peptide between the protein coding
sequences [Szymczak et al., 2004]. The nuclear localisation of the fluorescent protein is
achieved by using histone fusion protein H2B-EGFP construct and there is the final protein
coding sequence CreERT2 conditionally expressing Cre during induction with tamoxifen [Feil
et al., 1997]. For this experiment we did not utilise the CreERT2 sequence for lineage-tracing
but simply use this line to sort Brachyury expressing cells.
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3.14.2 Mouse crosses, embryo collection and microscopy
Crosses were setup between TnEGFP-CreERT2/+ on the ICR background and wild-type mice
C57BL/6J and these would be expected to produce F1 embryos with 50% heterozygous
TnEGFP-CreERT2/+ and 50% wild-type mice T+/+, fig. 3.55. This was performed at the Gurdon
Institute with the help of Caroline Lee. 2 dams were sacrificed at day 7 post-plug by Caroline
Lee and uteri harvested. The uteri were collected and embryos dissected out in the lab of
Professor Alfonso Martinez Arias in the Department of Genetics. 12 embryos were collected
and imaged using a confocal microscope by Dr Ben Steventon. 2 embryos were clearly
pre-streak during dissection under the dissecting microscope and were therefore discarded
and excluded from downstream processing.
Wild type X T-nucEGFP
Fig. 3.55 Wild type to Brachyury-2A-nucEGFP-2A-CreERT2 [Imuta et al., 2013] cross is
predicted to provide 50% GFP and 50% WT murine embryos.
The embryos, the litter from which they were derived and whether GFP was assessed to
be present on confocal microscopy is reported in table 3.12. Microscopy of the embryos
was used to in an attempt to identify heterozygous TnEGFP-CreERT2/+ embryos so that fewer
single cell suspensions would need to be generated to expedite single cell sorting into lysis
buffer and reduce the time from harvesting to storage at −80 ◦C. Unfortunately on initial
assessment it appeared that all embryos except embryo 2, were positive for EGFP. This was
highly improbable given the cross.
Subsequent FACS showed that only 3 of the 10 embryos were in fact the required het-
erozygous TnEGFP-CreERT2/+ genotype. Later review of the stored images in fact confirmed
concordance between the confocal images and the findings at FACS. The spurious expression
seen in the other embryos is likely related to the recognised auto-fluoresence of extra-
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embryonic tissues and possibly rushed setting of laser intensity and gain settings [McGrath
et al., 2003; Perea-Gomez et al., 2007]. Expression of EGFP was limited to embryos 6, 9,
and 10 table 3.12.
Table 3.12 Overview of embryos harvested from TnEGFP-CreERT2/+ and T+/+ cross. Embryos
were collected from 2 litters and litter mates are shown. The stage of the embryo as assessed
during dissection under the bright field dissecting microscope - NP, neural plate; HF, head
fold; MLS, mid to late streak. Presence or absence of EGFP on confocal microscopy and
presence of EGFP+ cells during FACS.
Embryo Litter Stage EGFP on confocal EGFP on sort Yolk sac
1 1 NP No No Present
2 1 NP No No Absent
3 1 HF No No Present
4 1 MLS No No Present
5 1 NP No No Present
6 1 MLS Yes Yes Present
7 1 EHF No No Present
8 1 EHF No No Absent
9 2 MLS Yes Yes Present
10 2 MLS Yes Yes Present
11 2 Pre-streak ———-Discarded———
12 2 Pre-streak ———-Discarded———
3.14.3 FACS
During single cell suspension generation and prior to FACS, multiple antibodies conjugated
to selected fluorophores were incubated with the single cells to allow index sorting for FLK1,
E-CAD, TIE2, EPCAM, CD31, PDGFRα and CKIT. The antibodies and associated fluo-
rophores are summarised in table 3.13. The anitbody/fluorophore sort panel was developed
together with Dr Vasilis Ladopoulos.
Sorting was performed at the flow cytometry core facility in CIMR by Dr Chiara Cossetti on
a 5 laser sorter. Embryo 2, the GFP -ve embryo on initial confocal observations was expected
to be homozygous for the wild type alleles T+/+ and was used as a negative control to set
voltages including EGFP.
As there was a limited supply of cells, OneComp beads were used for the single stain
controls to adjust compensations. The main population of cells was gated followed by singlet
selection and exclusion of non-viable cells by DAPI fig. 3.57. A summary of the numbers
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Embryo 1
Embryo 2
Embryo 3
Embryo 4
Embryo 5
Embryo 6
Embryo 7
Embryo 8
Embryo 9
Embryo 10
Fig. 3.56 Collage of selected confocal images from each embryo. Only embryos 6, 9 and 10
display EGFP signal within the epiblast. The remainder show signal due to auto-fluoresence
of the extra-embryonic tissues as has been previously reported by McGrath et al. [2003];
Perea-Gomez et al. [2007].
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Table 3.13 Staining protocol including antibody, fluorochrome and the dilutions used. LP,
long pass.
Antibody Fluorophore Laser wavelength nm & Filter Dilution
CKIT BV421 405 460/50 1:100
E-CAD biotin 1:100
Streptavidin PCPCy5.5 488 670/30 1:200
CD31/PECAM1 PE 561 585/29 1:200
PDFGRα PECF594/Texas Red 561 610/20 1:400
FLK1 PECy7 561 750LP 1:200
TIE2 APC 640 670/30 1:200
EPCAM/CD326 APCCy7 640 750LP 1:200
BRACHYURY nEGFP 488 530/40
Viability DAPI 355 460/50 1:5000
and percentages of cells in the gates for embryos 2 and 10 are summarised in tables 3.14
and 3.15.
There is a significant enrichment of cells in the GFP +ve selection gate P4 in embryo 10 as
compared with embryo 2 19.72 % vs. 0.41 %. Additionally the GFP +ve cells additionally
appear to be mostly PDGFRα +ve fig. 3.57.
The cells were sorted directly into freshly prepared chilled lysis buffer in 96 well plates,
ensuring they were delivered into the lysis buffer in the centre of the well. Only the Brachyury
expressing cells were sorted into 2 plates per embryo and stored for subsequent processing at
−80 ◦C.
3.14.4 Library preparation and sequencing
Libraries were generated as previously described using the Smart-Seq2 protocol fig. 3.4
and section 3.3 [Picelli et al., 2014] with the help of Dr Fernando Calero-Nieto and Sonia
Nestorowa. After spiking in ERCCs and reverse transcription the cDNA product underwent
PCR pre-amplification for 21 cycles. SPRI bead selection was used to remove primer dimers
and TSO concatemers section 3.3.
DNA quantification and size distribution assessment was performed showing product in a
number of wells an example of an assay is shown in fig. 3.58. Libraries were then generated
by tagmentation, enrichment PCR and SPRI bead cleanup. The libraries were again checked
for size distribution (fig. 3.58) then quantified and diluted ready for submission to the
sequencing facility at CRUK.
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Fig. 3.57 Summary of sort layout (Continued on next page ...)
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Fig. 3.57 Summary of sort layout (contd.). Top left: Selection of main cellular population.
Top right: Singlet enrichment. This is key in single cell sorting to ensure low doublet sorting.
Middle left: Viability staining with DAPI. Cells with damaged membranes allow DAPI in
to bind to DNA and become positive. Middle right: Abscissa represents GFP fluoresence
and the ordinate represents FLK1 fluoresence, dots in blue are gated as GFP -ve while the
purple dots represents cells gated as GFP +ve. Lower panels: In both abscissa represents
GFP fluoresence and ordinate PDGFRα fluoresence. Lower left plot is of embryos 2 which
is T+/+ and so has no GFP +ve cells, while the lower right plot is of embryo 10 which is
TnEGFP-CreERT2/+ and the majority of the PDGFRα +ve cells are GFP +ve.
The cDNA product trace (fig. 3.58a) after cleaning still shows significant contamination from
primers and possible TSO, suggesting there was little mRNA starting material. A possible
reason for this was that at the time of collecting the cells we had in a bad batch of RNAase
inhibitor which may have degraded the samples. This subsequently leads to the relatively
small peak in the trace of the final library fig. 3.58b.
Libraries were submitted so that each 96 well plate was sequenced on a lane of a sequencing
flow cell on the Illumina HiSeq2500 in high throughput mode.
Table 3.14 Embryo 2 FACS table indicating numbers of cells in each gate using the strategy
shown in fig. 3.57 for a GFP -ve T+/+ mouse embryo.
EGFP PDGFRα
Populations Events % Total % Parent Mean Mean
All Evenets 6369 100.00 6 67
P1 4876 76.56 76.56 3 65
P2 3912 61.42 80.23 3 62
P3 3467 54.44 88.62 2 65
P4 26 0.41 0.75 14 56
3.14.5 Alignment and QC
The raw reads from 2 plates for each of the 3 TnEGFP-CreERT2/+ embryos were returned from
the CRUK as zipped fastq files, see section 3.3, box 3.1, and table 3.3. Initial QC was
performed using the fastQC tool [Andrews, 2010]. Due to a technical failure with the
sequencer the initial run returned very few reads so the libraries were sequenced twice and
the counts combined. The files were unzipped and aligned to a modified reference genome
that included the EGFP sequence by Evangelina Diamanti using the splice aware aligner
GSNAP [Wu and Nacu, 2010]. Gene counts were generated using HTSEq on the aligned
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(a)
(b)
Fig. 3.58 Bionanalyser trace from (a) cleaned cDNA product and (b) cleaned library.
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Table 3.15 Embryo 10. FACS table indicating numbers of cells in each gate using the
strategy shown in fig. 3.57 for a GFP +ve TnEGFP-CreERT2/+ mouse embryo. There is a much
higher proportion of cells relative to both total and parent P3 population in P4 as compared
to embryo 2, see table 3.14.
EGFP PDGFRα
Populations Events % Total % Parent Mean Mean
All Evenets 2469 100.00 11 64
P1 1745 70.68 70.68 9 64
P2 1265 51.24 72.49 10 61
P3 1087 44.03 85.93 10 64
P4 487 19.72 44.80 18 119
SAM files again using a modified Gene Transfer Format (GTF) file [Anders et al., 2015]. The
combined counts were then used together with the reference experiment previously discussed.
QC was now performed using the previously defined cut-offs. Due to the low mRNA content
and high sequencing depth an additional QC filter was applied whereby all cells with greater
than 80 % PCR duplicates were removed from further analysis, so that 334 TnEGFP-CreERT2/+
cells remained for downstream analysis table 3.16. Gene expression was then normalised
across both datasets together.
Table 3.16 Summary of the numbers of cells from the different embryos in the Brachyury
experiment. The sample identifier corresponding to a lane on the sequencing flowcell, the
embryo from which it was derived, the number of cells passing the inital QC and those that
remained after removing cells with very high numbers of duplicates.
Sample
identifer
Embryo Passed
Initial QC
Passed & has
< 80% duplicates
11309 6 41 20
11310 6 76 67
11311 9 79 69
11313 9 83 70
11314 10 84 78
11471 10 57 30
Feature selection was performed on the remaining cells by looking for highly variable genes
as described by Brennecke et al. [2013] resulting in 1534 highly variable genes.
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Fig. 3.59 Panel of QC filters as seen previously in figs. 3.15, 3.49 and 3.50. Noticeably a
high number of reads are not aligned.
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3.14.6 Data exploration
Performing de-novo PCA on the gene expression data having performed QC and selected
the highly variable genes can provide an overview of how the new cells fit with the previous
reference dataset fig. 3.60a. PC1 does not provide any useful separation of the various
cell populations and has not been displayed. Reassuringly the new dataset does not cluster
completely separately from the reference dataset suggesting, that the QC and normalisation
have been effective at reducing major batch effects. Importantly we must also keep in
mind that the genetic background of these mice is different from the reference set and the
TnEGFP-CreERT2/+ phenotype is not completely benign and recognised to have a shorter tail.
Additionally the TnEGFP-CreERT2/+ cells from mid to late streak stage appear to almost plug
the gap between the unsorted E6.5 epiblast population and the later Flk1+ sorted nascent
mesodermal progenitors. Additionally though the PCA is different from that calculated
solely on the reference data it appears to perform equally well in segregating the defined
populations, cf. fig. 3.13. In conjunction with filling the void the TnEGFP-CreERT2/+ embryos
also generated BRACHYURY+ cells that are sparsely scattered through the endothelial and
blood progenitor clusters.
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Fig. 3.60 (a) PCA recalculated on combined TnEGFP-CreERT2/+ and reference data. Showing
that the TnEGFP-CreERT2/+ cells appear to bridge the previous hiatus of cells between the
E6.5 epiblast and the nascent mesoderm. (b) TnEGFP-CreERT2/+ cells projected onto reference
dataset cf. fig. 3.13.
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An advantage of PCA is that the new data set can be readily projected onto the reference
using the gene weights that were calculated, in much the same way as was done for the Tal1-/-
data fig. 3.52b. The TnEGFP-CreERT2/+ cells project directly between the E6.5 epiblast and the
nascent mesoderm even more convincingly, completing what appears to be an arc of related
cell types on the PCA shown in fig. 3.60b.
In this instance there was a subtle difficulty in that the TnEGFP-CreERT2/+ data set cell counts
were aggregated using a more recent GTF file. This meant that 2 genes that had previously
been annotated and used for the projection in the reference experiment were now not available.
These 2 genes carried very little weight amongst the prinicipal components of interest and so
had little effect on the final positions of the points.
On the PCA it is difficult to identify the previously characterised polarisation of the epiblast
cluster and the anterior and posterior domains within the nascent mesoderm. These were much
better presented on the tSNE, furthermore during the comprehensive exploration and analysis
of the data it was the tSNE to which we often referred and used as a reference map. It follows
therefore that a more intuitive representation may be found if the new Tal1nEGFP-CreERT2/+
cells could be mapped onto the tSNE calculated on the reference data fig. 3.61.
The new TnEGFP-CreERT2/+ cells map into the hiatus between the E6.5 unsorted epiblast
and the nascent mesoderm as they did on the PCA. But additionally our familiarity with
the substructure of the tSNE suggests that the cells appear to arise from the polarised
tip of the E6.5 epiblast cluster as previously characterised in section 3.8. This is where
the E6.5 epiblast cells appeared to be undergoing an epithelial to mesenchyme transition
(EMT) as demonstrated by their gene expression profiles, consistent with cells delaminating
and transiting through the primitive streak. From here the cells appear to stream towards
the nascent mesoderm fanning out in an arc generating both the anterior and posterior
domains fig. 3.61.
To assess the fidelity of the ‘projection’ on to the tSNE we looked at expression profiles
of known genes just as we did for defining cluster identity in section 3.7.2. The key genes
clearly in this case would be those related to pluripotency and gastrulation in particular
EMT fig. 3.62. Using the genes previously identified as differentiating the anterior and
posterior domains it is clear that few if any posterior domain cells have been captured by
the TnEGFP-CreERT2/+ data. This though is not surprising on review of the reference dataset.
Using the coarse time scale data based on embryos staged during microscopy, fig. 3.37 shows
that while the anterior domain of the nascent mesoderm is replete with cells in the PS stage,
the posterior domain appears to have a peak density around the neural plate stage and is
relatively sparse at PS. Considering the TnEGFP-CreERT2/+ embryos were harvested from an
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Fig. 3.61 (Continued from previous page) (a) Mapping the new TnEGFP-CreERT2/+ cells onto
the reference tSNE, see fig. 3.18b. The cells map well into the space between the polarised tip
of the E6.5 epiblast cluster and fan out towards the nascent mesoderm giving the impression
of a branching ontogenic time-course. An additional population lies below the tip of the
main cluster. Other cells are scattered amongst the extra-embryonic ectoderm and endoderm
clusters, endothelial and blood progenitor populations. (b) Confirms that the cells from
the different embryos do not cluster together but intermingle. Embryo 6 appears to have
consisted of cells that were developmentally earlier than embryos 9 and 10, having little
representation in the posterior nascent mesoderm, endothelial or blood progenitor clusters.
earlier developmental stage based on microscopy appearance it is consistent that they have
generated relatively few cells mapping to the posterior nascent mesoderm. Additionally T
expression in the posterior domain appears to be rapidly downregulated and is significantly
lower than that of cells in the anterior domain fig. 3.63a suggesting the possibility that sorting
on T at this stage of development may miss a significant proportion of this population.
The pattern generated on the tSNE displays an intriguing hour-glass figure, the E6.5 epiblast
and the TnEGFP-CreERT2/+ cells forming the two bulbs with a connecting stalk of cells. The
epiblast cells therefore appear not only to converge on the primitive streak in spatio-temporal
dimensions but they also seem to converge in terms of their gene expression profiles forming a
narrow path between the source and destination populations. The low density of cells sampled
that map to this region suggest that the ingressing cells either progress rapidly through this
convergent state or that the cells become highly proliferative immediately afterwards.
Looking at cell cycle genes which are highly related to proliferation there is no clear signature
of differences in proliferative state between the TnEGFP-CreERT2/+ cells compared to the cells
in the polarised region of the E6.5 epiblast or the convergent belt region fig. 3.63b. Cells
associated with the region of interest are homogeneously in the G2/M or S phases of the
cell cycle suggesting they are all proliferating. These observations lead us to speculate that
cells transit rapidly between these two populations following a narrow trajectory in gene
expression space with little or no ascertainable fate bias until entering the main body of
the TnEGFP-CreERT2/+ cells. This is consistent with experimental findings from epiblast cell
transplant experiments suggesting high degrees of fate plasticity [Le Douarin and Teillet,
1973].
An alternative possibility is that our sampling strategy of selecting only TnEGFP-CreERT2/+ or
the limited range of embryo stages has led to the sparsity in this region. With regards to
the former, it is unlikely that cells along this developmental journey would down regulate
and then immediately up-regulate T sufficiently within such a narrow time-window so as
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Fig. 3.62 Gene expression profiles in TnEGFP-CreERT2/+ and reference cells on the tSNE
(Continued on next page ...)
148
3.14 Brachyury plugs the hiatus
Fig. 3.62 Gene expression profiles in TnEGFP-CreERT2/+ and reference cells on the tSNE
(Contd ...). EMT genes Mixl1 and Snai1 are expressed in the polarised tip of the E6.5 epiblast
cluster and the TnEGFP-CreERT2/+ cells (Upper panels in purple). Genes that were previously
found to be expressed highly in the anterior domain of the nascent mesoderm (Middle panels
in green) and those expressed highly in the posterior domain (Lower panels in blue).
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Fig. 3.63 (a) T expression is significantly lower in the posterior domain of the nascent
mesoderm compared with the anterior domain. (b) Cell cycle stage was assigned to cells
within the whole dataset. Between the tapered end of the E6.5 epiblast culture and the
TnEGFP-CreERT2/+ cells there is no appreciable difference in proportions in the different cycles
of cell stage but nearly all cells are in either G2/M or S phase indicating active proliferation.
to lead to such a sampling bias. Since all the analysed embryos were at mid to late streak
stage, the possibility that collecting earlier embryos would fill out this sparsity in the putative
convergent region cannot be excluded. Focused dissection of the streak without selection
may help to bridge this gap.
The outlier cluster lying between the main TnEGFP-CreERT2/+ body and E6.5 epiblast clusters
was of particular interest and has a gene signature at this developmental stage consistent
with cells derived from the node or organiser and surrounding structures. The genes that are
differentially expressed in this cluster relative to the remaining TnEGFP-CreERT2/+ cells were
identified.
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Fig. 3.64 tSNE plots coloured by gene expression displaying genes highly expressed in the
putative node/organiser population.
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This chapter has focused chiefly on developing a fine grained map of FLK1+ cells during
gastrulation with a particular focus on haematopoiesis. Our lab has previously looked at a
similar population of cells but using qPCR where genes were selected by hand [Moignard
et al., 2015]. In this chapter with the use of Smart-Seq2 technology no apriori gene selection
was required [Picelli et al., 2014]. Being a plate based technique and in combination with the
use of a sorter allowed us to collect surface antigen data using index sorting and marry the
data together with gene counts.
The advantage of single-cell techniques as is well illustrated in this chapter is that by assaying
gene expression at a single cell level a pure population does not need to be isolated as
is required for bulk sequencing. Furthermore cell identity can be assigned post-hoc and
subsequent comparisons or alternative analysis performed using in-silico defined populations.
In-vivo experiments capture the true underlying biological processes that govern normal
development while in-vitro platforms may phenocopy a certain biological phenomenon but
do so for a limited time-course and lack fidelity. The limit with in-vivo strategies is that
our knowledge of cell types in embryos even in early development may be incomplete and
certainly we do not have sufficiently accurate markers to collect pure populations. This
combined with the extremely low numbers precluded use of bulk RNAseq methods.
3.15.1 Technical challenges
Single-cell methods do pose certain challenges mostly concerned with the very low input
mRNA. An individual cell may only contain 1 pM to 26 pM of RNA, most of which is ri-
bosomal RNA, and during harvesting and dissection gene expression will begin to change
[Ståhlberg and Bengtsson, 2010]. This is partly counteracted by performing all manipula-
tions at 4 ◦C except tissue dissociation into single cells where the duration of incubation
is minimised. In Smart-Seq2, mRNA enrichment is performed using poly-A enrichment
so biasing against non-polyadenylated RNAs such as long non-coding RNAs (lncRNAs).
Despite these limitations the numbers of genes that are assayed in multiplex is enormous
with no user dependent apriori gene selection.
The rate of capture of these mRNAs should at this stage be solely dependent on presence
or absence of a poly-A tail and not on the gene lengths. The amount of primers and TSO
added at this stage must be optimised and can be problematic in where cellular RNA content
is extremely low possibly due to poor tissue handling or because the cells themselves are in a
relatively quiescent phase for example stem cells. Smart-Seq2 then uses transcript switching
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to generate full length cDNA product which after some cycles of pre-amplification provides
the substrate for the Tn5 transposase used to generate libraries. At this stage the length of the
transcripts biases towards higher rates of capturing longer transcripts. Additionally in the
case of long transcripts there is a higher probability for the same molecule to be sampled
twice at different locations, generating two reads from the same molecule - under such a
circumstance there is no way of differentiating between the subsequent reads being generated
from the same or different mRNA molecules and may be considered to be a non-identifiable
duplicate. At the subsequent step these molecules are amplified and then sequenced. At the
point of sequencing given that gene counts tend to be low in single-cell experiments two
reads starting at same genomic locus are likely to represent PCR duplicates and these are
to some extent identifiable and may be removed. Depending on the quality of the libraries
generated, the number of cycles for the second amplification stage is adjusted and in poor
quality samples can lead to excessive numbers of duplicate reads.
The indexing of the Tn5 transposase to generate the transposome allows unique barcodes to
be added to the DNA fragments along with the obligatory sequencing adaptors. The use of
two transposomes allows indexing at both ends of the captured molecule at the same time as
adding the two different obligatory sequencing adaptors, the P5 and P7. In our experiment
by combining 8 indexed P5 adaptors and 12 indexed P7 adaptors we were able to multiplex
96-cells for the final PCR amplification and downstream sequencing reducing batch effects
at these stages and minimising sequencing costs. Multiplexed sequencing for single-cell is
very useful as deep sequencing gives diminishing returns in terms of finding novel transcripts
and often simply captures many more PCR duplicates.
A critical step within this tagmentation process is to ensure the correct ratio of transposase to
cDNA. Too much cDNA or insufficient transposase and the library fragment length will be
too long and too little cDNA or excessive transposase and the expected fragment length will
be to small. Library fragment length being important for efficient binding to the sequencing
flowcell and subsequent bridge amplification.
As alluded to earlier the amount of primer and TSO added at the initial reaction requires
careful optimisation as this can lead to high concentrations of primer dimers and TSO
concatemers which will sequester a large number of sequencing reads. In downstream
analysis during QC this is often seen as a high number of unmapped reads figs. 3.7, 3.49,
3.50 and 3.59. At this stage re-analysing the raw fastq files will show an abundance of reads
from primers dimers and TSO concatemers.
Normalisation of counts remains challenging especially when combining separate experi-
ments where batch effects predominate. Throughout this chapter for normalisation we have
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used the Bioconductor package ‘scran’ [Lun et al., 2016b]. This is an adaptation on earlier
methods that use size factors to normalise the data [Love et al., 2014]. The limitation that
‘scran’ attempts to address is a problem these methods run into for single cell experiments
where counts matrices are sparse. This is overcome by pooling what appear to be similar
cells, see section 3.5. The problem here for ‘scran’ becomes of a cyclical nature in that cells
are first clustered to normalise the data and then subsequent feature selection and formal
clustering is proposed. Empirically it has worked well in the current data set but can clearly
be problematic where batch effects predominate as they can overwhelm any clustering. Addi-
tionally some groups may well be too small to allow for adequate pooling and this can lead
to them being excluded or the algorithm failing. Additionally since this is a fast moving field
the package remains in development and version updates can lead to significant differences
in outcome, which become particularly noticeable due to exclusion of cells.
3.15.2 Cell type assignment
A major challenge after generating the data, in producing the reference map was to assign
cell identities. This was performed through an iterative process using prior knowledge of
the cells likely to be present at each stage and known markers. For example the blood cells
could be readily identified by their high expression of Hbb-bh1. Surface marker information
from the index sort particularly CD41 confirmed and provided confidence in this assignment.
The endothelial and blood progenitor populations were readily identified by expression of
markers such as Tie1, Tek and VE-Cad (Cdh5). The E6.5 cells populations, the epiblast
(Nanog, Pou5f1/Oct4), extra-embryonic ectoderm (Elf5) and endoderm (Ttr, Afp) were also
easily identified. Others for example the second heart field, nascent mesoderm, allantois and
especially the posterior mesodermal clusters were more difficult to assign. The problem is
that markers that were once thought to be highly specific turn out to be expressed in other
tissues separated by embryo location and/or developmental time.
To aid with cell type assignment a web application was deployed using Rook and rApache
(available at https://github.com/jeffreyhorner/Rook.git and http://rapache.net/). This displays
expression levels of user defined genes on the tSNE and is available on the Cambridge Stem
Cell Institute website http://gastrulation.stemcells.cam.ac.uk/allData.html.
Having assigned cell type we now have a set of single cell profiles that are with a particular
cell state. This was then used to identify cell types in the Tal1-/- data set. This could be
extended to provide an easy to access publicly available repository of previously sequenced
cell states that could help inform cell type assignment in future experiments.
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3.15.3 Mutants and reporters
This experiment was one of the first to evaluate a mutant mouse model at single cell resolution
[Scialdone et al., 2016]. The reference cells were used to infer cell type in the Tal1-/- cells
using a random forest algorithm implemented by Dr Antonio Scialdone. This produced
almost identical results to an alternative algorithm, the nearest medioid algorithm supporting
the cell type assignment. The mapping of cells on tSNE was also consistent with the assigned
clusters providing added reassurance. When performing differential expression only those
cells assigned endothelial identity and also mapping to the correct region of the tSNE were
included. Due to batch effects between experiments only wild type Tal1+/+ cells from the
Tal1 experiment were used for comparison against Tal1+/- cells.
The Brachyury reporter mouse despite the limitations of having an abnormal phenotype still
does produce viable hetrozygous offspring and though development may not be completely
normal the embryo still undergoes very similar morphological changes and most if not all cell
types are produced in the desired quantities and anatomical locations. At our current level of
mechanistic understanding any mechanisms we do uncover that govern cell differentiation or
gross morphology will be maintained in even such a model organism and any models we do
generate should be resilient to such differences - the ideal model would be able to recapitulate
the complete development of the mouse with the abnormal tail in the heterozygous.
Specifically interrogating the early time-point by using this reporter we have been able to
sample a population that was missed with the FLK1 sorting strategy. Despite the poor quality
of the sequencing libraries from this sample it neatly slotted into the space between the
unsorted E6.5 epiblast and the nascent mesoderm when mapping onto a tSNE calculated on
the high quality reference data set. This gives some insight into how high quality data can be
used to make sense of other data sets by using algorithms that can take advantage of prior
information.
3.15.4 Novel pathway discovery and validation
Enriched expression of the genes Alox5, Alox5ap and Ltc4s, integral components of the
lipoxin/leukotriene branch of the arachidonic acid pathway was discovered within a subset of
endothelial cells. This enrichment though not apparent with unsupervised methods was hinted
at through the structure of the endothelial cluster on tSNE. The pathway was discovered
by hand selecting genes known to be associated with the first yolk-sac derived wave of
definitive haematopoiesis that generates erythroid myeloid precursors (EMPs) and finding
highly correlated genes. Since only a handful of genes were present within the clusters these
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genes stood out on inspection fig. 3.40. Subsequent GO analysis for biological process terms
showed strong enrichment for the lipoxin/leukotriene pathway table 3.9.
To validate the pathway we used the 5-lipoxygenase (ALOX5) inhibitor Zileuton which
is licensed for prophylactic use in asthma. This showed clear dose-dependent inhibition
of colony formation in an in-vitro culture system while addition of leukotriene C4 led to
the induction of increased colony formation fig. 3.45. In combination this provided strong
evidence in support of the pathway in developmental haematopoiesis.
Interestingly Zileuton has been studied in the context of sickle-cell anaemia in a bid to
achieve an increase in the fraction of foetal haemaglobin, HbF [Haynes et al., 2004]. Zileuton
is a derivative of hydroxyurea and its role in sickle cell anaemia has been predicated on its
structural resemblance to hydroxyurea [Haynes et al., 2004; Rohrman and Mazziotti, 2005],
which has been used in sickle cell disease. Alternatives to hydroxyurea have been sought
due to its bone marrow suppressive effects and Zileuton has been suggested as an alternative
worthy of further study [Haynes et al., 2004; Rohrman and Mazziotti, 2005].
The leukotriene branch is not unique amongst the arachidonic acid pathways implicated as
having a role in developmental haematopoiesis. In zebrafish, the epoxyeicosatrienoic and
the prostaglandin branches have been proposed as important pathways in embryonic blood
development [Li et al., 2015; North et al., 2007]. Using leukotriene C4 promoter driven
expression of EGFP, Strid et al. [2008] showed specific promoter activity in monocytic and
myeloid leukaemia lines and confirmed expression of Ltc4s transcript.
Finkensieper et al. [2010] demonstrate that both Alox5 and Alox5ap are expressed at Day 6
of EB formation from ES cells and by day 10 ALOX5+/CD68+ (CD68 was used as a specific
marker of macrophages) co-expressing cells and ALOX5+/CD45+ co-expressing cells were
seen prominently on immunohistochemistry. Using high performance liquid chromatography
they demonstrate synthesis of related leukotrienes LTB4 and LTD4 in EBs between days 6 to
10. They also show that leukotrienes play a role in vasculogenesis and that pharmacological
inhibition of leukotriene receptors and small hairpin RNA silencing exert anti-angiogenic
effects in differentiating ESCs.
Wang et al. [2015] found up-regulation of Alox5 by real-time PCR in sorted human CML
progenitors but not in patients in remission after treatment with tyrosine-kinase inhibitors. In
an in-vitro model of leukaemia stem cells (LSCs) in Chronic myeloid leukaemia (CML) they
cultured LSCs identified on flow cytometry as Lin-cKit+Sca1+ from CML patients with the
tyrosine kinase resistance mutation T315I in Bcr-Abl. They show apoptosis after Zileuton
treatment but not after Imatinib (a tyrosine kinase inhibitor). In a xenograft model after
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transferring human mutant Bcr-Abl-T315I CML cells into NOD/SCID mice they found that
intra-peritoneal injection of Zileuton inhibited LSCs compared with normal saline controls
and imatinib treated mice.
We have shown for the first time in-vivo that all three Alox5, Alox5ap and Ltc4s are co-
expressed within a subset of FLK1+ endothelial cells in the gastrulating murine embryo. This
now provides a basis for further mechanistic studies into the observations seen in in-vitro
systems described above. Additionally we highlight an alternative mechanism by which
not only Zileuton but also the widely used drug hydroxyurea may increase HbF fraction in
sickle-cell patients.
Inspecting the heatmap fig. 3.40 the close relationship of other genes to leukotriene associated
genes suggests they may have an important role to play in haematopoietic stem cell emergence.
Jag2 is a Notch related gene that is highly correlated with Alox5. Other genes such as Eltd1
a pro-angiongenic adhesion G-coupled protein receptor and Ldb2 the Lim-domain binding
protein 2 suggested as a key driver of transendothelial migration of leucocytes are good
candidates for further study [Masiero et al., 2013; Mylona et al., 2013; Shang et al., 2014].
The related gene Ldb1 a transcriptional cofactor has already been proposed as novel player
in early murine haematopoiesis. These very preliminary observations highlight how there
continue to be many opportunities to gain further insights into processes governing early
development within this dataset.
3.15.5 Pseudotime and pseudospace
It is appealing to consider that sampling embryos and generating single cell suspensions at
different developmental stages can allow the reconstruction at molecular levels of processes
governing early embryonic development, essentially pasting together cross-sectional snap-
shots into a continuity - a pseudotime. This idea is predicated on the logical assumption that
cell differentiation is a smooth process taking place in gene expression space and that cells
that are most similar to each other by gene expression will be most likely to be ontogenically
related. Then by simply defining a starting point we can string together cells that are most
closely related up to an end point.
This idea is not new to single-cell assays in fact it forms the basis of many scientific
observations. For example gross embryology in eutherian placentals is based on specimens
collected, fixed, stained and observed under the microscope. Embryo development has then
been described according to what is seen on these cross-sectional snapshots on occasion
consolidated together with longitudinal observations from model organisms. A problem
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specific to our current method of generating single cells is that we lose almost all spatial
context unless focused dissection is used.
It is not only the loss of spatial relationships that hampers computational reconstruction of
a pseudotime. Evolution has led to the re-purposing of many biochemical and molecular
pathways for alternate purposes activated in different tissues. This leads to disparate cell
types sampled concurrently sharing a common gene expression set making assessment of
similarity difficult. For example proliferating cells in the same phase of the cell cycle may
have many genes highly expressed that are common. This signal may be sufficient to swamp
any cell type signal so causing cells to be close to each other by cell cycle (or any other
biological process with a common gene set) belying their developmental origins.
Additionally our assays have limited fidelity. Single cell RNAseq is prone to drop-out where
genes that may be expressed at low-levels are highly likely to have zero counts, though
randomly some counts will be captured in a few cells. Due to the large number of such genes
a different subset may be randomly sampled from cells that are very similar again making
assessing similarity difficult.
Despite these caveats thoughtful interpretation of visible spatial relationships in dimensional-
ity reduction plots can help identify populations that are linked ontogenically or spatially
to identify pseudo-temporal or pseudo-spacial relationships. Examples are given in this
chapter where a clear pseudotime relationship exists between the blood progenitor and blood
clusters. Another pseudo-temoporal relationship is revealed by the Brachyury data between
the polarised tip of the E6.5 epiblast cluster and the nascent mesoderm. The latter was not
formally investigated partly because of batch effects between the datasets.
Clearly not all neighbouring populations are temporally related. Morphogen gradients
can lead to spatial relationships between juxtaposed populations and this is seen within
the nascent mesoderm cluster which can itself be sub-clustered into anterior and posterior
domains. Making sense of such relationships, deciding on subsequent algorithms to be used
and interpretation continue to heavily rely on human input.
3.15.6 Summary
Harnessing the advantage of single-cell sequencing we have generated a high quality map
of Flk1 cells during gastrulation. On this map we reveal both pseudo-temporal and pseudo-
spacial relationships. Further we use the pseudo-temporal relation to identify patterns of
gene expression. Having established cluster we further refine the clusters using previous
knowledge of developmental biology and key genes to define a cardiac sub-cluster within the
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pharyngeal mesoderm and intriguingly activation of the leukotriene pathway during early
yolk-sac definitive wave haematopoiesis.
Characterisation of the mutant Tal1-/- using the previous map as a reference we confirm a
failure of haematopoiesis with production of no blood progenitor or blood cells. Focusing
on the putative endothelial cluster we also again re-affirm failure of activation of the blood
programme but also show no evidence to support the suggestion that these cells having failed
to progress towards a blood fate now adopt an alternative cardiac fate.
Finally we show that the reference data set combined with sophisticated computational
techniques that can incorporate prior information can overcome experimental batch effects
allowing the Brachyury data to be assimilated and revealing a nodal population on tSNE not
apparent on PCA.
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Chapter 4
Single-cell census of mouse
organogenesis
4.1 Background
Early embryological development is a highly dynamic process, during which an organism
undergoes major changes in macroscopic appearance underpinned by morphological cellular
movements and molecular changes in epigenetic landscape, gene expression and proteome.
Traditionally dynamics have been investigated by collecting cross-sectional samples at time
intervals and inferring dynamics from serial static images and molecular signatures are
garnered from bulk cellular samples either from heterogenous cell populations or from ESC
differentiation models.
The previous chapter focused specifically on gastrulation the period during which coordinated
cellular movements transform the bilaminar disc into a trilaminar structure. Post gastrulation
there is a significant expansion in cell number and the redistributed cells now begin to
generate the primordial organs with contributions from the relevant germ layers in particular
the mesoderm - the source of vasculature that is required ubiquitously across all organ
systems. As organogenesis progresses and so that the developing organism can achieve
eventual autonomy, the diversity of functions and therefore cell types that perform them
expand considerably.
Though there are multiple incarnations of single cell sequencing protocols including scRNA-
seq , CEL-seq, MARS-seq, STRT-seq and Quartz-seq, Smart-seq2 was used for experiments
described in the previous chapter as it has no requirements for specialist equipment and pri-
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marily due to the familiarity with the protocol within the Göttgens laboratory [Hashimshony
et al., 2012; Islam et al., 2011; Jaitin et al., 2014; Ramskold et al., 2012; Sasagawa et al.,
2013; Tang et al., 2009]. Smart-seq2 using the appropriate indexes can be performed on
either 96-well or 384-well plates [Picelli et al., 2014].
Some of the limitations of Smart-seq2 have been discussed, see section 3.15.1. They include
lots of pipetting steps and requirement for use of multiple plates with increasing cell numbers,
both can lead to variations within experiments resulting in more failures in some plates than
others biasing cell types that are finally sampled and creating batch effects. This can be
further confounded by sorting different populations by plate so making it difficult to ascertain
the cause of any variation. Duplicate reads where multiple reads are produced from the same
mRNA molecule cannot be unambiguously identified when using Smart-seq2 in contrast this
problem is resolved in some protocols by the use of unique molecular identifiers (UMIs).
These are a random sequence of nucleotides that are added to each molecule along with a
cell identifier and form an integral part of some protocols. Post-sequencing the cell barcodes
are demulitplexed and as each UMI corresponds to a single mRNA molecule these counts are
often referred to as digital gene expression (DGE). Advantages of Smart-seq2 include it has
reasonable scalability with automated clean up steps, no requirement for specialist equipment
and sampling of full-length transcripts that may potentially be used for enumerating splice
variants.
For sampling all cell types in a mouse embryo immediately after gastrulation during very
early organogenesis with increasingly complex cell ensembles, Smart-seq2 was impractical
and cost prohibitive. In this context emerging droplet based methods such as Drop-Seq and
InDrop offer the ability for much greater scalability whilst concurrently reducing library
preparation and sequencing costs and reducing batch effects by early pooling of barcoded
cells and increased multiplexing [Klein et al., 2015; Macosko et al., 2015]. In this chapter
we used a droplet based proprietary platform, 10x Genomics® Chromium™ to generate
single-cell libraries from E8.25 mouse embryos to capture the earliest stages of organogenesis
[Zheng et al., 2017].
4.2 Embryo collection and data generation
Embryos were harvested from two time-mated B6CBAF1/J dams crossed with B6CBAF1/J
males at E8.25, fig. 4.1. One litter being resorbed was discarded, from the remaining litter,
7 embryos were harvested and single-cell suspensions generated. A critical step in this
workflow was that the single cell suspensions had to be made up to an appropriate cell
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B6CBAF1/J X B6CBAF1/J
Fig. 4.1 A male B6CBAF1/J and a female B6CBAF1/J were crossed to yield F2 embryos.
B6CBAF1/J, an F1 cross, were generated by crossing a female C57BL/6J with a male CBA/J.
concentration. Drop-seq based technologies such as the 10x Genomics® Chromium™ as
summarised in fig. 4.2 use a microfluidics device to bring cells and enzymes together with
barcoded beads into a nanolitre-scale Gel Bead-In-EMulsions (GEM). The 14 bp bead
barcodes are randomly sampled from a pool of ∼750,000, so each cell has a unique barcode.
In the first generation technology used in this experiment but now discontinued up to 6000
cells could be sampled in a single experiment. Collisions or different cells receiving the same
barcode can conceivable occur by two mechanisms. Firstly by random chance two captured
cells can be captured in two separate GEMs but by chance both GEMs contain beads with
identical cell barcodes, an index collision. Probability of no collision pc can be calculated as:
pc =
n−1
∏
k=0
q− k
q
, n≤ q
Where n is the number of cells sampled and q is the pool of available indices. The probability
of no collisions in a 1000 cell experiment is 0.51 but by the time an experiment has 6000
cells the probability of no collision is extremely small 3.55×10−11, i.e. collisions are almost
certain. The distribution of the number of collisions in experiments with varying numbers of
cells were simulated and are shown in fig. 4.3. The number of collisions can be minimised
by sampling fewer cells.
The second mechanism by which mRNA moieties from two different cells can receive the
identical cell barcode is by becoming incorporated into the same GEM. This risk is mitigated
by adding cells at a limiting dilution so that the majority of GEMS have no cells and the
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Fig. 4.2 Summary of the 10x Genomics® Chromium™ workflow. Cells are loaded at a
limiting dilution so that most (∼93 % to 99 %) GEMs generated will contain no cells with the
aim that the remainder contain a single cell. Image taken from 10x Genomics® Chromium™
user manual.
remaining are most likely to only have one. This rate can again be controlled by keeping
the number of cells per experiment low. 10x Genomics® Chromium™ helpfully provide
a table of suggested cell dilutions and expected multiplet rates table 4.1. Such a table can
be generated by estimating the overall multiplet rate using mixed species cells where a
collision between cells of two different species can be easily identified and therefore the
overall collision rate inferred.
Table 4.1 Approximate expected multiplet rates at different cell loading concentrations for
the first generation 10x Genomics® Chromium™ protocol.
Multiplets rate (%) Number of cells loaded Expected number of cells recovered
1.1 2600 1200
1.8 4300 2000
2.7 6400 3000
3.6 8500 4000
4.5 10,700 5000
5.3 12,800 6000
After generating single-cell suspensions from the 7 litter-mate embryos cells were counted
using a Neubauer chamber haemocytometer, providing an estimate for cell concentration and
the assessing the effectiveness of the dissociation, as clumps of cells can clog channels on
the microfluidic chip scuppering the experiment.
Embryos 2, 3 and 4 were selected for further processing owing to the higher cell yield.
Images of the embryos are shown in fig. 4.4.
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Fig. 4.3 Distributions of the numbers of cells with a barcode shared with another cell,
when sampling the given numbers of cells from a library of ∼750,000 unique cell barcodes.
Distributions shown were calculated on 1000 simulations.
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Table 4.2 Cell concentrations from each embryo after re-suspending dissociated cells in
004% BSA. Calculated after cells counted on Neubauer chamber haemocytometer.
Embryo Cell concentration (cells/µl)
1 95
2 235
3 710
4 365
5 45
6 90
7 165
Each of the 3 embryo single cell suspension samples was split equally so as to be processed
across two lanes of the microfluidics chip. The cells with reagents, GEM beads and the
partitioning oil were loaded onto the chip and the cells were incorporated into GEMs by the
10x Genomics® Chromium™ instrument. The resulting emulsions with each cell trapped
with a single bead in an oil droplet was then incubated for reverse transcription fig. 4.5a.
Care was taken when transferring samples from the microfluidics chip to the PCR plate to
ensure the emulsion was not disrupted.
After reverse transcription within each individual GEM the generated cDNA was uniquely
barcoded so the emulsion could be disrupted and the cDNA pooled for subsequent steps. The
cDNA was then amplified, sheared and the adaptors and sample indices were incorporated
into the final library [Zheng et al., 2017]. The sample indices allowed sample pooling
and massive multiplexing on the sequencer. There were 4 sample sequences allocated to
each sample index so 24 sample sequences in this experiment table 4.3. The libraries were
generated by Dr Fernando Calero-Nieto.
Table 4.3 Sample indices used in this experiment and their corresponding 8 bp sequences
Sequence
Embryo
Sample
Index 1 2 3 4
2 SI-3A-A3 AAAGCATA CTGCAGCC GCCTTTAT TGTAGCGG
2 SI-3A-A4 AGAACGCC CATGGCAG GTCTTTGA TCGCAATT
3 SI-3A-A5 ATTGGGAA CAGTCTGG GGCATACT TCACACTC
3 SI-3A-A6 ACGGGACT CTTTCGAC GAACATGA TGCATCTG
4 SI-3A-A7 AGGTCATA CTCATCAT GCTGAGGG TAACGTCC
4 SI-3A-A8 ATGATACG CCACAGAA GACTGTTC TGTGCCGT
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(a) (b)
(c) (d)
Fig. 4.4 Oblique anterior view of embryo 2 where head fold, cardiac crescent , anterior
intestinal portal and allantois are clearly visible and the visceral endoderm has been mostly
removed (a). (b) Embryo 3 where the visceral endoderm has been split to allow a lateral view
of the embryo. Allantois and amnion can be seen. Embryo 4 is image postero-superiorly
(c). (d) Image of dissociated cells in Neubauer chamber haemocytometer from a different
experiment but representative of the current experiment.
The sample libraries were diluted and submitted to the sequencing core at Cancer Research
UK Cambridge Institute by Dr Nicola Wilson. The libraries were sequenced over all 8
lanes of a single flowcell on the Ilumina® HiSeq™ 2500 on high-throughput mode. The
sequencing core returned the sequenced reads as zipped demultiplexed fastq files. The
demulitplexed files were processed using Cell Ranger v2.1 which performed preliminary QC
and produced aggregated count matrices for further analysis.
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Fig. 4.5 (a) Barcoded primers are released from beads after encapsulation of cells and into
GEMs. These primers containing an anchored oligo-dT that captures cellular mRNAs ready
for reverse transcription when a TSO is added to the 3′ end of the cDNA molecule allowing
subsequent efficient amplification, see section 3.2 for further details of transcript switching.
The primers additional have a 10 bp randomer providing a UMI. (b) Construct of the final
library. The read 1 primer binds at R1 and the cDNA sequence is read. The i7 primer binds
to a region of R2 and reads the cell barcodes. The sample index is read from the grafted P5
oligomer and the read 2 primer binds at R2 after the complementary strand is generated to
sequence the UMI. Image from [Zheng et al., 2017].
7106 cells were identified by Cell Ranger after aggregating all 6 samples from 3 embryos.
Further filtering removed cells with greater than 5% counts mapping to mitochondrial genes
or cells with more than 6000 expressed genes, see fig. 4.7. 6978 cells passing all QC
parameters, were sequenced to a mean depth of ≈100,000 reads per cell, with median
expression of 10,223 (IQR 7447 to 13,132) UMIs and a median of 2828 (IQR 2352 to 3247)
genes, see fig. 4.8. The 51,158 annotated genomic features were filtered with only 21,818
expressed in a minimum of 3 cells retained for downstream analysis.
Inspecting the counts plot shows two branches of cells suggesting some cells despite being
sequenced to equivalent depths express different numbers of genes. The cause is immediately
unclear but the effect is consistent across embryos and is not due to a batch effect from an
outlying sample or embryo, right most panel in fig. 4.7. Postulating on the nature of these
two populations it is conceivable that these are two different cell populations with differing
amounts of mRNA possibly due to cell type, proliferative state or cell cycle stage. It is
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intriguing these two populations are so noticeable during pre-processing, such an early stage
of the analysis.
aggregate
Cells ChromiumTM Library Sequencing Pipelines
count
count
count
count
aggregate
count
count
Embryo 2
Embryo 3
Embryo 4
Fig. 4.6 Experimental and computational workflow. Each embryo was processed across two
channels of the microfluidics chip generating technical replicates. The generated libraries
were pooled and sequenced across 8 lines of a flowcell on the Illumina HiSeq 2500 on
high-throughput mode. Resulting fastq files were processed separately using Cell Ranger’s
count command and then aggregated together using Cell Ranger’s aggr command.
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Fig. 4.7 Data filtered to remove cells with greater than 5% mitochondrial mapped reads
or those with greater than 6000 different genes expressed. Thresholds are depicted by the
horizontal dashed lines.
Normalisation in bulk RNAseq data often involves normalising for gene length but was not
applied in the previous Smart-seq2 dataset with the understanding that comparisons were
being made between cells and not between genes, so that the same gene in different cells will
have the same bias. In the case of digital gene expression where due to the UMI tagging only
the 3′ end of the molecule is assayed, gene length has no effect on capture probability for
transcripts beyond a minimum length which for the 10x Genomics® Chromium™ protocol
is ≈400bp. This residual transcript length limitation exists because of size selection used
after shearing cDNA during library preparation.
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Fig. 4.8 Summary of cell counts, numbers of genes expressed in cells and the percentage
reads mapped to mitichondrial genes
Data was normalised by calculating size factors using scran’s clustering approach and further
gene filtering was performed by finding highly variable genes. In this case the method by
Brennecke et al. [2013] provided a poor fit to the mean, coefficient of variance relationship,
fig. 4.9a. A much simpler linear model was therefore fitted to the log transformed values,
fig. 4.9b and the 7585 genes with positive residuals were defined as highly variable and
retained for further analysis.
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Fig. 4.9 (b) Log linear model fitted to mean coefficient of variance relationship is robust to
the haemaglobin outliers. Model using algorithm described by Brennecke et al. [2013] does
not fit the data correctly (a).
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4.3 Defining clusters
4.3 Defining clusters
A distance matrix, D ∈ R6978×6978 was calculated from the resulting data matrix of 6978
cells and 7585 genomic features using:
Di j =
1− src(celli,cell j)
2
, where src is the Spearman Rank correlation
The Spearman rank correlation provides a dissimilarity metric that is resilient to any cell-wise
gene count normalisation as it is based on gene ranks but can still be effected by library
sequencing depth due to the effect of drop-out. Lowly expressed transcripts will be randomly
captured so that even in a simulation, identical cells will have a different set of genomic
features with zero counts so generating a dissimilarity. Further different cell types may
well have differing cardinalities for the lowly expressed transcript set so that dissimilarities
between cells of the same type may be different between cell types. Additionally if these sets
of lowly expressed transcripts have high cardinality, dissimilarity may be largely driven by
them rather than more ‘informative’ genomic features.
A graph was generated from the dissimilarity matrix by applying a Gaussian kernel as
described for diffusion maps by Haghverdi et al. [2015] with some modifications to remove
spurious edges using roots. Louvain clustering was performed on the graph to identify 22
clusters from which 19 were co-localised on tSNE and could be annotated to identify cell
type. Dimensionality reduction was performed on D using the tSNE algorithm, fig. 4.10.
Cluster identities were specified by reviewing differential gene expression between the set of
cells in target cluster and its complement. This was done by first filtering for:
1. Genomic features with a minimum sum of normalised log transformed counts across
all cells of 1.
2. A minimum fold change between the selected cluster and all remaining cells of 5.
3. Genomic features where fewer than 20% of the reference cells (i.e. those not in the
cluster) express the gene above the mean in the target cluster population.
By applying this filter fewer genes were tested so increasing power when correcting for
multiple testing.
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Fig. 4.10 tSNE dimensionality reduction of 6978 single cell expression profiles on 7585
genomic features. 19 clusters were defined using Louvain clustering on a graph calculated
from a distance matrix based on the Spearman rank correlation related distance. Colours are
grouped by the tissues germ layer of origin. Key genes used to identify cluster identity are
summarised in table 4.4.
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4.3 Defining clusters
Table 4.4 Summary of annotated cell clusters, final post-QC cell numbers and identified
marker genes. Associated colours used in fig. 4.10 are shown in rectangles to the left; colours
are grouped together by germ layers. Key genes were identified by filtering for only those
with a fold change greater than 2 in the selected population and applying the student t-test
with Welch’s correction.
Cluster
Cell
number Key genes
Forebrain 361
Fezf1, Fezf2, Six3, Pax6, Otx2, Hesx1,
Lhx2, Lhx5, Rax, Six3
Mid and
Hindbrain
454
En1, Fgf8, Fgf15, Hoxb1, Vgll3, Pax5,
Hes3
Neural
crest
201
Sox10, Foxd3, Wnt1, Tfap2a, Tfap2b,
Cmtm5, Apod
Neural
tube
596 Fgfbp3, Hoxd4, Mafb, Arhgef28
Placodes 584
Dlx5, Ripply3, Wnt6, Tfap2a, Gjb3, Foxi2,
Foxg1, Sema3a
Neural &
mesodermal
progenitors
559
T , Sox2, Nkx1-2, Fgf17, Hes7, Fgf8,
Wnt3a
Early
mesoderm
293
Tbx6, Mesp2, Ripply2, Dll1, Dll3, Rspo3,
Hes7
Somitic
mesoderm
263
Aldh1a2, geneTcf15, Meox1, Meox2,
Uncx, Cd36, Cer1
Continued on next page
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Table 4.4 – continued from previous page
Cluster
Cell
number Key genes
Mixed
mesoderm
680
Foxf1, Osr1, Lhx1, Hoxd1, Hoxd9, Nxf3,
Hand2
Pharyngeal
mesoderm
357 Ebf1, Ebf2, Six2, Batf , Cped1, Ebf1, Tbx1
Cardiac
mesoderm
279
Tnnt2, Hspb1, Mesp1, Tnni1, Myl4, Myl7,
Acta2, Actc1, Csrp3, Tnnc1, Ankrd1,
Smarcd3, Hspb7, Asb2, Myh6, Pgam2
Extra-embryonic
mesoderm
406
Plac1, Pitx1, Hoxa10, Hoxa11, Hoxc10,
Tbx4
Amnion 103 Postn, Tdo2, Lum, Wisp1, Plac8
Endothelium 290
Kdr, Lmo2, Pecam1, Sox17, Hhex, Fli1,
Gata2, Tek, Eng, Tal1, Lmo2, Etv2,
Gadd45g
Blood 672
Hbb-bh1, Hba-x, Hbb-bh0 Car2, Blvrb,
Gypa, Gata1, Klf1
Notochord 68 Noto, T , Shh, Samd3, Nog, Defa30
Primordial
germ cells
12 Dppa3, Nanog, Pou5f1, Kit
Continued on next page
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4.3 Defining clusters
Table 4.4 – continued from previous page
Cluster
Cell
number Key genes
Definitive
endoderm
384
Apela, Cpm, Foxa1, Trh, Pyy, Nepn, Pax9,
Gpx2
Visceral
endoderm
284
Afp, Ttr, Amn, Apoa1, Apom, Apoa4,
Lgals2
Post filtering, differential gene expression was calculated using the student t-test with Welch’s
correction for differing group sizes within the filtered gene set. Multiple testing correction was
performed using independent hypothesis weighting and p < 0.05 was considered significant
[Ignatiadis et al., 2016]. Allocation of cellular identity to the clusters for some was very
straightforward but not clear for others, table 4.4. The blood cluster could be immediately
identified by high expression of haemaglobin genes Hba-a1, Hbb-bh1, Gypa amongst others.
The endothelial cluster with high expression of Pecam1 Sox17, Kdr and VE-Cadherin was
also readily recognised.
The primordial germ cell cluster despite consisting of only 12 cells (7 from embryo 2, 1 from
embryo 3 and 4 from embryo 4) was identified using this clustering method and differential
genes expression analysis allowed immediate allocation of cell type, table 4.5. This cluster
expressed known markers such as Dppa3(Stella), Nanog, Ifitm3 and Pou5f1. Kit is also
expressed highly within the PGC cluster but the corrected p value is not significant.
Dppa3 is very highly and specifically expressed in this cluster with a fold change of 5350.
Simply looking at genes highly correlated with Dppa3 also identifies other known PGC
related genes including Prdm14 and Sox15. Dnd1 has 53 times greater expression in PGCs
than other cells has been shown to be required for PGC survival and suppression of germ cell
tumours in mice [Yabuta et al., 2006; Yamaji et al., 2017].
Sex determination could not be phenotypically assessed under the microscope at this early
stage but was evaluated by assessing expression of Y chromosome genomic features and Xist
expression independently and both methods showed that embryos 2 and 3 were male and
embryo 4 was female, fig. 4.12. The only Y chromosome genomic feature that remained
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Fig. 4.11 Dppa3 is almost exclusively expressed in the PGC cluster. Unlike other genes
described Dppa3 appears to be truely specific to the PGC cluster within the E8.25 stage
embryo. Gene expression is plotted so that cells that have high expression are brought to the
fore.
after early gene filtering was Gm29650 and this was expressed in 17, 22 and 0 cells from
embryos 2, 3 and 4 respectively, consistent with the Xist result.
Reassuringly contributions to the different clusters is consistent across the embryos except for
embryo 2 having much lower contributions to the blood and visceral endoderm populations
due to it being almost wholly excised during dissection, see table 4.6 and fig. 4.4. This
highlights how dissection of different embryonic tissues can help validate cell type assignment
using a miss one out protocol. In this way multiple embryos with overlapping tissues could
be used to validate all cell types by their known spacial localisation.
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4.3 Defining clusters
Table 4.5 Genes identified as differentially expressed between the 12 primordial germ cells
and all other cells. Fold change, unadjusted p values and IHW adjusted p values are reported
[Ignatiadis et al., 2016].
Gene Fold change Unadjusted p values IHW adjusted p values
Psme1 5.42 2.10×10−6 6.33×10−6
Pou5f1 2.38×101 4.86×10−6 1.38×10−5
Ifitm3 1.08×101 5.00×10−6 1.42×10−5
Klf5 1.78×101 7.56×10−4 1.78×10−3
Dnd1 5.32×101 1.35×10−3 3.17×10−3
Fam222a 2.02×101 5.11×10−3 1.03×10−2
Alpl 9.53 7.44×10−3 1.67×10−2
Bst2 8.33 1.07×10−2 1.96×10−2
Tfap2c 1.01×101 1.32×10−2 2.34×10−2
Ttc28 5.48 1.32×10−2 2.42×10−2
Ypel3 5.15 1.31×10−2 2.73×10−2
Tapbp 1.98×101 1.58×10−2 2.87×10−2
1700019D03Rik 7.52 1.84×10−2 3.20×10−2
Esrp1 1.01×101 2.31×10−2 4.05×10−2
Nanog 2.60×102 2.58×10−2 4.32×10−2
Dppa3 5.35×103 2.60×10−2 4.39×10−2
Pla2g16 6.40 2.54×10−2 4.44×10−2
Gjb3 1.18×101 2.34×10−2 4.69×10−2
0.0
0.4
0.8
1.2
0.0 0.5 1.0 1.5 2.0
Log 10 normalised counts
de
ns
ity embryo2
3
4
Fig. 4.12 Histograms showing distributions of Xist expression in the 3 embryos. Embryos 2
and 3 have no appreciable Xist expression while embryo 4 shows strong expression in most
cells. The plot has been trimmed along the y-axis.
175
Single-cell census of mouse organogenesis
Table 4.6 Each cluster received equivalent contributions from the different embryos except
for the blood and visceral endoderm clusters.
Embryo
Male Female
Cluster 2 3 4
Forebrain 123 124 114
Mid/hindbrain 153 143 158
Neural crest 52 78 71
Neural tube 204 198 194
Placodes 214 211 159
Neural & mesodermal progenitors 192 171 196
Early mesoderm 107 95 91
Somitic mesoderm 80 74 109
Pharyngeal mesoderm 152 84 121
Mixed mesoderm 234 267 179
Cardiac 92 90 97
Extraembryonic mesoderm 160 112 134
Amnion 25 44 34
Notochord 29 20 19
Endothelium 100 105 85
Blood 11 387 274
Definitive Endoderm 119 176 89
Visceral Endoderm 29 156 99
Primordial germ cells 7 1 4
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4.4 Within cluster substructure
4.4 Within cluster substructure
Fine grained further characterisation of major clusters was performed by iteratively clustering
major clusters where substructure was evident on manual inspection.
4.4.1 Definitive endoderm
The lungs, gastrointestinal tract, thyroid, thymus, liver and pancreas amongst others will form
from or receive significant contributions from the definitive endoderm. Cluster allocation
was refined by focusing specifically on the definitive endoderm cluster, redefining highly
variable genes and re-clustering. 7292 highly variable genes were identified amongst the 384
definitive endoderm cells.
7 sub-clusters were identified using Louvain clustering, one cluster formed of a single outlier
cell was excluded. tSNE and directed graph layout (DrL) were used to visualise the cell
relationships in 2 dimensional plot, fig. 4.13. Marker genes were identified by performing
differential gene expression analysis and some key genes are summarised in fig. 4.14. The
hindgut and midgut were readily recognised using marker genes.
Hou et al. [2007] performed a systematic search of genes in the endoderm focusing on the
early definitive endoderm between 0 - 6 somite stage; foregut and hindgut at 8 - 12 somite
stage. Here we have in-silico dissected out the definitive endoderm at the 4 paired somite
stage. They revealed genes such as Pyy and Nepn (referred to as 5730521E12Rik) expressed
in the foregut endoderm. Pyy at the 4 somite stage has two expression domains on the lateral
wings and centrally in the medial ventral anterior foregut on validation in-situ hybridisation
experiemnts [Hou et al., 2007]. The DrL also appears to split the Pyy expressing foregut
into two domains one of which is very closely related to the pharyngeal endoderm, fig. 4.13
seemingly revealing the two Pyy expressing foregut domains. The embryos described here
were at an earlier stage than [Hou et al., 2007] but even at this early time-point substructure
consistent with later genes is identified furthermore this is consistent with in-situs from this
earlier paper, fig. 4.15.
An interesting finding is the Ttr expressing cells within the definitive endoderm cluster. On
the tSNE of all cells in fig. 4.10 a subset of this group of cells is midway between the visceral
endoderm cluster and the definitive endoderm cluster. Kwon et al. [2008] have shown using
genetic lineage tracing that cells from the visceral endoderm colonise the embryonic gut.
Here we see a sub-cluster of Ttr+ Afp+ expressing cells, the same genes used as markers
by Kwon et al. [2008], that were computationally clustered with the definitive endoderm.
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Single-cell census of mouse organogenesis
Table 4.7 Table of the number of cells allocated to each of the endodermal sub-clusters and
the colours used.
Colour Cell type Numbers
Pharyngeal 1 62
Pharyngeal 2 48
Foregut 67
Midgut 29
Hindgut 85
VE derived 25
Unclear 56
In-silico dissection by recursive clustering therefore captures this intriguing process of
integration of visceral endoderm cells into the embryonic gut.
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Fig. 4.13 tSNE dimensionality reduction on left and a directed recursive layout (DrL) on the
right. Both separate out the major clusters but DrL resolves the Louvain clusters more clearly,
clusters are better defined and relations between clusters are more apparent. The anterior
endodermal clusters and the visceral endoderm component are clearly separated from the
mid and hindgut. The final cluster labelled ‘Unclear’ is difficult to assign with only a single
gene (Pms2) being differentially expressed between it and its complement fig. 4.14. Colours
for the different clusters are defined in table 4.7.
2 Louvain clusters have been allocated as pharyngeal arch endoderm. Both clusters are
very similar in terms of gene expression, both expressing Six1, Pax1, Pax9, Irx3 and Irx5
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4.4 Within cluster substructure
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Fig. 4.14 (Continued on next page)
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4.4 Within cluster substructure
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Fig. 4.14 Selection of genes and boxplots of their expression patterns across the Louvain
clusters helped to assign putative cell type identities.
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Single-cell census of mouse organogenesis
Fig. 4.15 In-situ hybridisation to Pyy in a 4 somite pair embryo from Hou et al. [2007]
showing 2 domains of expression, laterally marked by arrow and median anterior endoderm
marked by arrowhead.
[Becker et al., 2001; Bonnard et al., 2012; Chuang et al., 2018; Kaltenbach et al., 2009; Zou
et al., 2006]. One gene that is significantly higher in the Pharyngeal 2 cluster is Ttr with a
fold change of 2.45 (p = 0.032) possibly indicating that this represents a visceral endoderm
component to the pharyngeal endoderm.
The final cluster is very difficult to define, remains unassigned and has been labelled Unclear.
The only gene specifically expressed in this sub-cluster is Pms2 a gene involved in apoptosis
[Marinovic-Terzic et al., 2008; Shimodaira et al., 2003; Zeng et al., 2000]. Assaying a larger
number of cells within these subsets may allow improved clustering and more powerful
differential expression analysis.
4.4.2 Neural & mesodermal progenitors
A similar approach to that applied to the definitive endoderm can be applied to the neural
and mesodermal progenitor cluster which likely consists of unipotent neural progenitors,
unipotent mesodermal progenitors but also bipotent neuromesodermal precursors (NMP). A
characteristic signature of these cells is co-expression of both Brachyury/T and Sox2. To focus
in and identify relationships within the mesodermal populations the neural and mesodermal
progenitor, neural tube, early mesoderm, mixed mesoderm and somitic mesoderm cell
populations were selected and highly variable genes recalculated so identifying 2391 cells
and 7713 genomic features.
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4.4 Within cluster substructure
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Fig. 4.16 tSNE and DrL side by side of neural and mesodermal progenitors (NAMP), early
mesoderm (EM), neural tube, mixed mesoderm and somitic mesoderm populations coloured
as shown in table 4.4. The new tSNE calculated on this subset of 2391 cells and 7713
genomic features is similar to the tSNE with all cells. The DrL displays the cells as almost
bipartite with a potential bifurcation.
The tSNE for the mesodermal and neural tube populations fig. 4.16, as seen previously with
the tSNE calculated for the definitive endoderm fig. 4.13 has a more diffuse appearance
with clusters less tightly defined. Part of the reason for this may be that the populations are
more homogenous and the variable gene calculation is therefore more prone to selecting
biologically irrelevant features i.e. those that show variation between embryos or batches
producing noise.
Despite the described difficulties with feature selection, the DrL, the right panel in fig. 4.16,
separates the clusters and suggests relationships between the clusters that were not apparent
on the tSNE. Applying Louvain clustering identified a Sox2 T Cyp26a1 co-expressing cluster
within the neural and mesodermal precursor population, fig. 4.17.
Having defined an NMP-like cluster, genes highly expressed in this cluster as compared to
the other mesodermal clusters were identified. The top 50 genes that are significantly more
highly expressed are summarised in table 4.8. This includes genes in pathways recognised to
be activated in NMPs including Brachyury/T , Nkx1-2, Cdx1, Cdx2, Cdx4, Wnt5b. Multiple
Hox genes are also expressed differentially including Hoxa7, Hoxa9, Hoxb8, Hoxb9, Hoxc4
Hoxc6, Hoxc8, Hoxc9 and the long non-coding Hoxaas3 and Hoxb5os [Diez del Corral and
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Fig. 4.17 Combined gene expression of Sox2, T and Cyp26a1 on a single plot similar to a
fluorescent microscopy image. A sub-population of NAMP cells is marked by concomitant
high expression of these marker genes suggesting that these represent NMP or NMP-like
cells. The Louvain clustering in the right panel splits that NAMP population into two, one of
which corresponds to this NMP-like population. Compare clustering with previous coarse
clustering fig. 4.13. LPM - Lateral plate mesoderm.
Morales, 2017; Henrique et al., 2015; Turner et al., 2014]. Table 4.8 now provides a list of
new candidate genes that may be useful in identifying NMPs.
Another interesting feature of both tSNE of all cells in fig. 4.10 and the tSNE of the meso-
dermal and neural tube subset of cells fig. 4.17 is that there is an outlier subset of neural
tube and in fig. 4.10 this includes cells from the mid/hindbrain cluster. This subset likely
corresponds to a set of cells derived from NMPs which has been proposed to contribute to
not only posterior spinal cord and presomitic mesoderm but also anterior spinal cord and
hindbrain [Henrique et al., 2015]. Midbrain and hindbrain precursors produced from in-vitro
mESC differentiation assays have been shown to express En1 and Otx2 [Turner et al., 2014].
On fig. 4.17 the early root cells are not clear. They may be at the Sox2, T , Cyp26a1 cells but
alternatively there may be a more primitive progenitor in the salmon coloured cluster at the
bottom of the plot. This expresses genes similar to the NMP cluster such as T and Cyp26a1
but does not express Sox2. Additionally genes such as Mixl1 and Snai1 are expressed highly
with several Claudins Cldn6, Cldn7 and Cldn9, suggesting these cells may be undergoing
EMT so possibly representing remaining streak cells at the node-streak border.
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4.4 Within cluster substructure
Louvain clustering has additionally split the mixed mesoderm cluster into a posterior meso-
derm and a lateral plate mesoderm. On the DrL the posterior mesoderm appears to be further
segregated into a postero-lateral mesdoerm and possibly paraxial mesoderm. It has not been
possible to define any intermediate mesoderm though its progenitors at least must be present.
The lateral plate mesoderm (LPM) also consists of two leaves the splanchnopleure or the
somatopleure LPM but this separation has not be established with current approaches.
Table 4.8 Top 50 genes more highly expressed in the NMP cluster relative to other meso-
dermal clusters. Unadjusted p-values and IHW adjusted pvalues are given [Ignatiadis et al.,
2016].
p-value
Gene Fold Change Unadjusted IHW adjusted
Hoxaas3 2.78 1.08×10−125 6.20×10−122
Slc2a3 2.46 1.46×10−82 2.38×10−79
Cdx2 3.21 1.78×10−69 2.57×10−66
Grsf1 2.39 6.04×10−68 6.91×10−65
Hoxc8 4.09 8.77×10−68 8.44×10−65
Cdx1 2.86 2.65×10−66 1.90×10−63
Nkx1-2 7.28 1.53×10−65 9.76×10−63
Hoxb9 3.43 2.00×10−63 2.01×10−60
Hoxb8 2.91 6.42×10−62 4.95×10−59
Epha5 6.00 6.67×10−58 2.14×10−55
Cdx4 3.10 3.69×10−57 1.11×10−54
Hes3 5.80 8.30×10−56 2.38×10−53
Hoxb5os 2.44 5.05×10−53 1.31×10−50
Cystm1 5.98 6.21×10−51 1.55×10−48
Fgf8 4.61 2.26×10−46 5.17×10−44
Etv4 5.06 5.25×10−46 1.16×10−43
Stmn2 2.67 1.25×10−44 2.48×10−42
Greb1 2.44 4.29×10−36 6.31×10−34
Acot7 3.21 2.71×10−36 6.78×10−34
Pdgfa 3.00 8.76×10−35 1.23×10−32
Hoxa7 3.21 9.27×10−31 9.46×10−29
Fgf17 4.73 8.08×10−29 7.76×10−27
Lix1 3.55 1.59×10−28 1.47×10−26
Continued on next page
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Table 4.8 – continued from previous page
p-value
Gene Fold Change Unadjusted IHW adjusted
Pmaip1 8.44 1.92×10−28 2.03×10−26
Gap43 3.13 2.32×10−28 4.14×10−26
Mgst1 2.32 1.58×10−27 1.56×10−25
Evx1os 4.02 1.54×10−25 1.30×10−23
Hoxa9 3.75 2.64×10−25 2.21×10−23
Hoxc6 4.67 5.14×10−25 4.14×10−23
Lhpp 2.63 9.34×10−24 7.09×10−22
T 3.26 5.79×10−23 4.34×10−21
Smim3 3.01 4.88×10−22 3.42×10−20
Hes7 2.71 5.42×10−22 3.73×10−20
Rasgrp2 4.96 6.00×10−22 4.09×10−20
Sox2 2.80 2.43×10−21 2.76×10−19
Hoxc4 2.86 6.94×10−21 4.46×10−19
Foxb1 2.49 3.64×10−20 2.27×10−18
Cyp26a1 3.36 7.19×10−20 4.30×10−18
Sp8 3.92 9.70×10−20 4.90×10−18
Hoxc9 3.39 2.79×10−19 1.63×10−17
Scg5 3.55 2.91×10−18 1.59×10−16
Tcea3 3.96 5.14×10−18 2.33×10−16
Wnt5b 2.58 1.11×10−17 5.62×10−16
Tpd52 2.50 4.86×10−17 2.07×10−15
Spint2 2.40 6.08×10−17 2.96×10−15
Ezr 2.17 3.88×10−17 3.26×10−15
Ccnjl 2.29 1.54×10−16 6.14×10−15
Fgfbp3 2.60 1.15×10−15 4.26×10−14
Epha1 5.70 1.02×10−15 7.54×10−14
Car2 2.12 2.42×10−15 8.67×10−14
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4.5 Cardiac divergence convergence
4.5 Cardiac divergence convergence
The cardiac pump must be one of the earliest organs to begin functioning so that the growing
organism can meet demands of nutrient delivery and waste disposal as diffusion alone
becomes inadequate.
The developing heart receives cell contributions from both the first and second heart fields.
The first heart field is derived from the lateral plate mesoderm while the second heart field
from the pharyngeal mesoderm. The tSNE in fig. 4.10 reconstructs these relationships
simply from distances calculated by their transcriptome wide expression patterns. It is quite
surprising that a naïve analysis can reveal this convergence back towards a cardiac fate from
cells that have previously diverged.
To study this in more detail the mixed mesoderm, pharyngeal mesoderm and cardiac clusters
were analysed separately from the remainder of the cells. There were 1316 cells within these
groups and 7453 genomic features were found to be variably expressed. Dimensionality
reduction was performed using DrL and separated the cardiac cells into 2 clear clusters,
fig. 4.18. Louvain clustering clearly differentiates the two and on DrL it is apparent they are
related to both the pharyngeal mesoderm, the source of the second heart field or the mixed
mesoderm which includes the lateral plate mesoderm, the source of the primary heart field.
Nkx2-5, Mef2c, Smarcd3/Baf60c, Gata4, Tbx5 and Tbx20 are known cardiac associated genes
and are expressed in the expected region of the DrL, fig. 4.20 [Colombo et al., 2018; Kelly
et al., 2014; Neshati et al., 2018; Ryan and Chin, 2003; Singh et al., 2005; Takeuchi and
Bruneau, 2009; Vincentz Joshua W. et al., 2008].
It is tempting to consider the two clusters may represent the first and second heart fields
but gene expression suggests otherwise. Particularly expression of Irx4 suggests that one of
the clusters consists of Irx4+ cells fated to become ventricular myocardium while the cells
populating the other cardiac cluster which are almost exclusively Irx4- form either atria or
outflow tract [Bruneau et al., 2000; Nelson et al., 2014].
Having identified these 2 cardiac populations computationally we can in-silico compare
gene expression between the ventricular fated Irx4+ and alternate fated Irx4- cells. After
multiple testing correction using IHW this identified 1087 differentially expressed genomic
features, 22 are exclusively expressed in a subset of the putative ventricular cluster and 63
are transcription factors table 4.9. The top 20 up and down regulated genes are clustered
on the heatmap in fig. 4.19. These genes represent possible candidates for differentiating
between ventricular and other cardiac precursors as early as the 4 somite stage. In addition
to Irx4 which was not in the top 20 up-regulated genes, Myl2 the ventricular isoform of
187
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Fig. 4.18 DrL with cells coloured by previously defined clusters, table 4.4 in the left pattern.
Cells coloured by newly calculated clustering in right panels shows cardiac cluster is split in
to two distinct clusters.
myosin light chain was expressed 118 times higher (IHW adjusted p = 1.2×10−28) in the
putative ventricular cluster as compared to the atrial/OFT cluster [Sheikh et al., 2015] further
adding support that this cluster be assigned ventricular myocardium. Other Iroquois-related
homeobox genes Irx1 (fold change 34.9 IHW adjusted p = 1.65× 10−9) and Irx2 (fold
change 21.2 IHW adjusted p = 2.32×10−6) were also significantly highly expressed in the
ventricular myocardial cluster as has been previously described [Christoffels et al., 2000].
Bertrand et al. [2011] have shown that Hoxb1 is down-stream of retinoic acid and marks
a sub-domain of the second heart field contributing to the atria and the inferior wall of the
OFT. Other genomic features differentially expressed between the putative ventricular and
atria/OFT clusters for example the apparent differential expression of Wnt-related genes
(Sfrp5 and Fzd7) may suggest promising target pathways for directing differentiation towards
different cardiac cellular components [Abu-Elmagd et al., 2017; Fujii et al., 2017]. The
genes Nr2f1 (COUP-TFI) and Nr2f2 (COUP-TFII) are also known to be required for atrial
induction [Devalla et al., 2015; Pereira et al., 1999].
Of the 22 genes exclusively expressed in the ventricular cluster Klk1 has been linked with
cardiac hypertrophy [Chao et al., 2010; Moreau et al., 2005], Cacna1c has been shown to be
down-regulated in rat atria compared to ventricles and mutations have been associated with
ventricular tachy-arrythmias in humans [Bai et al., 2016; Hatano et al., 2006], and Mitf has
been suggested to regulate cardiac growth and hypertrophy [Tshori et al., 2006].
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Fig. 4.19 Heatmap of genes expressed differentially between the putatively assigned Irx4+
ventricular myocytes and Irx4- atrial/OF cells.
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Single-cell census of mouse organogenesis
Table 4.9 63 transcription factors identified to be differentially expressed between the two
cardiac clusters identified using Louvain clustering fig. 4.18. Fold change is relative to the
atria/OFT cluster. Unadjusted p-values and IHW adjusted pvalues are given [Ignatiadis et al.,
2016].
p-value
Gene Fold Change Unadjusted IHW adjusted
Hopx 6.30 1.44×10−13 1.52×10−12
Foxf1 0.07 5.23×10−13 5.12×10−12
Nr2f2 0.08 1.50×10−11 1.23×10−10
Hoxb2 0.22 3.02×10−11 2.41×10−10
Irx1 34.87 2.50×10−10 1.65×10−9
Irx4 7.43 7.13×10−10 4.43×10−9
Hoxb1 0.06 3.31×10−9 1.88×10−8
Twist1 0.15 9.58×10−9 4.92×10−8
Nr2f1 0.09 1.54×10−8 7.84×10−8
Etv5 11.02 1.85×10−8 9.14×10−8
Irx2 21.23 5.89×10−7 2.32×10−6
Hoxb4 0.04 1.04×10−6 3.85×10−6
Hoxa1 0.14 1.10×10−6 4.04×10−6
Tgif1 0.31 2.79×10−6 9.08×10−6
Rora 7.78 4.29×10−6 1.32×10−5
Zfp608 4.70 1.42×10−5 4.02×10−5
Hoxd1 0.07 2.02×10−5 5.57×10−5
Gli3 0.26 2.13×10−5 5.84×10−5
Alx1 0.16 2.55×10−5 6.91×10−5
Twist2 0.16 2.70×10−5 7.19×10−5
Tcf21 0.11 2.71×10−5 7.20×10−5
Snai2 0.13 2.76×10−5 7.22×10−5
Prox1 5.19 2.83×10−5 7.39×10−5
Stat3 3.31 6.01×10−5 1.46×10−4
Mitf ∞ 1.16×10−4 2.62×10−4
Nfya 0.18 3.57×10−4 7.09×10−4
Hoxb5 0.05 4.53×10−4 8.56×10−4
Hey2 3.81 6.85×10−4 1.23×10−3
Continued on next page
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4.5 Cardiac divergence convergence
Table 4.9 – continued from previous page
p-value
Gene Fold Change Unadjusted IHW adjusted
Zfp9 0.08 7.16×10−4 1.28×10−3
L3mbtl3 0.27 7.88×10−4 1.38×10−3
Tfap4 0.29 9.84×10−4 1.66×10−3
Ets1 0.04 1.10×10−3 1.84×10−3
Zbtb44 6.75 1.11×10−3 1.86×10−3
Etv4 5.43 1.63×10−3 2.64×10−3
Tbx18 0.12 1.89×10−3 2.98×10−3
Bach2 3.24 1.94×10−3 3.04×10−3
Fosl2 13.71 1.95×10−3 3.05×10−3
Tox3 0.22 2.04×10−3 3.16×10−3
Rarb 0.23 2.46×10−3 3.71×10−3
Gli1 0.10 2.52×10−3 3.77×10−3
Capn15 0.18 2.71×10−3 4.04×10−3
Hoxa5 0.16 3.76×10−3 5.32×10−3
Zfp654 5.98 3.87×10−3 5.47×10−3
Snai1 0.22 4.02×10−3 5.62×10−3
Tshz1 0.32 5.11×10−3 6.93×10−3
Zfp105 0.28 5.23×10−3 7.07×10−3
Zbtb2 0.20 7.24×10−3 9.30×10−3
Sox6 4.37 9.64×10−3 1.20×10−2
Myc 0.33 1.04×10−2 1.27×10−2
Barx1 4.95 1.08×10−2 1.31×10−2
Ncoa1 4.37 1.40×10−2 1.65×10−2
Zfp959 0.27 1.69×10−2 1.95×10−2
Hes7 5.43 2.20×10−2 2.46×10−2
Zfp618 0.23 2.24×10−2 2.48×10−2
Zbtb37 0.30 2.98×10−2 3.22×10−2
Creb3l1 0.30 3.01×10−2 3.24×10−2
Stat6 3.52 3.36×10−2 3.57×10−2
Tfeb 3.35 3.40×10−2 3.61×10−2
Sox13 0.30 3.66×10−2 3.86×10−2
Continued on next page
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Single-cell census of mouse organogenesis
Table 4.9 – continued from previous page
p-value
Gene Fold Change Unadjusted IHW adjusted
Zbtb46 3.94 3.70×10−2 3.88×10−2
Pou6f2 3.61 3.75×10−2 3.92×10−2
Zbtb26 3.34 3.97×10−2 4.13×10−2
Nr1d1 3.27 4.01×10−2 4.15×10−2
At the E8.25, 4 somite pair stage, the cardiac crescent has formed from the first heart field
and additional cells from the second heart field are gradually recruited. This suggests a
possible continuity of cells from the second heart field subset of pharyngeal mesoderm
towards the heart while those from the first heart field have likely already been specified
at this stage. Assuming the DrL at least partly captures a differentiation process from the
pharyngeal mesoderm toward the second heart field some of the genes appear to be expressed
in a step-wise fashion towards both Irx4+ ventricular and Irx4- cells with Mef2c and Nkx2-5
expressed early while Tbx5 and Tbx20 are expressed later, fig. 4.20. Differentiation protocols
that incorporate such ordered gene activation may therefore more faithfully recapitulate
developmental processes by following such a step-wise approach rather than activating all
genes concurrently [Takeuchi and Bruneau, 2009].
Using these known genes other genes with similar expression profiles may be identified
using a guilty by association approach so that highly correlated genes may also be involved
in cardiomyogenesis. This identifies multiple genes some previously known to be associ-
ated with cardiogenesis but others not previously implicated. Filtering the genes only for
transcription factors with p < 0.01 identified 126 transcription factors positively correlated
to the known cardiac genes and 144 transcription factors negatively correlated within this
subset of cells in the 4 somite pair stage mouse embryo. The top 50 most highly positively
correlated transcription factors are summarised in table 4.10. This table includes several
genes known to play a critical role in cardiogenesis including Mef2c, Casz1, Gata5, Hopx,
Irx4 and other Iroquois homeobox factors [Bonachea et al., 2014; Bruneau et al., 2000; Chen
et al., 2002; Christoffels et al., 2000; Hempel et al., 2017; Huang et al., 2016; Nelson et al.,
2014; Schneider et al., 2015; Vincentz Joshua W. et al., 2008].
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4.5 Cardiac divergence convergence
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Single-cell census of mouse organogenesis
Table 4.10 Top 50 transcription factors most significant positively correlated to Nkx2-5,
Smarcd3, Gata4, Tbx5 and Tbx20 within the selected subset of cells fig. 4.18. Spearman’s
rank correlation was performed. Unadjusted p-values and IHW adjusted pvalues are given
[Ignatiadis et al., 2016].
p-value
Gene Correlation Unadjusted IHW adjusted
Mef2c 0.69 7.97×10−185 1.74×10−181
Casz1 0.48 1.52×10−77 7.28×10−75
Gata5 0.41 6.47×10−54 1.63×10−51
Hopx 0.38 3.39×10−47 6.38×10−45
Irx4 0.38 8.89×10−46 3.30×10−43
Gata6 0.37 6.00×10−43 8.12×10−41
Zbtb20 0.36 5.29×10−42 8.77×10−40
Plagl1 0.32 3.97×10−32 4.59×10−30
Tsc22d1 0.29 9.93×10−28 6.82×10−26
Fosb 0.29 1.17×10−26 1.07×10−24
Fos 0.29 2.12×10−26 1.14×10−24
Prox1 0.29 1.11×10−26 1.72×10−24
Esrrg 0.28 3.77×10−25 5.86×10−23
Prdm6 0.24 1.64×10−18 8.33×10−17
Smad6 0.23 1.73×10−17 9.91×10−16
Id2 0.22 3.71×10−16 1.27×10−14
Mef2d 0.22 2.60×10−16 2.18×10−14
Prrx2 0.22 1.09×10−15 3.45×10−14
Tead1 0.20 7.59×10−14 2.41×10−12
Hey2 0.20 2.51×10−13 1.62×10−11
Tbx2 0.20 5.14×10−13 4.40×10−11
Nr2f1 0.19 2.36×10−12 8.07×10−11
Stat3 0.19 2.36×10−12 8.29×10−11
Hes6 0.19 3.33×10−12 1.15×10−10
Barx1 0.19 2.22×10−12 2.02×10−10
Klf2 0.19 9.68×10−12 2.52×10−10
Creb3l2 0.18 2.10×10−11 6.61×10−10
Peg3 0.18 4.66×10−11 9.85×10−10
Continued on next page
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Table 4.10 – continued from previous page
p-value
Gene Correlation Unadjusted IHW adjusted
Lrrfip1 0.18 6.68×10−11 1.55×10−9
Klf4 0.18 7.27×10−11 2.17×10−9
Cdip1 0.17 3.09×10−10 6.66×10−9
Jund 0.17 5.02×10−10 7.60×10−9
Arid3b 0.17 4.75×10−10 8.78×10−9
Pou6f2 0.17 3.27×10−10 2.02×10−8
Nfe2l2 0.17 1.44×10−9 3.60×10−8
Grhl1 0.17 1.09×10−9 6.84×10−8
Klf6 0.16 6.31×10−9 9.72×10−8
Tfeb 0.17 1.69×10−9 1.03×10−7
Irx2 0.16 9.19×10−9 2.06×10−7
Zim1 0.16 8.30×10−9 2.67×10−7
Zfpm1 0.16 1.21×10−8 3.48×10−7
Hif1a 0.15 4.17×10−8 4.85×10−7
Hand1 0.15 3.05×10−8 4.95×10−7
Bhlhe40 0.16 1.17×10−8 5.78×10−7
Nr4a1 0.15 5.53×10−8 8.31×10−7
Esrra 0.15 4.61×10−8 1.21×10−6
Mafk 0.15 6.50×10−8 1.24×10−6
Pbx3 0.15 7.03×10−8 1.34×10−6
Rit1 0.15 8.54×10−8 1.61×10−6
Creb3 0.14 1.41×10−7 2.25×10−6
4.6 Transcriptional termination variants
The single cell transcriptomic analysis has been performed on gene level data that is to say
all gene isoforms are assumed to count towards the same genomic feature. Yet different gene
isoforms can have differing, even opposing functions [Hakre et al., 2006]. Due to the low
depth of single cell data even that produced by protocols such as Smart-seq2 discussed in
section 3.2, isoform level data is difficult to infer accurately though this has been performed
195
Single-cell census of mouse organogenesis
for bulk RNAseq [Qiu et al., 2017a; Shen et al., 2014]. Additionally the 10x Genomics®
Chromium™ protocol and most methods that incorporate UMIs to avoid bias from PCR
duplicates can only capture one end of the mRNA molecule, usually the 3′ end. This therefore
precludes a complete splice variant analysis.
In the case of the current 10x Genomics® Chromium™ protocol, the mRNAs are captured
on barcoded anchored oligo-dT at the 3′ end of the molecule, so that the terminal part of
the mRNA molecule is captured and so theoretically any variation of termination site may
be determined. Figure 4.5a summarises the 10x Genomics® Chromium™ protocol and
the sequences used have been previously given in table 3.2 and fig. 3.4; together these
demonstrate where the cDNA insert fragment is located in the final library construct. The
reads from the sequencer correspond to the 98bp along this fragment starting from the Read
2 end. The length of the library without including the insert length can be calculated as
183bp plus the insert length, table 4.11. From the bioanalyser trace of the final library we
can calculate the expected length which is between 300 to 700 bp fig. 4.21. We therefore
can deduce that the fragment will be 117 to 517 bp in length with only the first 98 bp being
sequenced due to the sequencing protocol used. The library size distribution, keeping in
mind that the abscissa is log-scaled, fig. 4.21, will to some extent determine the distribution
of read pile-up and will be expected to be centered at ≈ 250 bp upstream of the annotated
transcription termination site.
Table 4.11 Constituent parts of the 10x Genomics® Chromium™ library molecule and their
sequence lengths in base pairs (bp).
Name Sequence Length (bp)
P7 CAAGCAGAAGACGGCATACGAGAT 25
10X cell barcode NNNNNNNNNNNNNN 14
Read 2 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG 34
UMI NNNNNNNNNN 10
Oligo-dT TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 30
Insert - Variable
Read 1 CTGTCTCTTATACACATCTGACGCTGCCGACGA 33
Sample index NNNNNNNN 8
P5 GTGTAGATCTCGGTGGTCGCCGTATCATT 29
Total 183 + Insert
A useful finding would be if for the same genomic feature multiple peaks were identified,
suggesting variant transcription termination sites which may then be used as additional
features and exploited in defining disparate cell types. Figure 4.22 shows that reads are
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Fig. 4.21 Representative bioanalyser tracies of the post cDNA amplification reaction QC
(top), the post shearing fragments (middle) and of the final library (bottom) from the 10x
Genomics® Chromium™ single cell protocol, demonstrating the final library size is between
300 to 700 base pairs (bp). 197
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mapped not only to a single location but there are multiple peaks for each of the example
genes shown. Each peak is ≈ 400bp as was expected. Some reads are clearly distributed
over splice sites see Hoxc8 for example fig. 4.22.
This is not an exhaustive set. A systematic approach here would be useful to identify all such
genomic features and then to re-annotate the GTF file so that they can be differentiated to
see if they correspond to any biological effect. This has not been pursued here but is part of
continuing work. Additionally it can be seen that peaks for some genes for example Cdx4
and Nkx-2 lie beyond the end of the annotation so these reads will have been incorrectly
discarded when assigning reads to genes.
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Fig. 4.22 Multiple peaks are found on the 3′ untranslated regions of multiple genomic
features. This suggest that the oligo-dT is hybridising at different regions so suggesting
transcipts terminating at different genomic locations. Arrows on the gene marks indicate 5′
to 3′ direction.
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4.7 Conclusions
The 10x Genomics® Chromium™ platform allows for many more cells to be assayed though
sequencing depth is reduced and drop-outs become more severe of a problem. Despite these
drawbacks the large number of cells appear to overcome the reduced signal to noise ratio
per cell. The variety of cell types and large numbers of each type allowed for robust and
confident cell assignment for many clusters in the 4 somite stage murine embryo, fig. 4.10.
The large dataset poses additional problems in terms of computational resource utilisation.
The large datasets require large amounts of long-term storage but additionally create problems
with memory as many calculations. Taking advantage of sparsity can help reduce the storage
and short-term memory requirements. But even then calculation of a distance matrix is
O(n2) in memory and time for n cells. Again changing tact by using a similarity matrix and
retaining only nearest neighbours can help reduce memory utilisation. Initial data analysis
and normalisation was in this case performed in Python rather than R due to its favourable
memory utilisation and better performance.
Feature selection is a key early step and the Brennecke et al. [2013] method has been used
in the previous chapter. On the current dataset despite altering various parameters it was
unable to give any reasonable fit to the data and so a linear fit was used and all genes with
variation above the fitted line were included for downstream analyses. This concept of finding
a relationship between gene expression and variability and then selecting genes that vary
beyond a certain amount based on their mean is rather simplistic and rather naïve. Apparent
gene variability can have many causes but biologically the most relevant genes are likely to
be those that can discriminate between cell types.
A large part of this chapter has focused on clustering and sub-clustering cells. Many examples
are given but in this large dataset many avenues of investigation remain unpursued. The Pyy
expressing foregut domains identified by sub-clustering the definitive endoderm are clearly
split on the DrL and on in-situ hybridisations at the corresponding embryonic stage figs. 4.13
and 4.15. Though not performed here, the in-silico recovery of these two sub-domains
provides an opportunity to perform differential expression to identify novel genes that can
differentiate between the two sub-domains.
Different aspects of the dataset can be appreciated using alternative analytic approaches. For
example the original tSNE allows appreciation of convergence of previously divergent cell
types back on to a cardiac myocyte cell type. Sub-setting the data, recalculating variable
genes and plotting using DrL as implemented in the roots package presents a different
appreciation of the data, now separating atrial and ventricular fated cardiomyocytes. Looking
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for a single analytic technique that can concurrently display all biologically useful properties
of a dataset given their complexities is likely to be futile and the more pragmatic approach
of using a few approaches and then manually exploring the data with some background
knowledge can often be quite revealing.
In summary this chapter has focused on a 10x Genomics® Chromium™ generated dataset
and using multiple techniques have demonstrated how cell type identity may be assigned
using an iterative approach. This method has been successfully used on a diverse set of
cell types from the definitive endoderm to cardiac mesoderm. At the end of the chapter
transcriptional termination variants are briefly introduced and it is demonstrated that the 3′
10x Genomics® Chromium™ protocol appears to capture this additional information that
may be useful if collected systematically.
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5.1 Background
High throughput and massively multiplexed single cell transcriptomic methods such as
Smart-seq2 and droplet technologies have developed rapidly and as discussed in previous
chapters pose several analytic challenges around the central problem of large sparse datasets
with noisy measurements. Zero counts are a particular problem and can have multiple origins,
examples include:
1. Gene is not expressed in the cell and no such mRNA moieties are present.
2. Gene is expressed
• but no mRNA moities are captured by hybridisation to the oligo-dT.
• mRNA moities are captured and amplified
– but not sheared (either physically or by use of a transposome) to the desired
length
– and are sheared to the desired length
* but not captured on the flowcell to form an adequate cluster
Other than the first in this list the remainder produce false negatives. The probabilities of
the events that cause these false negatives are clearly related to and dependent upon the
underlying true expression level i.e. the number of mRNA moities in the cell that may
be captured at the initial step, assuming the remainder of the experimental conditions are
optimised. This apparent increase in the number of zeros in datasets goes by several different
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names but in single cells is often called zero-inflation or drop-out. Several methods for
inferring drop-outs have been adopted and applied to single-cell data but despite these
inference methods zero-inflation effectively adds additional noise to the data.
Visualisation techniques commonly used to explore single-cell data include PCA, tSNE, multi-
dimensional scaling (MDS), diffusion maps and SPRING [Andrews and Hemberg, 2018;
Becht et al., 2018; Ding et al., 2018; Rostom et al., 2017; Taskesen and Reinders, 2016].
Applying even the same method on a given dataset but selecting different features can
expose different aspects of the data. But as described in the previous chapter applying
different dimenionality reduction techniques can help appreciate different aspects of the same
dataset. In this chapter with view to simulating a continuous process of ontogenic progression
an alternative visualisation technique has been developed and published as an R package.
tSNE is commonly and successfully deployed in exploring single-cell data but currently
no method exists to allow the user to add new data points to a pre-existing embedding and
the latest Rtsne package is tweaked to allow this. Finally a novel method is developed to
simulate developmental progression by training a deep neural network on plausible single
cell transitions.
5.2 Reconstructing ordered ontogenic relationships
The R package roots was developed with view to reconstructing ordered ontogenic relation-
ships from single cells data. Below follows a description, the algorithm and some examples
of its use. This has been used in previous chapters but is discussed here in further detail.
5.2.1 Overview
Abstractly cells may be considered to be resident in a high-dimensional gene expression
space. This simplistic view excludes other key properties for example their spacial posi-
tioning, cellular neighbourhood and cell to cell signalling, surrounding molecular signalling
milieu and their epigenetic and proteomic landscapes. Distance between cells may then be
considered to be some dissimilarity between their gene expression vectors. This allows a cell
to cell similarity to be calculated for all cells and a graph to be generated. Since a distance
and thus a similarity may be calculated between all cells a fully connected graph is created
and can be used to generate a transition matrix whereby a cell may theoretically transition
from one state to another with a probability inversely related to the distance.
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Such graphs give rise to appreciable probabilities on non-plausible transitions. An example
in 3-dimensional space may be that of travelling on Earth, represented as a circle in fig. 5.1.
The problem can be seen in fig. 5.1a where only the starting and end points are sampled
leaving the underlying surface or manifold unidentified. Any transition inferred between
these two points by calculating a distance in Euclidean space would therefore be implausible
and the true distance would be very different. Alternatively sampling more heavily in the
region of interest would reveal the surface of the planet and so plausible interim states. This
arc in a high-dimensional space would correspond to the underlying manifold and using
these intermediate states would uncover a plausible and accurate journey without unrealistic
short-cuts.
A
B
(a)
A
B
(b)
Fig. 5.1 (a) Low or minimal sampling strategy with only the initial and final cell states
sampled does not provide sufficient information to infer the manifold and suggests a transition
takes a cell through an implausible path, red arrow. (b) Increasing sampling density evenly
across the unknown manifold and allowing only short transitions determines the underlying
manifold and reveals a plausible journey, green arrow.
This partly highlights the importance of heavy sampling density to avoid implausible transi-
tions. Sampling density is even more important when we consider that our measurements are
noisy. Clearly where more fine grained ascertainment is required or dimensionality of the
landscape and complexity of the underlying manifold increases the sampling density must be
increased substantially. The minimum sampling density though is difficult to determine and
is likely to be different at different parts of the manifold. Furthermore, simply extending this
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thought experiment it can be appreciated that sufficient sampling density will also depend on
the signal to noise ratio of the measurements.
5.2.2 Algorithm
Normalisation
A data matrix A ∈Rn×m of n cells, C and m genes G is re-normalised using background gene
expression. For each cell c ∈C a set of background genes, G′c is defined as those that have
counts less than a user-defined proportion α of the library size.
Aci < α ∑
g∈G
Acg, ∀i ∈ G′c ⊂ G
The background gene set G′ is then the intersection between each cell’s background gene set
across all cells.
G′ =
⋂
c∈C
G′c
The background gene set G′ is then considered to be a house-keeper gene heuristic. Cell
counts are then normalised using this set G′ and re-scaled by the mean library size to give
the normalised counts matrix A¯.
A¯cg =
Acg
∑
i∈G′
Aci
∑
g∈G,c∈C
Acg
n
Feature selection
Having normalised the data the genes are filtered by using hard lower bounds for mean gene
expression µ for each gene across the whole dataset and the Fano factor σ
2
µ , where σ
2 is the
variance.
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µg =
1
n ∑c∈C
A¯cg
σ2g =
1
n−1 ∑c∈C
(
A¯cg−µg
)2
The hard bounds select a subset of genes Gˆ⊂ G for downstream analysis, such that:
µi > β and
σ2i
µi
> δ , ∀i ∈ Gˆ⊂ G
No mean-Fano factor relationship is fitted as performed by Brennecke et al. [2013] but
simple hard thresholds were used and selected manually by inspection resulting in a filtered
normalised matrix Aˆcg ∈ Rn×m
∗
.
Orthogonalisation and distance calculation
Each feature or gene expression is mean centred and scaled.
µ˜g =
1
m∗ ∑c∈C
Aˆcg, µ˜ ∈ Rm
∗
σ˜2g =
1
m∗−1 ∑c∈C
(
Aˆcg− µ˜g
)2
, σ˜ ∈ Rm∗
A˜ = Σ−
1
2
(
Aˆ−h · µ˜Tg
)
, A˜ ∈ Rn×m∗,h ∈ Rn
where Σi= j = σ˜2i and Σi̸= j = 0, Σ ∈ Rm
∗×m∗
and hc = 1, ∀c ∈C
PCA dimensionality reduction was performed retaining a user-defined l number of eigen-
vectors. To speed this up the large sparse matrix Arnoldi algorithm as implemented in
rARPACK was utilised [Arnoldi, 1951]. Each cell was now represented by a vector of length
l. Euclidean distances between all cell pairs were calculated in PCA space, generating a fully
populated dense distance matrix D ∈ Rn×n.
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Gaussian kernel width estimation
A Gaussian kernel, L is calculated as in section 3.10.1 using the distance matrix, D. It is
parameterised by σi. These are calculated as described by Haghverdi et al. [2016] and require
a user selected k-nearest neighbour. The kernel width for each cell σi is then calculated
accordingly.
σi =
2
√
Di,k
2
where Di,k represents the distance between cell i and its k-th nearest neighbour. The entries
of L are then calculated as previously shown in section 3.10.1
Li, j = 2
√
2σiσ j
σ2i +σ2j
exp
− ∥∥ci− c j∥∥2
2
(
σ2i +σ2j
)
 , for i ̸= j,
and Li, j = 0, for i = j
where ci,c j ∈ Rn are column/row vectors of D. Now the entries of the matrix L may be
considered un-normalised transition probabilities.
Transition matrix calculation
This is now normalised to give the Markov matrix, L¯ ∈ Rn×n with entries:
L¯i, j =
Li, j
∑ j Li, j
All off diagonal entries in L¯ will be non-zero so giving a finite probability to some transitions
between very different cells that are biologically implausible. To reduce this effect all
transition probabilities below a threshold are set to zero. One method of setting such a
threshold, ε , was to the find the highest threshold that ensures all cells have at least one
non-zero transition probability. Thus giving a sparse Markov matrix Lˆ ∈ Rn×n.
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so that Lˆi, j = 0, ∀L¯i, j < ε
and Lˆi, j = L¯i, j, ∀L¯i, j ≥ ε
ε = min
i
(
max
j
(
L¯i, j
))
Another method could be to assume that one can reasonably select a maximum number
of cells that a single cell within the sampled population should be able to transition to
with equivalent probability, for example in our dataset this may be taken to be 10% of the
population so that a threshold transition probability of ≈ 1700 may be set. Such thresholds
may be set iteratively after defining clusters so that cells from different clusters have different
thresholds. This approach was not followed here.
Despite making the matrix sparse some spurious edges will remain and these are removed
by assuming that if cell i is can transition to cell j directly there must exist at least one
second order transition between cells i and j. So that any transition i→ j with no second
order transition is regarded spurious and set to zero. To reduce computational complexity all
second order transitions, S ∈ Rn×n are calculated using the adjacency A ∈ Rn×n.
Ai, j = 1, ∀Li, j > 0
Ai, j = 0, ∀Li, j = 0
S = A2
Now edges are pruned from the Markov transition matrix, Lˆprunedi, j ∈ Rn×n.
Lˆprunedi, j = Lˆi, j, ∀Si, j > 0
Lˆprunedi, j = 0, ∀Si, j = 0
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By pruning the transition matrix from all the cells C some will have no transitions and will
form end points from which it is impossible to transition out. These cells were removed to
leave a set C′ ∈C where all cells have at least one potential transition possibility.
∑
j
Lˆprunedi′, j > 0, ∀i′ ∈C′ ⊂C
The probabilities will require re-normalisation to account for the transitions that have been
disallowed in the previous two steps to give a new matrix L˜ ∈ R|C′|×|C′|.
L˜i′, j′ =
Lˆprunedi′, j′
∑ j′ Lˆ
pruned
i′, j′
, ∀i′, j′ ∈C′ ⊂C.
This matrix L˜ ∈ R|C′|×|C′| is now taken as a representation of the underlying manifold of the
cell expression space sampled.
Some downstream clustering and visualising algorithms though require a symmetric matrix
as input. The Markov matrix was therefore symmetrised:
L˜symi, j = L˜
sym
j,i = max
(
L˜i, j, L˜ j,i
)
Clustering
Clustering can now be performed by looking for modules within the graph representation
of the cells. In this case Louvain modularity was used due to its advantages as described in
Blondel et al. [2008]:
• Unsupervised requiring no selection of the number of clusters, intuitive and easy to
implement.
• Extremely fast and has been used on hundreds of millions of nodes.
• Somewhat overcomes the resolution limit problem of modularity by initially starting
with all cells separately and iteratively combining nodes so that intermediate results
may be meaningful.
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Louvain clustering is based on optimising modularity, Q defined as:
Q =
1
2m∑i, j
[
L˜symi, j −
kik j
2m
]
δ
(
ci,c j
)
, where i, j ∈C′
m =
1
2∑i, j
L˜symi, j
ki =∑
j
L˜symi, j
δ
(
ci,c j
)
=
{
1, if ci = c j
0, if ci ̸= c j
and ci is the community to which cell i belongs. The algorithm as implemented in igraph
was used [Csardi and Nepusz, 2006]. If instead of using the symmetric L˜sym the normalised
Markovian matrix L˜ was used, ki would be defined as 1 and 2m would be equivalent to the
number of cells, this may allow for further optimisation as it will not need to be recalculated
at each iteration.
Data visualisation
Data visualisation is a key step and allows exploration of the data and can allow the user to
discriminate relationships between cells and clusters. Graph based visualisations provide a
natural way of visualising the manifold L˜. The OpenOrd algorithm provides a means where
all nodes repel each other and edges allow for nodes to be attracted to each other and is based
on the Fruchterman-Reingold algorithm [Fruchterman and Reingold, 1991; Martin et al.,
2011].
A 2-dimensional representation where each cell c1, . . . ,cn is represented by a 2-tuple vector(
x11,x
2
1
)
, . . . ,
(
x1n,x
2
n
)
where the superscript denotes the tuple index and the subscript repre-
sents the vector/cell index. The complete vector may then be denoted g and the position of
each cell indexed using gi. The optimum cell position in the reduced dimensionality space,
g∗ is then identified by solving the following:
g∗ = argmin
g
∑
i
(
∑
j
(
L˜symi, j d
(
gi,g j
)2)
+Dxi
)
d
(
gi,g j
)
=
∥∥gi−g j∥∥2
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where Dxi is the density of points around xi [Martin et al., 2011]. OpenOrd uses a greedy
algorithm with a simulated annealing schedule. Additionally Martin et al. [2011] employ:
• Edge-cutting, to remove highly stressed edges,
• Parallelisation to speed-up graph generation and
• Multi-level graph layout, adopted from Hendrickson and Leland [1995]; Walshaw
[2003] where a sequence of graphs is produced utilising a coarsening step and average-
link clustering.
The OpenOrd implementation supplied with igraph where it is called ‘DrL’ was used [Csardi
and Nepusz, 2006].
Code availability
The roots algorithm is implemented in R and freely available through CRAN (https://cran.
r-project.org/package=roots) or GitHub (https://github.com/wjawaid/roots).
5.2.3 Usage and Examples
This algorithm has been used extensively to generate the plots produced in chapter 4, where
Louvain clustering was used for the clustering shown on the tSNE in fig. 4.10 and several
plots were generated with the roots in figs. 4.13, 4.16 to 4.18 and 4.20. Comparing DrL to
tSNE when subclustering the definitive endoderm, fig. 4.13 shows clusters are much better
defined and segregated in the DrL compared to tSNE. Though the clusters can be somewhat
appreciated in tSNE, the result on DrL is much more apparent and aesthetically pleasing.
The definitive endoderm above is not the only example. The same is also true for the neural
and mesodermal progenitors in fig. 4.16. Again the different clusters can be appreciated on
the tSNE but are much more condensed and relationships more apparent on the neighbouring
DrL. These spacial co-localisations allow correlation with known biological relationships
supporting cell type assignment and suggesting ontogenic origins. Furthermore Louvain
clustering on these population subsets after re-calculating variable genes appears to reveal
deeper substructure.
Re-analysing the cardiac assigned cells using the new ‘roots’ algorithm, in section 4.5
revealed a different aspect of the data separating atrial and ventricular components. This
was not apparent previously on the tSNE but by focusing in on this specific subset of cells a
different aspect of the data could be appreciated resolving atrial and ventricular fated cell
types.
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To look beyond the current datasets, the roots algorithm was also applied to the adult murine
haematopoietic system and compared to diffusion maps and a more recent and related
visualisation technique called SPRING [Weinreb et al., 2018]. Bone marrow harvesting, cell
sorting by FACS and library preparation were performed by Sonia Nestorowa and Dr Nicola
Wilson; sequencing data was processed by Evangelia Diamanti and downstream analysis
including generation of the SPRING map which was not part of the original publication was
performed by Fiona Hamey.
Harvested bone marrow cells were sorted on lineage negative Lin- and C-KIT+ and index
sorted for FLK2, CD34, SCA1 and CD16/32 to allow retrospective population assignment
[Nestorowa et al., 2016]. 3 main populations were sorted, the long-term HSCs (LT-HSC),
haematopoietic stem and progenitor cells (HSPCs) and haematopoietic progenitors (Prog) as
shown in fig. 5.2.
Data visualisation in Nestorowa et al. [2016] was predominantly performed using a diffusion
map representation as shown in fig. 5.3. This displays the major subtypes with LT-HSCs
positioned towards the upper apex, MPP and LMPP cells towards the rightward apex,
granulocytes at the lower apex and erythroid cells and megakaryocytes positioned along the
tail to the left fig. 5.3.
The SPRING layout was calculated by Fiona Hamey and is displayed in the lower left panel
in fig. 5.3. This representation more clearly separates specific cell types into finger like
projections from a central cloud, displaying better separation of the terminal cell types.
In comparison the roots representation calculated using the new algorithm provides an
alternative more tree like representation ridding the layout of a disorganised central cloud.
Furthermore the roots layout separates out the megakaryocyte and erythroid cells from the
remainder. This large separation or gap between the cell types may be indicative of the
sorting strategy omitting intervening cells between the progenitor SCA1- and HSPC SCA1+
gates. The groups here were identified on the roots layout and were further characterised
and assigned identity by Dr Joakim Dahlin. Not only does the roots representation appear to
better segregate disparate cell types more effectively in addition it appears to better preserve
ontogenic relationships with megakaryocytes not appearing to originate from some central
cloud but there appears to be a common megakaryocyte erythroid precursor from which both
arise, lower right panel of fig. 5.3.
An additional cluster of cells appears to condense just below the monocyte cluster with high
and very specific expression of Aif1 and Spp1 indicating a monocyte/macrophage or possibly
even a dendritic cell type fig. 5.3 [Elizondo et al., 2017].
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Fig. 5.2 Sorting strategy for adult haematopoiesis data, from Figure 1 in Nestorowa et al.
[2016]. Post selecting cells and removing multiplets, the upper left panel displays cells were
sorted selecting for Lin- cells. These cells were subsequently sorted using 2 gates to select
C-KIT+ cells that were either SCA1+ or SCA1-. Notably the SCA1 gates were separated so
that intermediate cells remained unsampled. The Lin-SCA1-C-KIT+ progenitor cells were
further indexed by CD16/32 and CD34 markers and Lin-SCA1+C-KIT+ were further indexed
by CD34 and FLK2. To increase sampling of the rare LT-HSC population more cells were
sorted from this gate, see Nestorowa et al. [2016] for further details. A, LT-HSCs; B, MPP;
C, LMPP; D, MEP; E, CMP; F, GMP
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Fig. 5.3 Upper panels are a diffusion map representation of the data recalculated from data
downloaded from the website of Nestorowa et al. [2016] (compare with figure 2 in Nestorowa
et al. [2016]). The same populations are marked with the same colour as in the legend at
the top in the remainder of the plots. The upper left figure is coloured according to the cell
sorting strategy used, see fig. 5.2. The diffusion map to the right is coloured according to
more specific cell characterisation performed retrospectively by Dr Joakim Dahlin as shown
in legend panel above figures. Lower left is the SPRING representation of the same data
calculated with parameter optimisation by Fiona Hamey. The lower right panel displays the
roots visualisation showing a hierarchy that is more consistent with our current understanding
of haematopoietic differentiation. Pop 1 to Pop 3 are lymphoid populations retrospectively
identified by Dr Joakim Dahlin.
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5.3 Projecting on tSNE
5.3.1 Background
Maaten and Hinton [2008] developed tSNE as a machine learning tool for dimensionality
reduction with wide application but it has been widely adopted and become the de facto go to
dimensionality reduction technique in single cell RNAseq [Becht et al., 2018; Briggs et al.,
2017; Cao et al., 2017; Grün et al., 2015; Grün and van Oudenaarden, 2015; Habib et al.,
2016; Ibarra-Soria et al., 2018; Jaitin et al., 2016; Lai et al., 2017; Scialdone et al., 2016;
Taskesen and Reinders, 2016]. Given its popularity, several computational tools provide
integrated use of tSNE including Seurat, Scanpy, Scater and a proprietary tool from 10x
Genomics® called Cellranger [Butler et al., 2018; McCarthy et al., 2017; Wolf et al., 2018].
A particular disadvantage of tSNE as compared with PCA or diffusion maps is that there is
no way of positioning new data points on a pre-constructed map. This ability if it existed
would be very useful when trying to interpret new data given that a user may already have
previous related data and may be familiar with a previous representation. Re-performing
tSNE on the combined dataset depending on the number of new data points can drastically
change the original layout.
To address this the tSNE algorithm has been adapted so that new points may be projected
onto a pre-calculated embedding.
5.3.2 Algorithm
To explain the adaptation to the algorithm the tSNE algorithm as first described by Maaten
and Hinton [2008] will be initially summarised.
Stochastic Neighbour Embedding (SNE)
Given a dataset of n cells C and m genomic features G, a matrix of log-transformed normalised
gene expression values is given by X ∈ Rn×m. The expression vector xi ∈ Rm represents
the gene expression vector for cell i so that X T = {x1,x2, . . . ,xn}. Similar to diffusion
maps (see section 3.10.1) and the calculation of the first order Markov matrix in roots (see
section 5.2.2), the conditional probability p j|i, the probability that cell xi chooses cell x j as its
neighbour is calculated by applying Gaussian probability density centered at xi with variance
σ2i . The conditional probability is then given by:
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p j|i =
exp
(
−
∥∥∥x2i − x2j∥∥∥2/2σ2i )
∑k ̸=i exp
(
−∥∥x2i − x2k∥∥2/2σ2i )
A low-dimensional embedding Y ∈ Rn×d where in the remainder of this work d = 2 is then
sought so that the conditional probabilities q j|i approximate p j|i. In a similar fashion as for
X , each cell i is represented by the d-dimensional vector yi ∈ Rd . In the SNE algorithm
originally proposed by Hinton and Roweis [2002] q∗j|i in the low dimensionality space is
calculated in the same manner as p j|i
q∗j|i =
exp
(
−
∥∥∥y2i − y2j∥∥∥2)
∑k ̸=i exp
(
−∥∥y2i − y2k∥∥2)
The cost function Co is then defined the Kullback-Leibner divergence between the two
conditional probability distributions and the gradient ∂C∂yi :
Co =∑
i
KL(Pi||Qi) =∑
i
∑
j
p j|i log
p j|i
q j|i
and
∂Co
∂yi
= 2∑
j
(
p j|i−q j|i+ pi| j−qi| j
)(
yi− y j
)
Selection of σi is clearly critical in adjusting probabilities p j|i inducing a distribution Pi
over all cells from cell i. Maaten and Hinton [2008] recognise that the variance must be
set individually for each data point. This is achieved by a user selected perplexity Perp(Pi)
based on Shannon’s entropy H, where:
Perp(Pi) = 2H(Pi), and
H(Pi) =−∑
j
p j|i log2 p j|i
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A σi is then found that produces the user selected constant perplexity which can be inter-
preted as a smooth measure of the effective number of neighbours [Maaten and Hinton,
2008]. Adjusting perplexity can therefore affect the final visualisation with smaller per-
plexities breaking apart clusters into smaller units and higher perplexities leading to a more
homogeneous crowded map.
t-Distributed Stochastic Neighbour Embedding (tSNE)
In tSNE, Maaten and Hinton [2008] make 2 changes to the algorithm: first they use a
symmetrised probability distribution in both high and low-dimensional spaces and second
they address the crowding problem by using Student’s t-distribution with one degree of
freedom, taking advantage of it’s thick tails in the low-dimensional space.
pi j =
p j|i+ pi| j
2
,
qi j =
1+
(∥∥yi− y j∥∥2)−1
∑k ̸=l 1+
(
∥yk− yl∥2
)−1 ,
Co = KL(P||Q) =∑
i
∑
j
pi j log
pi j
qi j
and the gradient is now given by:
∂Co
∂yi
= 4∑
j
(
pi j−qi j
)(
yi− y j
)(
1+
∥∥yi− y j∥∥2)−1
Maaten and Hinton [2008] then use gradient descent with momentum to optimise the cost
function. They have shown by using the thicker tailed t-distribution in the low dimensional
space rather than a Gaussian allows for a more separated cluster structure.
Modification allowing projection on previously calculated embedding
Now a simple tweak can help project n∗ new data points in a matrix X ∗ ∈ Rn∗×m and
X ∗T = {x1,x2, . . . ,xn∗} onto a pre-existing embedding Y ∈ Rn×d originally derived from a
reference datasetX ∈ Rn×m. Now for all cells c ∈C in the reference dataset forming the
original embedding:
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∂Co
∂yc∈C
≜ 0
Positions for the new set of cells, C∗, must now be calculated. For all cells indexed i ∈C∗
and j ∈ C∪C∗ the gradient is calculated in the usual method as described above. This
ensures that at each update only the newly added data points are allowed to move on the
low-dimensionality embedding and optimised
∂Co
∂yi
= 4∑
j
(
pi j−qi j
)(
yi− y j
)(
1+
∥∥yi− y j∥∥2)−1 , ∀i ∈C∗, j ∈C∪C∗
This allows the newly added cells to somewhat influence the landscape when other cells are
projected as the Kullback-Leibner divergence is calculated against j ∈C∪C∗. If instead the
Kullback-Leibner divergence was calculated solely against j ∈C then the new cells will have
no influence and the algorithm will be more consistent with a projection as available for PCA
and diffusion maps.
Implementation
The modified algorithm was implemented by adapting the most up-to-date Rtsne Git reposi-
tory from GitHub (https://github.com/jkrijthe/Rtsne) [Krijthe, 2015]. The implementation
by [Krijthe, 2015] uses the Barnes-Hut algorithm for optimisation [Maaten, 2014]. The
Barnes-Hut algorithm is not used when projecting. The modified algorithm is available
through GitHub at https://github.com/wjawaid/Rtsne.
5.3.3 Examples
The algorithm was initially tested for convenience using the ‘iris’ dataset within R, introduced
by Ronald Fisher in 1936 containing 3 plant species and four features measured for each
sample, an excerpt is given in table 5.1 [Fisher, 1936].
tSNE dimensionality reduction was performed on the iris dataset and is shown in fig. 5.4.
This shows clear separation of setosa species from versicolor and virginica. But the 3 species
are also clearly separated from each other. Means were calculated for all features in each
species and these were used as new data points and projected onto the pre-existing embedding.
The new data points outlined in black are also presented on fig. 5.4. It is immediately evident
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Table 5.1 An excerpt from the iris data showing the features collected in the different species
[Fisher, 1936].
Sepal Length Sepal Width Petal Length Petal Width Species
5.1 3.5 1.4 0.2 setosa
4.9 3.0 1.4 0.2 setosa
4.7 3.2 1.3 0.2 setosa
4.6 3.1 1.5 0.2 setosa
5.0 3.6 1.4 0.2 setosa
7.0 3.2 4.7 1.4 versicolor
6.4 3.2 4.5 1.5 versicolor
6.9 3.1 4.9 1.5 versicolor
5.5 2.3 4.0 1.3 versicolor
6.5 2.8 4.6 1.5 versicolor
6.3 3.3 6.0 2.5 virginica
5.8 2.7 5.1 1.9 virginica
7.1 3.0 5.9 2.1 virginica
6.3 2.9 5.6 1.8 virginica
6.5 3.0 5.8 2.2 virginica
that the original data points are in exactly the same position as before. Additionally it is easy
to appreciate that the newly calculated means project centrally within their corresponding
species on the tSNE, giving confidence that the algorithm works well at least for this small
data set.
Table 5.2 Average (mean) features for the 3 species used as data points to project onto the
preexisting dataset on fig. 5.4.
Species Sepal Length Sepal Width Petal Length Petal Width
setosa 5.01 3.43 1.46 0.25
versicolor 5.94 2.77 4.26 1.33
virginica 6.60 2.98 5.56 2.03
The algorithm was applied to a single cell dataset discussed in an earlier chapter. In fig. 3.61
Brachyury cells from an intermediate time point mapped between the E6.5 cluster and the
E7.25 nascent mesoderm cluster. This allowed identification of node or organiser-like cells
within the Brachyury dataset. Additionally the projection does not appear to be affected by
cell cycle nor embryo batch figs. 3.61 and 3.63b.
Having projected onto a pre-existing embedding, another utility for this technique may be to
use prior knowledge to inform an embedding. One way to test this using the Iris data is to posi-
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Fig. 5.4 tSNE representation of iris data with 3 species in different colours as indicated
by the legend. The averages as shown in table 5.2 are then projected on to the pre-existing
embedding and have been highlighted with a black outline. The average data points appear
to be well centred over the corresponding species, suggesting the algorithm is performing
well on this relatively small dataset.
tion the 3 average values as a user may like to position them. For example in this case all three
average data points may be placed on the x-axis at co-ordinates (−15,0),(0,0) and (15,0)
for setosa, versicolor and virginica respectively. Then given this layout, to position the
individual data points on to this preconditioned landscape using the projection adaptation to
the tSNE, fig. 5.5. This shows that this preconditioning of the landscape can help arrange the
new data in a way that may be more meaningful to the user.
In fig. 5.5, it is an average of iris sepal features for each species that was used to precondition
the tSNE landscape but for single cell RNAseq this could be for example bulk data with
known spacial localisation. Building on this, data from Peng et al. [2016] was downloaded
from the GEO repository.
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Fig. 5.5 Generating a prior information based pre-existing embedding can help drive the
tSNE dimensionality reduction in an informed manner. This allows prior information to be
incorporated into the tSNE.
Peng et al. [2016] aimed to identify spacially resolved transcriptomes for mouse embryos at
mid-gastrulaiton. They harvested 3 mouse embryos at E7.0 and embedded each in Optimal
Cutting Temperature (OCT) in a known orientation. They then sectioned the embryos
precisely using a cryostat microtome into 22 sections with alternate sections being used for
either imaging or RNAseq analysis. Laser capture micro-dissection was used to capture ≈20
cells from 4 quadrants in 10 of the more proximal sections and from 2 segments in the most
distal section, fig. 5.6. During the data collection they managed to get samples from 41 of the
potential 42 segments for the reference embryo, Embryo 1 in their dataset. These segments
were subsequently processed using a low input RNAseq protocol. The missing segment from
the anterior in slice 3 was inferred by using the mean between the anterior segments of slices
2 and 4. They present their data using corn plots where each dot represents a segment and
colour represents expression level of a selected gene fig. 5.6.
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Fig. 5.6 Experimental protocol used by Peng et al. [2016]. Mid-gastrulation (E7.0) mouse
embryos were harvested, embedded in OCT and sectioned as displayed in the figure. Alternate
sections were used for sampling and RNAseq analysis. Laser capture micro-dissection was
used to harvest cells from four quadrants from each slice except the most distal: anterior, A;
posterior, P; right, R and left, L. For the most distal slice (S1) only anterior and posterior
segments were captured. Each segment consisted of ≈20 cells. Figure reproduced from Peng
et al. [2016].
Additionally Peng et al. [2016] harvested 70 individual cells from either the posterior or
anterior aspect of the embryo. This now provides a potential test data set for the modified
Rtsne algorithm to try and computationally post-hoc reconstruct spatial localisation of the
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single cells. Peng et al. [2016] present gene expression data in a corn plots as shown in the
lower right panel in fig. 5.6.
In the first instance, the new single cell data points were projected onto the corn plot
representation of bulk data, fig. 5.7. This was performed by pre-conditioning the tSNE
landscape with the spacially resolved transcriptomic data and then using the new tSNE
projection algorithm from section 5.3.2 to map the single cells onto the pre-conditioned
landscape. The red and black points have a preponderance towards either the posterior or
anterior part of the embryo, respectively. Though there exists this preponderance the spatial
reconstruction seems poor with many cells located between the left and right segments. This
is unsurprising as the corn plot representation of the data was to allow visualisation of 3D
data on a 2D page and so produces non-metric distances for which this tSNE algorithm
cannot account.
There is an alternative modification of tSNE that attempts to manage non-metric distances by
producing multiple maps with different weightings for data points but this is unnecessarily
complicated and counter-intuitive for the current purpose [Cook et al., 2007; van der Maaten
and Hinton, 2012]. A more intuitive approach is to simply expand the low-dimensionality
space to 3 dimensions so that the right to left, anterior to posterior and proximal to distal
axis are all orthogonal to one another fig. 5.8. Now the red and black points are more clearly
separated and the Euclidean distance used in the tSNE algorithm for measuring relative
distances between the single cells, in the low dimensionality space better representative of
the spatial data.
Peng et al. [2016] also perform a spatial reconstruction but to do so they first go through
several steps to define a set of ‘zip-code’ genes. This gene set is used to calculate rank
correlation coefficients and a smoothing process using rank correlations of adjoining regions.
In the tSNE projection proposed here only those genes that are unexpressed have been filtered
and the remaining genes used to calculate the projection in an unbiased way. The tSNE
projection may therefore be further improved by selecting only informative genes.
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Fig. 5.7 Corn plot with single cell data from Peng et al. [2016] projected on tSNE. The
large grey dots represent the regions of the embryo with spatially resolved oligocellular
transcriptomic data that were used to pre-condition the tSNE landscape. Red dots represent
cells harvested from the posterior and black points from the anterior of mid-gastrulation
mouse embryos. This corn plot has non-metric distances in the 2D representation of the 3D
data with right and left locations sandwiched between anterior and posterior. This makes
it impossible to accurately position a cell based on mutual distances. Above the plot labels
represent A, anterior; P, posterior; R, right and L, left.
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Fig. 5.8 3D positioning of single cell data using the novel tSNE algorithm on a landscape
preconditioned using bulk oligocellular data. The 3D representation gives rise to distances in
the low dimensional space that are congruent with the known spacial localisation of the bulk
data in a single mapping. Red dots are gene expression profiles from cells harvested from
the posterior and blue points profiles of cells from the anterior of mid-gastrulation mouse
embryos The grey points represent the reference bulk data.
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5.4 Simulating developmental processes
A chief motivation for reconstructing ontogenic trajectories is so that gene expression changes
can be determined to allow gene interactions to be inferred. This may then allow identification
of key driver genes that play central roles in directing cell fate. These observations may then
be incorporated into differentiation protocols to achieve more faithful production of cells for
potential cellular therapies.
To achieve this a reliable developmental path must be inferred for subsequent analysis before
trying to simulate along such a pathway. A previously generated data set of early in-vivo
haematopoiesis with a bifurcation event towards blood and endothelium has been exploited.
Moignard et al. [2015] used qPCR to characterise single-cells sorted on RUNX1 and FLK1
in mouse embryos at four time points between E7 and E8.25, fig. 5.9. The data is similar
to that introduced in section 3.2 except here only 42 manually selected gene features were
assessed.
Fig. 5.9 Experimental protocol for Moignard et al. [2015] data set. Single cells were sorted
from four time points between E7 and E8.25 from mouse embryos for FLK1 which was used
to capture the early mulitpotent cells and RUNX1 to capture later blood fated cells which
down-regulate FLK1. A bifurcation between endothelial and blood fated cells should be
captured using this protocol.
The gene features were manually selecting for genes that are known or postulated to be
involved in yolk sac haematopoiesis and endothelial development. This data was collected
and processed by Dr Victoria Moignard, see Moignard et al. [2015] for further details.
Moignard et al. [2015] visualise the qPCR data using diffusion components 1, 2 and 4, see
fig. 5.10a. This shows computational reconstruction of a developmental trajectory from early
FLK1 primitive streak cells towards endothelial and blood fates.
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Fig. 5.10 Diffusion maps reconstructed from Moignard et al. [2015]. Colours are consistent
with those in the experimental protocol overview fig. 5.9. (a) An overview diffusion map
very similar to that published in the original paper fig. 5.9. (b) Minimum spanning tree on
the diffusion map. (c) Shortest paths from the root at the lower left towards endothelial and
blood end points - Common path in blue, blood trajectory in red and endothelial trajectory in
purple.
5.4.1 Finding fate trajectories and dynamics of gene expression
The diffusion map here produces a representation which shows a bifurcating process repre-
sentative of fate diversification. A minimum spanning tree (MST) on the diffusion map may
therefore reproduce this bifurcation process and provide a good representation of the onto-
genic processes. A MST was generated and diameter paths from the root to both endothelial
and blood fates calculated fig. 5.10b. This allowed a common stem and the two blood and
endothelial segments to be defined. The MST was cut to generate two trajectories for each of
the blood and endothelial fate, fig. 5.10.
A principal curve was fitted independently to the two trajectories as was previously described
in section 3.10. The arc length from the root cell of the cell projection on to the principal
curve was taken to be a surrogate measure of developmental time i.e. pseudotime. Rescaling
was performed to ensure that both processes had the same pseudotime at bifurcation and
at the end. Gaussian process regression models were fitted to these rescaled pseudotimes
to compare gene dynamics between the blood and endothelial fates, fig. 5.11. The genes
for qPCR were selected manually to be informative of this bifurcating process and the gene
dynamic profile comparisons between blood and endothelial clearly show differences in most
genes for example Cdh5, Egfl7, Ets1, Gfi1b and HbbbH1.
A limitation with synthesising gene regulatory networks from static data is that although
relationships between genes may be identified for example using correlation it can be difficult
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or impossible to infer cause and effect i.e. the direction of edges between genes. Now given
the dynamics that have been reconstructed using pseudotime it may be possible to direct
edges between genes since any causal event must be temporally earlier than the induced
effect.
Cbfa2t3h Cdh1 Cdh5 Egfl7 Erg Ets1 Ets2
Etv2 Etv6 Fli1 FoxH1 FoxO4 Gata1 Gfi1
Gfi1b HbbbH1 Hhex HoxB2 HoxB4 HoxD8 Ikaros
Itga2b Kdr Kit Ldb1 Lmo2 Lyl1 Mecom
Meis1 Mitf Myb Nfe2 Notch1 Pecam1 Procr
Runx1 Sfpi1 Sox17 Sox7 Tal1 Tbx20 Tbx3
Fig. 5.11 Gene dynamics along trajectories identified in fig. 5.10c. Cells were mapped onto a
principal curve fitted to these trajectories and the corresponding arc length used as a surrogate
for pseudotime. The arc lengths along the two different trajectories were appropriately scaled
so that bifurcation and termination were assigned the same pseudotime. Gene expression
values were then smoothed using gaussian process regression and the inferred expression
profile along pseudotime is plotted as a line with the shaded region representing 95 %
confidence intervals. Red - haematopoietic fated path and blue - endothelial fated path.
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5.4.2 Autoregressive model
Decoding gene interaction networks can provide deeper insights into molecular mechanisms
and potentially allow researchers to target specific pathways to direct differentiation towards
desired fates and redirect away from undesired cell types. One way to achieve this is to
explicitly model associations between genes and if temporal dynamics are available this may
even allow for causative relationships to be identified.
The smoothed gene expression profiles along pseudotime can be used to regress gene
expression at a particular time point against gene expression at an arbitrarily earlier time.
Given that gene expression of a cell at time t ∈ Z in the interval [0,τ], is given by G(t) ∈ Rm
and for the expression of gene indexed i,Gi(t) then the expected value given by Gˆi(t) can be
regressed on the expression of all genes at an earlier point in pseudotime by finding all the
parameters αi ∈ Rm which are essentially regression coefficients.
Gˆi(t) = αi,1G1(t−δ )+αi,2G2(t−δ )+αi,3G3(t−δ )+ . . .+αi,mGm(t−δ )
=
m
∑
j=1
αi, jG j(t−δ )
αi = argmin
αi
τ
∑
t=δ
|Gˆi(t)−Gi(t)|
This is pictorially represented in table 5.3. Cells, represented by columns, are ordered in
pseudotime. Here ‘Gene 1’ for cell 2, which represents pseudotime 2, is considered to have
gene expression that is some linear combination of all gene expression values at pseudotime
0 or cell 0 - all coloured in red. The same is true for ‘Gene 1’ for cell 3. This same approach
can be used for all genes across all the dataset to infer all the α parameter values given in the
equation above.
A naïve implementation of this approach will generate some non-zero value for all α . In such
a case a hard threshold can be used so that all sufficiently small values are set to zero. An
alternative is to set a constraint known as the least absolute shrinkage and selection operator
(lasso), whereby the α values are constrained such that
m
∑
i=1
|αi| ≤ s
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Table 5.3 Table illustrating the essence of the autoregressive model. The model is trained so
that ‘Gene 1’ in all cells is regressed against the value of the other genes at a fixed earlier
pseudotime. The examples shown is how ‘Gene 1’ in cell 2 depends on all other genes at cell
0 and ‘Gene 1’ in cell 3 depends on all genes at cell 1.
Cell 0 Cell 1 Cell 2 Cell 3 . . . Cell τ
Gene 1 0.311 0.432 0.359 0.251 . . . 0.297
Gene 2 0.746 0.952 1.219 1.116 . . . 0.853
Gene 3 1.827 0.027 0.948 0 .912 . . . 0.846
Gene 4 1.978 2.814 1.668 1.866 . . . 1.377
...
...
...
...
... . . .
...
Gene m 0.537 0.577 1.015 0.756 0.911 1.640
where s is a user set constraint. The lasso though can be unstable for edge selection and a
more consistent bootstrapped lasso using subsets of the data was adopted from the ‘mht’
package implemented in R.
This same approach can be extended so that expression Gˆi(t) depends on several discrete
time points δ1, . . . ,δζ . This results in may more parameters that need to be estimated, so this
approach was not used.
Gˆi(t) =(α t−δ1i,1 G1(t−δ1)+α t−δ2i,1 G1(t−δ2)+ . . .+α
t−δζ
i,1 G1(t−δζ ))+
(α t−δ1i,2 G2(t−δ1)+α t−δ2i,2 G2(t−δ2)+ . . .+α
t−δζ
i,2 G2(t−δζ ))+
. . .+
(α t−δ1i,m Gm(t−δ1)+α t−δ2i,m Gm(t−δ2)+ . . .α
t−δζ
i,m Gm(t−δζ ))
=
m
∑
j=1
ζ
∑
k=1
α t−δki, j G j(t−δk)
Transcriptomic assays like qPCR assess the level of gene expression and there is an assump-
tion that this mirrors protein content but there will be some definite lag between production
of the mRNA moiety to the production of the mature active transcription factor, enzyme or
structural protein. It therefore seems reasonable to build in some temporal lag as it reflects
contemporary understanding of biology. Further higher concentrations of transcription fac-
tors may be related to the level of activation of a particular genomic locus and so it may be
more accurate to model the rate of change of the downstream gene’s counts rather than the
counts themselves.
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∆Gˆi(t) = αi,1G1(t−δ )+αi,2G2(t−δ )+αi,3G3(t−δ )+ . . .+αi,mGm(t−δ )
=
m
∑
j=1
αi, jG j(t−δ )
This was fitted separately for the smoothed gene profiles along both the blood and endothelial
fates. Genes i and j were defined as interacting where αi, j ̸= 0, activating when αi, j > 0 and
repressing when αi, j < 0. The networks so inferred are shown in figs. 5.12 and 5.13. Genes
are arranged in a circle and edges are directed. Blue edges indicate a positive interaction and
red edges a negative interaction. Given the gene expression dynamics in fig. 5.11, the two
networks appear consistent for example the HbbbH1 gene is included in the blood network
while it is completely disconnected in the endothelial network. Unfortunately these are linear
and very simplistic networks and since each network is inferred separately a bifurcating
process cannot be predicted by these networks. The utility of such models becomes limited
as they cannot directly provide any information on how gene perturbations may influence fate
bias, they can neither model complex non-linear relationships nor can they model bifurcating
processes.
The linear model shown here is simple and extremely limited unless higher order terms and
additional time points are included but increasing to higher order terms will additionally
increase the number of parameters that must be estimated. A problem for all models though
is that there exist genes with very similar profiles for example Gfi1b and HbbbH1 and this
collinearity can cause difficulties with inference.
5.4.3 Deep neural network
The concept of gene network inference can be abstracted to a model which takes a gene
expression vector and outputs a gene expression vector for a cell a single step further along
its fated journey as shown in fig. 5.14. The function takes in the gene vector of a cell at an
arbitrary time point t and outputs the gene expression of a cell one step further along t+1.
The previously described liner regression model may be considered graphically as shown
in fig. 5.15. There is essentially a single layer of linear functions between the input gene
vector and the output gene vector.
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Cbfa2t3h
Cdh1
Cdh5
Egfl7
Erg
Ets1
Ets2
Etv2
Etv6
Fli1FoxH1FoxO4
Gata1
Gfi1
Gfi1b
HbbbH1
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HoxB4
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Itga2b
Kdr
Kit
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Tbx3
Fig. 5.12 Autoregressive model inferred on the blood gene expression dynamics, see fig. 5.11
and compare with fig. 5.13. Blue edges represent positive activating interactions and red
edges represent negative inhibitory interactions.
Given this abstraction and following this line of thought a more complex non-linear function
may be conceived, consisting of multiple latent or hidden variables, fig. 5.16. This models
is consistent with a deep learning paradigm, rapidly gaining popularity and with novel
applications in the fields of artificial intelligence and more generally in machine learning.
Methods to train this type of model are widely available and one such method is back
propagation.
Despite the ability of this model to generate highly complex non-linear functions it remains
completely deterministic and given a single input will always produce exactly the same
output. A bifurcating system cannot therefore be faithfully modelled.
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Fig. 5.13 Autoregressive model inferred on the endothelial gene expression dynamics,
see fig. 5.11 and compare with fig. 5.12. Blue edges represent positive activating interactions
and red edges represent negative inhibitory interactions.
To enable modelling of a bifurcating system, the output of the neural network can be
considered to be the parameters of some random variable and a realisation of this random
variable then be the output gene expression vector, as graphically demonstrated in fig. 5.17.
Concretely using the gene expression example, the neural network will output the means
µ ∈ Rm and the gene output would be a realisation generated by sampling the random
variable, y:
y∼ N(µ, Σ), µ ∈ Rm,Σ ∈ Rm×m.
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Input
Gene
Vector
Network
function
Output
Gene
Vector
Fig. 5.14 Abstraction of a network inference function that can predict the next cell along
in a developmental trajectory. Such a function would enable the user to make predictions
of gene expression changes due to perturbations. The output can then be returned into the
network function so that a complete trajectory can be realised.
t+1 . . . Gene 1 . . .
t+0 Bias Gene 1 Gene 2
α0 α1 α2
Fig. 5.15 Graphical representation of a linear regression model where gene expression at a
time t+1 is determined using a linear model from gene expression of a known cell at time
t+0. This can be used iteratively to determine a whole gene trajectory, see figs. 5.12 to 5.14.
This representation can be extended to a more complex model, see fig. 5.16.
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t+1 . . . Gene 1 . . . Gene n
Bias m Hidden m,1 ...
Hidden
m,n
... ... ...
...
Bias 1 Hidden 1,1 ... Hidden 1,n
t Bias 0 Gene 1 . . . Gene n
Fig. 5.16 A more flexible model than linear regression as shown in fig. 5.15. Now several
hidden layers are present allowing for non-linear complex functions, a generalisation more
fitting of the network abstraction depicted in fig. 5.14. Though not annotated for clarity, each
interaction represented by an edge is parameterised in the same way as in fig. 5.15. A key
feature is that the network is trained so that given an input gene vector at time t, in blue, it
produces the expected gene vector at a time t+1, in orange. Further the new output can now
be returned to the input phase of the network. Such an architecture represents a recurrent
neural network.
A training dataset was generated from the qPCR gene expression data. A transition matrix
L with entries Li, j, was calculated from the normalised qPCR data X ∈ Rm×n of m genes G
and n cells C, in a manner similar to the diffusion map calculation as previously described in
section 3.10.1. To remain consistent with Moignard et al. [2015] the Gaussian kernel width
was set σ = 12 and only top 20 % of the nearest neighbours were retained.
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Input
Gene
Vector
Network
function
Params Random
Variable
Output
Gene
Vector
Fig. 5.17 Building on the neural network model. The deterministic output from the neural
network outputs a mean vector µ ∈ Rm which is used as the parameter for a random variable
y∼ N(µ, Σ). The realisation of the random variable y would be used as the input vector at
the next iteration. This built in stochasticity now may allow bifurcating trajectories.
d ji =
∥∥xi− x j∥∥2
and βi is a permutation of di
βi =
{
β 1i ,β
2
i , . . . ,β
n
i
}
such that,
β k+1i ≥ β ki , ∀k
and 20 % nearest neighbours were retained by setting,
αi = β
∥n/5∥
i
Now Li, j can be defined,
Li, j =
0, if i = j or
∥∥xi− x j∥∥2 > αi
exp
(
−∥xi−x j∥
2
2σ2
)
, otherwise
xi,x j ∈ Rm are columns of the matrix X representing qPCR measured gene expression of
cells indexed i and j, respectively. The transition matrix establishes a connectivity and allows
a random walk between cells to be implemented but overall generates no flux of cells from an
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early to late developmental time point. For faithful and biologically meaningful trajectories
only pseudotime consistent and branch honouring transitions are allowed. Specifically there
were 2 further constraints, first a pseudotime constraint so that any transitions that would
lead to a transition that went backwards in pseudotime were disallowed. Second a branching
constraint so that branch swapping was only allowed between contiguous branches. if either
constraint was unmet the transition was disallowed. This is summarise below by Fˆi, j.
The pseudotime was calculated using principal curve and branch assignment based on the
MST as described in section 5.4.1. Each cell was assigned to either set Br, the root branch in
blue; set Bb, the blood branch in red or set Be, the endothelial branch in purple, see fig. 5.10c.
Additionally each cell c indexed by i was assigned a rescaled principal curve pseudotime
pcti. A directed transition matrix, F representing a flux through the biological system was
therefore calculated honouring the branch structure and pseudotime.
Fˆi, j =

0, if c j ∈ Bb|ci ∈ Be
0, if c j ∈ Be|ci ∈ Bb
0, if c j ∈ Br|ci ∈ Bb
0, if c j ∈ Br|ci ∈ Be
0, if pct j < pcti
Li, j, otherwise
To avoid having cells with no outward transitions
F ′i, j =
{
1, if i = j, ∑k Fˆi,k = 0
Fˆi, j, otherwise
and
Fi, j =
F ′i, j
∑i F ′i, j
The training data is generating by randomly selecting 10,000 starting cells from a uniform
distribution between {1,2,3, . . . ,n} with replacement. 10,000 terminating cells are then
selected for each starting cell using a multinomial distribution parameterised by the row
vector F{i,·}.
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The qPCR gene expression data matrix, X was then mean centered and scaled by the standard
deviation. Finally the mean centered standard deviation scaled data was normalised to be in
the range [0,1].
µi =
∑ j Xi, j
m
σi =
∑ j
(
Xi, j−µi
)2
m−1
X ′i, j =
Xi, j−µi
σi
Xˆi, j =
X ′i, j−min j
(
X ′i, j
)
max j
(
X ′i, j
)
−min j
(
X ′i, j
)
This pre-processing has prepared the training data honouring the calculated pseudotime and
the branching structure. The artificial neural network architecture was selected with input and
output layers of 42 nodes with 3 intervening hidden layers of 100 artificial neurons fig. 5.18.
All nodes in all layers used the sigmoid activation function. For any single input-output
training set pair, activation of the n-th neuron in layer l is given by aln. The edge weight
between node a(l−1)m and node aln is given by ω
(l−1)
m,n . The number of neurons in layer l−1 is
r.
zln =
r
∑
i=1
ω(l−1)i,n a
(l−1)
i
aln =
1
1+ exp
(−zln)
The artificial neural net may be considered to output a probability since the domain of the
sigmoid function is [0,1], more specifically it outputs the probability that yi = 1. Though
in the specific case here the output is not a class but continuous gene expression the same
method has been adopted. Training the artificial neural network involves adjusting all the
weights to minimise the final error.
Training is performed using back propagation whereby the output of the final layer is
compared to the expected output from the training dataset and then this used to adjust the
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Layer 0 Layer 1 Layer 2 Layer 3 Layer 4
Gene 1
Gene 2
...
Gene 41
Gene 42
Hidden 1
Hidden 2
Hidden 3
...
Hidden 98
Hidden 99
Hidden
100
Hidden 1
Hidden 2
Hidden 3
...
Hidden 98
Hidden 99
Hidden
100
Hidden 1
Hidden 2
Hidden 3
...
Hidden 98
Hidden 99
Hidden
100
Gene 1
Gene 2
...
Gene 41
Gene 42
Fig. 5.18 Architecture of the artificial neural net used to model gene expression along
pseudotime. There were 42 input and output genes and 3 hidden layers with 100 neurons
each. Bias neurons have not been shown.
weights on the interaction between the penultimate and the final layer. The error is then back
propagated through all the layers iteratively, adjusting all relevant weights to improve the
predictive ability of the network.
In classification problems, given an individual training data point with xi ∈ Rm input gene
expression profile of gene set G, yi ∈ Rm output gene expression profile and the output of a
single layer of the artificial neural net hω(xi) ∈ Rm, the probability of the expression of gene
expression L(ω) for a single data point is calculated:
p(yi|xi,ω) =∏
j∈G
hω(x
j
i )
y ji (1−hω(x ji ))(1−y
j
i )
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since
p(yi = 1 |xi,ω) =∏
j∈G
hω(x
j
i )
y ji and
p(yi = 0 |xi,ω) =∏
j∈G
(1−hω(x ji ))(1−y
j
i )
so the probability across all data points N:
p(y |x,ω) =∏
i∈N
∏
j∈G
(hω(x)
j
i )
y ji (1−hω(x) ji )(1−y
j
i )
and the log-probability
L(ω) = ∑
i∈N
∑
j∈G
(y ji ) log
(
hw(x)
j
i
)
+(1− y ji ) log
(
1−hw(x) ji
)
The cost function J(ω) is given by the average of the negative log probability:
J(ω) =− 1|N|L(ω)
The negative log probability is now used as the cost function J(ω) and the parameters ω are
found that minimise this cost function using a conjugate gradient descent algorithm. Back
propagation can now be used to calculate the errors starting at the output level and then
propagate the error to lower layers iteratively terminating at the input level.
Taking the simple case of two layers of neurons with sigmoid activation functions, the m
neurons in the first layer indexed by i and the n neurons in the second output layer indexed
by j, see fig. 5.19, partial differentials for the predicted output hω(x) j can be calculated.
The sigmoid function can be considered a compound function, broken into its constituents
and the chain rule applied as follows,
z = ωx, z ∈ Rn,ω ∈ Rn×m,x ∈ Rm
r = 1+ exp(−z)
hω(x) =
1
r
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hω(x) j = 11+exp(−z j)
Gene 1 Gene 2 z j = ω·, jx Genen− 1 Gene n
Hidden 1 Hidden 2 xi
Hidden
m− 1 Hidden m
ω1, j ω2, j ωi, j ωm−1, j ωm, j
Fig. 5.19 Two layers of a neural net to help demonstrate both forward and back propagation.
The activation of the hidden layer are given by xi and the weights on the edges into a single
output node indexed j are labelled ω·, j. The activation of the j-th node in the upper output
layer is labelled hω(x) j
.
so,
∂ z j
∂ωi j
= xi
∂ r j
∂ z j
=−exp(z j)= 1− r j
∂
∂ r j
hω(x) j =− 1r2j
therefore,
∂
∂ωi j
hω(x) j =
∂ hω(x) j
∂ r j
∂ r j
∂ z j
∂ z j
∂ωi j
= xi
r j−1
r2j
= xihω(x) j(1−hω(x) j)
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and
∂
∂ z j
hω(x) j = hω(x) j(1−hω(x) j)
Having established the partial differential of the j-th output with respect to the weights
∂
∂ωi, j hω(x), the partial differentials of the cost function J(w) with respect to the weights may
be calculated,
∂
∂hω(x) j
J(ω) =− 1|N|
(
y j
hω(x) j
+
y j−1
1−hω(x) j
)
=
1
|N|
(
hω(x) j− y j(
hω(x) j
)(
1−hω(x) j
))
additionally
∂
∂ z j
J(ω) =
∂hω(x) j
∂ z j
∂J(ω)
∂hω(x) j
=
1
|N|(hω(x) j− y j)
and finally,
∂
∂ωi, j
J(ω) =
∂ z j
∂ωi, j
∂J(ω)
∂ z j
=
1
|N|xi(hω(x) j− y j)
This now allows the final stratum weights to be adjusted to reduce error for a single training
case but for back propagation to work the error or gradient must be propagated down to the
activity of the neurons in the immediately adjacent layer, for demonstrative purposes a single
neuron in that layer xi is considered. Since the activity of this lower level has effects on
multiple output level neurons as demonstrated by the blue interactions in fig. 5.19, all these
partial derivatives must be summed together,
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∂
∂xi
J(ω) =∑
j
∂ z j
∂xi
∂J(ω)
∂ z j
=
1
|N|∑j
ωi, j(hω(x) j− y j)
Having calculated the partial differentials of the cost function with respect to the activation
of the lower level neurons the algorithm can be applied iteratively to update all weights of
the network, layer by layer.
The neural network model has m×n different weight parameters and to counter against over-
fitting and allow generalisation to new data, L2 regularisation was used which is essentially
similar to weight-decay. The regularisation term was parameterised using λ . Now the cost
function becomes,
J(ω) =− 1|N|
(
∑
i∈N
∑
j∈G
(y ji ) log
(
hw(x)
j
i
)
+(1− y ji ) log
(
1−hw(x) ji
))
+
λ
2|N|
(
∑
l
∑
m
∑
n
ω2m,n
)
λ ∈ R+, l ∈ L,m ∈ kl,n ∈ (k)l+1
L represents all layers of the neural net, and kl all neurons on layer l. Now the gradient of the
cost function with respect to the weight ωi, j is given by
∂
∂ωi, j
J(ω) =
1
|N|xi(hω(x) j− y j)+
λ
|N|ωi, j
All components of the neural network have been described, data normalisation, scaling and
centering, production of input and output gene expression vectors as the training dataset, the
architecture of the network including activation functions, the cost function with regularisa-
tion and the back propagation algorithm. With all these in place a neural network training
was implemented in Octave using the conjugate gradient descent function fmincg which was
written by Carl Rasmussen [Eaton et al., 2015; Rasmussen, 2002].
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Having trained the network it was used to make de-novo predictions, taking as input a given
gene expression vector and outputting the gene expression vector of the next cell along
the pseudotime. The initial input of a starting cell selected from within a region of the
developmentally earlier cells was given to the network and the output used as parameters of a
Gaussian for each gene. This realisation was then used as the new input to the neural network
as summarised in fig. 5.17. The output was plotted on a diffusion map with early points
coloured blue and the final points in red, see fig. 5.20. De-novo gene expression vectors
were visualised by projecting onto the pre-constructed diffusion map. The network was able
to generate gene expression profiles that projected meaningfully on the diffusion map and
strikingly reproduce the bifurcating process on which it was trained. It was able to generate
both blood as displayed in fig. 5.20a and endothelium, fig. 5.20b.
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(b)
Fig. 5.20 Gene expression profiles generated by the neural network reconstructs the bi-
furcating developmental trajectories from early mesodermal progenitors to blood (a) and
endothelium (b)
.
Gene perturbations can be simulated in the network by simply resetting a the expression of a
gene to an off or on level. For example Tal1 may be knocked out by setting the gene to off
and 50 trajectories simulated, the resulting final gene expression profiles can be plotted on the
diffusion map, fig. 5.21. The neural network predicts that knocking out Tal1 or Gfi1b blocks
embryonic blood production while knocking out Cdh5/VE-Cadherin blocks an endothelial
cell fate in keeping with known biology [Anderson et al., 2015; Moore et al., 2018; Robb
et al., 1995].
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Gfi1b KO
Fig. 5.21 Each figure demonstrates end points of 50 simulations with the perturbations in
the title. Top left shows wild-type with balanced blood and endothelial fate. Top right shows
that the neural network predicts that Tal1 knock-out results in a failure of embryonic blood
production [Robb et al., 1995]. In a similar way bottom right shows Gfi1b knock-out blocks
embryonic blood development [Moore et al., 2018] and bottom left shows neural net predic-
tion after Cdh5 knock-out blocks endothelial production but still generates blood [Anderson
et al., 2015]. The bars above demonstrate relative ratios of blood (red), endothelium (purple)
or intermediate cell types (white).
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5.5 Conclusions
This chapter, in contrast to previous chapters, has focused on computational and mathematical
methods rather than generating biological data. Initially a novel visualisation tool roots was
described. The development of this method was influenced by existing methods which used
the concept of probabilistic transitions from one data point to another such as tSNE and
diffusion maps.
A key concept focused on in roots though is the idea of ‘plausible transitions’. As described
earlier this requires adequate sampling otherwise implausible short cuts are allowed between
two or more points on the high dimensional gene expression manifold. After assuming
adequate sampling this is achieved three fold. First by adjusting the Gaussian kernel as has
been described by Haghverdi et al. [2015].
Second by setting an empirical threshold on the number of other cells a single cell is equally
likely to transition to. So taking an overly simplistic example in a dataset of 5000 cells
where one expects at least 5 equally sized disparate cell types one may consider that an
individual cell is unlikely to be equally connected to more than 1000 cells so that any
transition probability under 11000 may be considered to be unrealistic. Though this is a
hard threshold it is relatively easy and intuitive for a user with some knowledge of their
experimental system to estimate.
Third despite having made the matrix sparse there will remain spurious edges connecting
cells from distant regions of the graph. To handle these spurious edges, edges are considered
authentic only if there exists a common neighbour, see section 5.2.2 for further details.
This makes the transition matrix further sparse and the sparsity gives an additional benefit
particularly useful in huge datasets as it reduces computational memory requirements and
permits the use of pre-existing implementations of functions designed to take advantage of
sparse matrices.
The sparse transition matrix was symmetrised and used as input for Louvain clustering
providing fast clustering and giving very reasonable clusters even identifying the small
primordial germ cell cluster in the 10X Genomics dataset, section 4.3. This population was
not identified by the clustering method used in the original publication [Ibarra-Soria et al.,
2018].
An alternative dataset generated from adult haematopoiesis was introduced and the roots
visualisation compared to current state of the art methods including tSNE, diffusion maps and
SPRING. The roots visualisation generates a plot that most closely fits our current knowledge
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of adult haematopoietic stem cell differentiation demonstrating the known relationship
between erythrocytes and megakaryocytes. Additionally the purposefully built-in sparsity
and removal of spurious edge algorithms allow roots to clearly demonstrate the gap between
the megakaryocyte-erythroid lineage and the remainder, consistent with the gap in the sorting
strategy.
Having described a novel visualisation technique the tSNE algorithm was then extended.
tSNE is widely deployed for single cell analysis and forms an integral part of several software
suites because of its performance and ability to separate different cell populations. It is a
probabilistic algorithm, based on calculating transition matrices in both gene expression space
and low-dimensionality space and minimising the difference between the two probability
distributions as assessed by the Kullback-Leibner divergence, see section 5.3. One limitation
of the tSNE algorithm as it stood was that there was no way of projecting onto a pre-existing
map though an alternative method of training a neural network to minimise the Kullback-
Leibner divergence and using this complex non-linear function to project new data points has
been proposed as a parametric version of tSNE [Maaten, 2009]. But this requires regenerating
the original tSNE using the new algorithm, altering the visual layout and necessitating a
re-interpretation.
As an alternative, in this chapter the current widely used tSNE algorithm was modified so that
pre-existing data points were fixed and had no influence on the newly defined cost function
still based on the Kullback-Leibner divergence. This allows new data points to arrange around
the previous points so fitting into the pre-existing embedding. This idea was further advanced
by considering that the user may have some preconceived idea about the gross structure of
their experimental data from previous work and so may want to influence the landscape. An
example is given with spacially resolved bulk sequencing data and then projecting single
cells on this pre-conditioned landscape. This modified tSNE algorithm therefore opens up
many more opportunities when wanting to visualise new data sets. The new tSNE algorithm
was used to interpret gene expression profiles of cells from the TnEGFP-CreERT2/+ mouse line
section 3.14.6.
A method that attempts to explicitly model gene interactions, the auto-regressive model, was
used as the basis for the development of a more flexible and powerful simulation model. The
auto-regressive model in a similar vein to other recent efforts attempts to model biological
molecular mechanisms by breaking the problem into pair-wise gene interactions and using
data to infer these explicitly. The neural network model in contrast is predicting gene
expression patterns along developmental trajectories and only implicitly modelling complex
gene interactions within the hidden layers.
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Gene interactions are not directly modelled in the neural network like in a autoregressive
model, rather the network is trained on gene expression patterns over a developmental
progression. Though superficially this may seem to be a disadvantage, it does allow one
to model complex gene dynamics without getting into the specific detail of how individual
genes are interacting and in no way detracts from the ability to investigate gene interaction
within the network. The complex functions a neural network is able to learn can allow it to
potentially model a different interaction between two genes depending on context i.e. the
cell’s gene expression state. Remarkably the network when combined with random Gaussian
noise was able to reproduce a bifurcating trajectory and given the limitation of the numbers of
genes and cell states present in the system was able to model genetic perturbations in-silico.
This network was implemented without any of the currently available tools available for deep
learning and was trained simply on a CPU rather than a GPU. Neural networks thrive on
large datasets and with increasing cell numbers and genomic features networks modelled in
this way may reveal previously unrecognised insights.
In conclusion this chapter summarises the mathematical and computational concepts that
have been formulated and implemented over the course of this PhD.
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Chapter 6
Discussion
This chapter is laid out according to the 4 aims set out in the introduction. Techniques
developed and used often help to address multiple aims, so pertinent features of the same
technique may be commented upon in the different subsections. Their development, use and
limitations are discussed along with potential opportunities for further development in future
work.
6.1 Identifying cell populations
A key promise of single cell transcriptomic sequencing, even for what are apriori believed to
be homogenous populations, is the potential to discover and define hitherto unrecognised cell
types. Some transcriptional heterogeneity identified may simply be related to the cell cycle
or other process unrelated to cellular identity but this in itself can be interesting, particularly
if cells of the same type in different stages of cell cycle favour alternative cell fates.
Key to identifying populations is selection of useful genomic features. In this body of work
feature selection has depended on choosing genes based on methods that have relied heavily
on the statistical concept of variability, in particular variability beyond a certain threshold for
a particular level of gene expression [Brennecke et al., 2013; Svensson et al., 2017]. Though
useful this denovo strategy fails to harness any previously acquired knowledge. As a second
step genes known to be important in a process, could have been hand picked and manually
added but an automated method here would be appealing. New strategies for gene selection
continue to be identified and there remains much room for improvement at this fundamental
step. It may be argued that selecting genes at an early step biases downstream analyses
and though this may be a potential hindrance, not selecting and using the whole dataset
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often leads to poor visualisations during dimensionality reduction and makes interpretation
difficult, as true biologically important signals are swamped in noise.
Use of spike-ins to differentiate technical variability from potentially interesting biological
variability introduces its own challenges, for example ensuring that sequencer reads are
not overly allocated to spike-ins rather than cellular reads. Variations in spike-ins from
experiment to experiment can render them unusable [Svensson et al., 2017]. Additionally
spike-in capture efficiency may not mirror that of endogenous mRNAs due to sequence
differences, shorter poly-A tails and lack of mRNA binding proteins [Svensson et al., 2017].
Having selected genes of interest, cell types have been identified using a variety of clustering
algorithms that have been described in detail. Clustering though depends on calculating
either similarities or dissimilarities. A variety of methods can be used but using absolute
values such as normalised counts can cause problems with data from different experiments,
in most part due to normalisation difficulties. Throughout this work similarities have been
calculated using methods that use ranks, for example rather than using Pearson correlation
the Spearman rank correlation has been widely used. Though this overcomes difficulties
of normalisation it is problematic for the many lowly expressed genes due to the effect of
dropout. Depending on the effective depth of sequencing of two cells, the number of dropouts
may vary effecting the similarity score, whether calculated on the absolute values or rank.
Similarities though can be calculated readily and used to generate graphs with edge weights
corresponding to similarities. These graphs are heavily connected as similarities based
on correlation methods will generate non-zero values for almost all pairwise comparisons.
Methods are described here to make the adjacency matrices on which the graphs are based
sparse and then further to remove spurious edges. Using the same datasets this has revealed
novel populations not identified by standard methods for example the germ cell population in
fig. 4.10 and table 4.4. Additionally it allowed the NAMP population to be subdivided into
the NMP and streak-like population that were not previously evident, fig. 4.17.
Pre-processing involves converting reads to counts which is performed by aligning reads
to an annotated genome. The 10x Genomics® Chromium™ data by virtue of the anchored
3′ oligo-DT barcoded primers offers an opportunity to identify and enumerate transcription
termination variants (TTV), as defined in section 4.6. These variants are clearly visible in the
combined reads data as shown in fig. 4.22 and demonstrated by the read pile-ups of about 400
bp width. Further work is required to assess whether these TTVs can provide any additional
information when segregating cell types. The combined data can be used to annotate new
potential features on the genome. Counts can then be generated according to the integrated
curated gene data and the new features to evaluate their utility. These TTV features may
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potentially allow for increased precision when defining clusters and sub-clusters one of the
primary premises of single cell techniques.
To generate single cell sequences, a single cell suspension must be generated from the
biological specimen of interest and neighbouring cells become spacially randomised in an
Eppendorf® tube. The loss of spatial context remains problematic and though methods are
reported for spatial transcriptomics there is a balance to strike between cell resolution and
mRNA capture efficiency. Here a method is introduced that can potentially reconstruct spatial
context by using less than single cell resolved transcriptional profiles as prior information
to pre-condition a tSNE landscape. In this way it may be possible to apply hybrid methods
combining techniques with good spatial resolution and good capture efficiency but limited
cellular resolution and single cell experiments with no spatial context to generate a spatially
resolved single cell map. The ability to position additional points on tSNE also allows data
to be added to a tSNE that has been previously extensively interpreted and annotated. Such
methods to our knowledge are novel and have not been previously described in the literature
in relation to single cell applications.
6.2 Tracing biologically plausible trajectories
The potential to use data on similarity between cells or cell populations, from snapshots at
different developmental time points to trace ontogenic relationships in a pseudo-time is very
appealing. Cells though are not simply defined by their transcriptional state, chromatin state
including structure, DNA modifications, histone modifications, proteomic state, pathway
activation and neighbouring cell signalling are just an example of additional signals driving
cell state and fate decisions. A key assumption in this work is that at some point all will
converge and influence transcriptional profile to achieve a change in cell state and that our
assays have the fidelity to capture this.
In this vein several algorithms and software implementations attempting to reconstruct
developmental journeys have been published. Some methods even date before single cell
resolved transcriptional assays and relate to microarray data [Magwene et al., 2003]. The
concept though is not new, morphological changes from static sections of embryos in
placentals combined with a variety of marking strategies have historically led to many of our
current insights into developmental biology.
Trapnell et al. [2014] described one of the earliest pseudotime construction methods designed
specifically for single cell transcriptomic data, called Monocle. Following feature selection
Monocle performs dimensionality reduction using independent component analysis (ICA)
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and a minimum spanning tree (MST) is fitted. The longest path through the MST is taken
as the main journey and a starting cell can then be defined. The same first author has
since presented a new trajectory inference algorithm named Monocle 2 [Qiu et al., 2017b].
This uses reverse graph embedding (RGE) to reconstruct trajectories in an unsupervised
way. Feature selection remains critical and is performed by first using PCA dimensionality
reduction followed by tSNE upon which clustering is performed based on density peaks.
Differential expression between the clusters is used to identify key genes to be included for
downstream analysis highlighting the utility of an iterative approach. The high dimensional
gene expression data from the selected genes is used for dimensionality reduction which
can be PCA, diffusion maps or an alternative. RGE is performed by automatically selecting
centroids, generating a spanning tree and repositioning cells iteratively until the tree and
cells converge. Qiu et al. [2017b] compare their technique to other state of the art single
cell trajectory methods and perform favourably across multiple datasets including simulated,
real wild-type neural and haematopoietic and perturbation data. Monocle 3 is the latest
incarnation and is an optimised implementation of Monocle 2 with the workflow shown in
fig. 6.1.
Fig. 6.1 The Monocle 3 workflow. From http://cole-trapnell-lab.github.io/monocle-release/
monocle3/
Not long after Monocle was introduced, Bendall et al. [2014] described Wanderlust, a
method designed for use with CyTOF mass spectrometry data that models non-bifurcating
trajectories. Though Wanderlust pseudotime reconstruction can be adapted to transcriptomic
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data its inability to model multiple fates severely limits its utility [Ji and Ji, 2016]. Wanderlust
generates an ensemble of graphs and uses waypoints to generate robust journeys [Bendall
et al., 2014]. Using the Wanderlust pseudotime algorithm Bendall et al. [2014] were able to
computationally reconstruct known hallmarks of human B lymphocyte development.
DeLorean a more recent algorithm uses a Gaussian process latent variable model with an
apriori structure on the latent space selected to represent a pseudotime along developmental
progression [Reid and Wernisch, 2016]. In this way repeated cross-sectional data can be
re-ordered along a developmental time-course. DeLorean explicitly models gene expression
changes along developmental progression as compared to other methods which infer cell
orderings. A limitation of this method is the computational time which is prohibitive for
large datasets.
Haghverdi et al. [2016] and Angerer et al. [2016] introduce Destiny an implementation using
diffusion pseudotime to order cells. This builds on a single-cell dimensionality reduction
and visualisation technique they introduced earlier [Haghverdi et al., 2015]. The underlying
methods have been described in detail earlier in sections 3.10.1 and 3.10.2. Diffusion
pseudotime is based on random walks on a graph, the same graph which forms the basis of
diffusion maps visualisations.
An alternative to diffusion pseudotime that has been used in sections 3.10.2 and 3.10.3
is to use diffusion maps or alternative dimensionality reduction visualisation technique
that captures a time-course process and use principal curves. For early embryonic blood
development both diffusion pseudotime and principal curve fitting were consistent with one
another fig. 3.33.
Though naïve unsupervised methods may seem attractive at first glance, alone they have
limited usefulness. The individual components of trajectory and pseudotime estimation
may be unsupervised but the data has been collected and experiment designed in a highly
supervised manner infact experiment design requires prior information and at the outset
requires heavy user supervision to design experiments to collect the data. Even reported
unsupervised methods focus on specific parts of the developmental process and are validated
based on prior information or further experiments that require biological knowledge and
expertise. Therefore in many respects naïve unsupervised methods have limitations on their
utility and can only be interpreted within a supervised setting.
The package roots potentially allows faithful computational reconstruction of relationships
between different cell populations as demonstrated in a heamatopoietic dataset. This identifies
a common megakaryocyte-erythroid precursor and supports a branching structure consistent
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with the current state of knowledge on haematopoiesis, fig. 5.3. This relationship was not
clearly identified in other state of the art pseudotime methods utilised to analyse the same
haematopoietic datasets. roots currently does not explicitly assign either a pseudotime or
branch to cells but this can be achieved using principal curves after manually selecting
branches.
One potential unexploited utility of ordering cells in time and inferring smoothed gene
expression profiles along journeys is to identify a robust relationship between gene expression
and drop-out, that can be used as a prior when inferring real expression from count data.
Such relationships can be visualised in fig. 3.34. This may allow for improved models for
inferring gene expression helping to reduce the difficulties described around drop-outs.
More recent methods have attempted to include isoform level data and shown that this
improves accuracy when identifying developmentally regulated genes [Qiu et al., 2017a].
Another advance has been the use of unspliced transcripts to infer an RNA velocity that can
help direct cells in trajectories [Manno et al., 2018]. Single-cell transcriptomics in this way
can identify not only the topology and trajectories but also in a data-driven manner, it can
infer the direction along trajectories that cells are likely to be travelling, potentially allowing
quantification of flux.
6.3 Identifying novel molecular pathways
In addition to identifying novel sub-populations of cells, single cell transcriptomics potentially
allows the identification of relationships between these populations. From the Smart-seq2
data of early gastrulation, unsupervised clustering revealed a coarse pattern of cell identities.
Prior biological knowledge allowed for the recognition of a subpopulation of cells within
the endothelial cluster that may indicate the emergence of the definitive wave of embryonic
blood. To achieve this, pioneer genes known to be involved in this wave of haematopoiesis
were identified and a set of genes highly correlated with these pioneer genes, within the
endothelial population, were used to cluster the cells.
The combination of single-cell data with a knowledge driven approach, allowed the identifi-
cation of evidence of activation of the leukotriene branch of the arachidonic acid pathway,
fig. 3.40. Three genes in particular stood out including Ltc4s, Alox5 and Alox5ap (FLAP) all
involved in the leukotriene biosynthesis branch of the arachidonic acid metabolic pathway,
table 3.9. Based on the in-silico identification of the leukotriene pathway, we postulated that
it played a role in early haematopoiesis and this was subsequently validated in an in-vitro
differentiation assay, using the leukotriene inhibitor Zileuton and LTC4. Interestingly hydrox-
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yurea, widely used in a clinical haematology setting and known to induce fetal haemoglobin
is chemically related to Zileuton. This may uncover a new mechanism by which hydroxyurea
and related compounds function.
Previous work involving large screens in zebrafish had suggested the involvement of the
epoxyeicosatrienoic acid and prostaglandin branches of the arachidonic acid metabolic
pathway in blood development but this is the first time the leukotriene branch has been
implicated [Li et al., 2015; North et al., 2007].
The data set therefore provides a rich source of information for post-hoc in-silico experimen-
tation. Identifying subgroups of cells using either unsupervised or supervised methods and
then performing deeper analysis can identify novel pathways. This can help filter hypotheses
and subsequently allow design of more resource intensive wet lab validation experiments.
6.4 Computationally simulating developmental processes
Having traced biologically plausible journeys, a more fundamental understanding of the
molecular processes that regulate cell state transitions along these trajectories could reveal
potential methods to direct in-vitro stem cell differentiation assays. Comparing inferred
regulatory processes between normal and mutant models with known phenotypes may reveal
deeper appreciation of how molecular pathways interact under normal and pathological
conditions. The purpose of temporal alignment now becomes evident. Not only can associa-
tive relationships be inferred but causation can be established, based on the highly intuitive
assumption that later events in time cannot cause earlier events but vice versa, the earlier
event may either directly or indirectly cause a future event.
A commonly deployed method is the use of differential equations or for the case of discrete
state transitions, difference equations. Though conceptually easy to grasp, vast numbers of
features and large numbers of interactions at differing orders can create a complexity that
can be difficult to solve, even with the huge numbers of cells that can be processed with the
latest single cell technologies.
Reducing gene activity to a binary state of being either on or off allows classical Boolean
logic rules to be inferred. These rules simply output whether the gene is on or off and cannot
classically model different levels of gene activation [Lim et al., 2016; Müssel et al., 2010;
Woodhouse et al., 2018]. This may not fit well with the contemporary paradigm in molecular
biology of gene activity controlled through promoters and multiple enhancers.
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Correlation and partial correlation related methods also present intuitive alternative methods
of generating networks. This method is introduced in the work and combined with a
bootstrapped lasso to generate robust and sparse connectivity. Though frequently used
and easy to interpret it is difficult to see how this simple model may faithfully reconstruct
development gene profiles. But despite this it forms the basis of thinking about a more
sophisticated model and this is described in detail in sections 5.4.2 and 5.5.
Correlation based methods of generating networks may be examined using an alternative
viewpoint, as a layer of inputs fully connected to a layer of outputs with linear activation
functions. These linear activation functions in a single layer are limited in the number
and types of interactions that they can potentially simulate. Deeper neural networks with
non-linear activation functions can simulate much more complex interactions and therefore
potentially more faithfully reconstruct biological trajectories.
Neural networks provide a conceptually alternative approach, primarily modelling behaviour
along trajectories rather than gene interactions themselves. In models based on differential
equations, difference equations, Boolean rules and correlation networks the gene to gene
interactions are explicitly parameterised and these parameters have an intuitive interpretation.
In contrast the neural network used in this work attempts to faithfully reconstruct branching
gene expression profiles along a given developmental process. Combining such a neural net
with a stochastic output can enable faithful reconstruction of a branching developmental pro-
cess, additionally allowing in-silico perturbations. In theory these in-silico experiments can
include multi-gene perturbations timed at specific developmental stages along the trajectory
and simulated in seconds, in contrast similar molecular perturbations would be impractical
experimentally. Though these networks do not formally model interactions, in-silico experi-
ments on the trained neural network can provide insights into the complex functions through
simulation.
The neural network used was a feed-forward neural network with input generated from the
previous stages output and built from the ground up. Though not a true recurrent network
it bears considerable resemblance. Platforms now exist for much quicker implementations
that harness the power of modern GPUs to allow highly parallelised training. Several
frameworks such as Caffe, Google’s Tensorflow and Theano exist that can allow higher
level implementation of neural networks [Abadi et al., 2015; Al-Rfou et al., 2016; Jia et al.,
2014]. These can be used to easily and quickly implement sophisticated recurrent networks
which may include for example long short-term memory (LSTM) modules. LSTM modules
allow the network to remember a previous state and allow historic events to influence later
decisions [Hochreiter and Schmidhuber, 1997]. New ideas and implementations including
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attentional interfaces and neural Turing machines are more sophisticated neural network
architectures for recurrent networks that may perform even better than conventional LSTM
recurrent networks [Graves et al., 2014; Xu et al., 2015]. These frameworks combined with
the latest GPUs can likely allow training on a full RNAseq dataset rather than the qPCR data
that was used here.
Ideally the work here would have been able to use these networks to identify novel molecular
pathways. Contemporary pseudotime inference algorithms, the data generating experiments
and the algorithms described herein are not sufficiently advanced to be able to predict and
identify molecular pathways with sufficient fidelity. Despite these limitations single cell data
combined with prior knowledge may reveal novel pathways as described in section 6.3.
6.5 Concluding remarks
This work has focused on using single cell resolved transcriptomic data to shed light on
normal developmental time-courses, describe the expression profiles and try to identify the
molecular signals that govern fate bifurcations. In summary the key advances reported in this
work have been
1. Identifying and validating a novel pathway, the leukotriene branch of arachidonic acid
metabolism, in early definitive wave embryonic blood development.
2. Revealing TTVs as a potential source of additional information for identifying cell
types, aiding clustering and potentially helping with pseudotime reconstruction.
3. Developing a graph based method, roots for reconstructing ordered ontogenic tra-
jectories from single cell transcriptomic data that was able to identify a common
Megakaryocyte-erythroid progenitor that was not evident using current state of the art
methods.
4. Adding functionality to the tSNE algorithm that allows new appropriately normalised
data to be added to a previously constructed embedding. This has been taken further
by showing that coarse bulk transcriptomic data may be used to reconstruct the sac-
rificed spatial context from single cell experiments. Analyses of cells from complex
organisms all processed together can cause cells that are spatially distinct but with
related functionality to be positioned very close or even amongst one another. Having
prior knowledge and the appropriate data of spatial relations can incentivise this novel
algorithm to position cells within a spacial context.
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5. Introducing a novel method of modelling dynamic systems by using pseudotime
ordered transcriptomic data to train a neural network so that it can inherently learn the
gene interactions allowing simulation of perturbation experiments.
Though this work has focused primarily on transcriptional assays some cell surface pro-
teomic data was collected. Single cell multi-omics is a rapidly advancing field and novel
technologies may soon be able to systematically collect a wide range of omics data including
transcriptomics, genomic, epigenomic and proteomic data from the same cell. This may
provide important further clues when inferring trajectories and developing in-silico models.
As described with the finding of TTVs, even analysing the currently available transcriptomic
data in more detail may provide rewarding novel insights.
Single cell data collection, development of novel algorithms and computational analyses to
be believable and robust need to be reproducible. Reproducibility and replicability are not a
modern problem in science but inability to reproduce analyses is a worrying problem. To
aid with reproducibility the work here has been, where possible curated into R packages and
submitted to the comprehensive R archiving network CRAN or is available through GitHub
repositories as indicated in the text. Furthermore Docker containers are available for each
chapter to reproduce all figures in this thesis.
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